



Analysis	  of	  transcriptional	  regulation	  by	  RcsB	  homo-­‐	  






I n a u g u r a l -­‐ D i s s e r t a t i o n 	  
zur	  
Erlangung	  des	  Doktorgrades	  
der	  Mathematisch-­‐Naturwissenschaftlichen	  Fakultät	  




Hans	  Derk	  Pannen	  
aus	  Geldern	  
	  


























Prof.	  Dr.	  Karin	  Schnetz	  
Prof.	  Dr.	  Jürgen	  Dohmen	  
Tag	  der	  mündlichen	  Prüfung:	  27.	  Oktober	  2015	  
	   	  
	  Zusammenfassung	  ...................................................................................................................................	  1	  
Abstract	  ...................................................................................................................................................	  2	  
1.	   Introduction	  ..........................................................................................	  3	  
1.1.	   The	  Rcs	  phosphorelay	  and	  its	  cognate	  response	  regulator	  RcsB	  ............................................	  4	  
1.2.	   Auxiliary	  regulators	  of	  RcsB	  belong	  to	  the	  FixJ/NarL-­‐family	  ....................................................	  7	  
1.3.	   Aims	  of	  this	  thesis	  ..................................................................................................................	  11	  
	  
2.	   Results	  ................................................................................................	  12	  
2.1.	   Homo-­‐	  and	  heterodimer	  formation	  of	  RcsB	  ..........................................................................	  12	  
2.2.	   Establishment	  of	  reporter	  systems	  .......................................................................................	  14	  
2.2.1.	   RcsB-­‐RcsB	  activates	  PrprA	  in	  a	  phosphorylation	  dependent	  manner	  ...........................	  15	  
2.2.2.	   RcsA-­‐RcsB	  activates	  Pwza	  in	  a	  phosphorylation	  dependent	  manner	  ............................	  18	  
2.2.3.	   BglJ-­‐RcsB	  reporter	  system	  .............................................................................................	  21	  
2.2.4.	   MatA-­‐RcsB	  activates	  PmatCFT073	  in	  a	  phosphorylation	  independent	  manner	  ................	  21	  
2.2.5.	   Search	  for	  potential	  DctR	  targets	  ..................................................................................	  26	  
2.2.6.	   Triple	  reporter	  system	  ...................................................................................................	  29	  
2.3.	   Relevance	  of	  particular	  residues	  of	  RcsB	  for	  specific	  RcsB	  dimers	  ........................................	  31	  
2.3.1.	   Identification	  of	  relevant	  amino	  acids	  within	  RcsB	  .......................................................	  31	  
2.3.2.	   The	  relevance	  of	  particular	  residues	  of	  RcsB	  varies	  with	  its	  interaction	  partner	  ..........	  33	  
2.4.	   Expression	  and	  stability	  of	  RcsB	  mutants	  ..............................................................................	  38	  
2.5.	   Protein-­‐protein	  interaction	  of	  RcsB	  mutants	  ........................................................................	  40	  
2.6.	   Mechanism	  of	  transcriptional	  activation	  ...............................................................................	  42	  
2.6.1.	   Interaction	  studies	  of	  RcsB	  with	  RNA	  polymerase	  by	  a	  bacterial	  two-­‐hybrid	  system	  ...	  42	  
2.6.2.	   Overexpression	  of	  the	  RNA	  polymerase	  α	  subunit	  .......................................................	  45	  
	  
3.	   Discussion	  ...........................................................................................	  52	  
3.1.	   Model	  ....................................................................................................................................	  53	  
3.2.	   Homo-­‐	  and	  heterodimerization	  of	  RcsB	  regulates	  a	  variety	  of	  cellular	  functions	  .................	  55	  
3.3.	   RcsB	  regulates	  targets	  dependent	  and	  independent	  of	  phosphorylation	  .............................	  56	  
3.4.	   Residues	  within	  and	  close	  to	  active	  site	  of	  RcsB	  play	  a	  role	  for	  phosphorylation	  dependent	  
activation	  ...........................................................................................................................................	  57	  
3.5.	   The	  mechanism	  of	  transcriptional	  activation	  by	  BglJ-­‐RcsB	  depends	  on	  the	  promoter	  .........	  58	  
	  
4.	   Materials	  and	  Methods	  .......................................................................	  61	  
4.1.	   Material	  .................................................................................................................................	  61	  
4.1.1.	   Bacterial	  strains,	  plasmids	  and	  oligonucleotides	  ...........................................................	  61	  
4.1.2.	   Media,	  buffers	  and	  antibiotics	  .......................................................................................	  74	  
4.1.3.	   Enzymes,	  kits	  and	  chemicals	  ..........................................................................................	  75	  
4.2.	   Methods	  ................................................................................................................................	  76	  
4.2.1.	   Standard	  molecular	  techniques	  .....................................................................................	  76	  
4.2.2.	   CaCl2	  competent	  cells	  and	  transformation	  ....................................................................	  76	  
4.2.3.	   Electro-­‐competent	  cells	  and	  electroporation	  ................................................................	  77	  
4.2.4.	   Mutagenesis	  PCR	  ...........................................................................................................	  77	  
4.2.5.	   Random	  mutagenesis	  screen	  ........................................................................................	  78	  
4.2.6.	   Promoter	  replacement	  and	  gene	  deletion	  ....................................................................	  78	  
4.2.7.	   Preparation	  of	  lysate	  and	  transduction	  .........................................................................	  79	  
4.2.8.	   Chromosomal	  integration	  .............................................................................................	  79	  
4.2.9.	   RcsB	  structure	  prediction	  ..............................................................................................	  80	  
4.2.10.	   β-­‐galactosidase	  assay	  ....................................................................................................	  81	  
4.2.11.	   Motility	  assays	  ...............................................................................................................	  81	  
4.2.12.	   RNA	  isolation	  .................................................................................................................	  81	  
4.2.13.	   Urea	  PAGE	  .....................................................................................................................	  81	  
4.2.14.	   cDNA	  synthesis	  ..............................................................................................................	  82	  
4.2.15.	   Microarray	  analysis	  .......................................................................................................	  82	  
4.2.16.	   qPCR	  analysis	  .................................................................................................................	  82	  
4.2.17.	   SDS	  PAGE	  and	  western	  blotting	  .....................................................................................	  83	  
4.2.18.	   Strep-­‐protein	  interaction	  experiment	  (SPINE)	  ..............................................................	  85	  
	  
5.	   References	  ..........................................................................................	  87	  
Abbreviations	  ........................................................................................................................................	  95	  
Figure	  Index	  ...........................................................................................................................................	  96	  
Table	  Index	  ............................................................................................................................................	  97	  
Danksagung	  ...........................................................................................................................................	  98	  
Erklärung	  ...............................................................................................................................................	  99	  
	  





Der	   FixJ/NarL-­‐typ	   Transkriptionsfaktor	   RcsB	   ist	   der	   Response-­‐Regulator	   des	   Rcs-­‐
Phosphorelays,	   einem	   komplexen	   Signaltransduktionssystem,	   welches	   die	   Integrität	   der	  
bakteriellen	   Zellhülle	   überwacht.	   RcsB	   reguliert	   die	   Expression	   zahlreicher	   Loci	   die	   mit	  
Motilität,	  Biofilmbildung	  und	  verschiedenen	  Stressantworten	  assoziiert	  sind.	  Dabei	  wird	  die	  
Aktivität	   von	   RcsB	   durch	   zwei	   Mechanismen	   gesteuert:	   Erstens	   durch	   das	   Rcs-­‐System,	  
welches	   einen	   konservierten	   Aspartatrest	   in	   der	   Empfängerdomäne	   von	   RcsB	  
phosphoryliert.	   Zweitens	   wird	   die	   Aktivität	   von	   RcsB	   durch	   Interaktion	  mit	   verschiedenen	  
Hilfsproteinen	   gesteuert.	   Solche	   sind	   RcsA	   (Regulation	   der	   Kapselsynthese),	   BglJ	  
(pleiotropischer	   Regulator,	   aktiviert	   bgl	   und	   leuO)	   sowie	   GadE	   (Säurestress).	   Diese	  
Hilfsproteine	   gehören	   ebenfalls	   zur	   Familie	   der	   FixJ/NarL-­‐Transkriptionsfaktoren.	   Zudem	  
wurden	   zwei	  weitere	   Transkriptionsfaktoren	   der	   FixJ/NarL-­‐Familie	   identifiziert,	  welche	  mit	  
RcsB	  interagieren:	  MatA	  (kontrolliert	  Synthese	  der	  Mat-­‐Pili)	  und	  DctR	  (in	  einem	  Acid-­‐Stress-­‐
Island	  kodiert).	  
In	  dieser	  Arbeit	  wurden	  die	  Voraussetzungen	  der	  transkriptionellen	  Aktivierung	  durch	  
RcsB-­‐Homo-­‐	   und	   Heterodimere	   analysiert.	   Zu	   diesem	   Zweck	   wurden	   geeignete	  
Reportersysteme	   für	   RcsB-­‐Homodimere	   und	   RcsB-­‐Heterodimere	   mit	   RcsA	   und	   MatA	  
entwickelt	   und	   getestet.	   Die	   Ergebnisse	   zeigen,	   dass	  MatA	   RcsB	   als	   Dimerisierungpartner	  
benötigt	   um	   den	  mat-­‐Promoter	   des	   UPEC-­‐Stammes	   CFT073	   zu	   aktivieren.	   Die	   Aktivierung	  
erfolgt	   hierbei	   unabhängig	   von	   einer	   RcsB-­‐Phosphorylierung.	   Zudem	   wurde	   gezeigt,	   dass	  
MatA-­‐RcsB	  die	  Motilität	  in	  E.	  coli	  K-­‐12	  hemmt.	  Des	  Weiteren	  bestätigen	  die	  Daten,	  dass	  die	  
transkriptionelle	   Aktivierung	   durch	   RcsA-­‐RcsB	   und	   RcsB-­‐RcsB	   von	   einer	   RcsB-­‐
Phosphorylierung	  abhängt.	  In	  dieser	  Arbeit	  wurden	  außerdem	  bestimmte	  Aminosäuren	  der	  
Empfängerdomäne	   von	   RcsB	   identifiziert,	   welche	   für	   die	   Aktivierung	   durch	   spezifische	  
Dimere	   notwendig	   sind.	   Hierbei	   hat	   sich	   gezeigt,	   dass	   RcsB-­‐Homodimere	   und	   RcsA-­‐RcsB-­‐
Heterodimere	  -­‐solche,	  deren	  Aktivität	  phosphorylierungsabhängig	  ist-­‐	  die	  größte	  Ähnlichkeit	  
aufweisen.	   Alle	   relevanten	   Aminosäuren	   sind	   innerhalb	   oder	   nahe	   des	   aktiven	   Zentrums	  
lokalisiert	   und	   tragen	   vermutlich	   zur	   Strukturveränderung	   bei,	   welche	   durch	  
Phosphorylierung	   induziert	   wird.	   Weitere	   Ergebnisse	   zum	   Mechanismus	   der	  
transkriptionellen	  Aktivierung	  deuten	  daraufhin,	  dass	  einige	  Promotoren	  durch	   Interaktion	  
von	   BglJ-­‐RcsB	   und	   RNA-­‐Polymerase	   in	   einem	   Pre-­‐Recruitment-­‐Mechanismus	   aktiviert	  




The	   FixJ/NarL-­‐type	   transcription	   factor	   RcsB	   is	   the	   response	   regulator	   of	   the	   Rcs	  
phosphorelay,	   a	   complex	   signal	   transduction	   system	   that	   senses	   perturbations	   of	   the	  
bacterial	  cell	  envelope.	  RcsB	  regulates	  expression	  of	  multiple	  loci	  related	  to	  motility,	  biofilm	  
formation,	   and	   various	   stress	   responses.	   The	   activity	   of	   RcsB	   is	   controlled	   by	   two	  
mechanisms.	   First,	   the	   Rcs	   phosphorelay	   controls	   RcsB	   activity	   by	   phosphorylating	   a	  
conserved	  aspartate	  residue	  within	   its	  receiver	  domain.	  Second,	  RcsB	  activity	   is	  modulated	  
by	   interaction	   with	   auxiliary	   proteins,	   such	   as	   RcsA	   (regulation	   of	   capsule	   synthesis),	   BglJ	  
(pleiotropic	   regulator,	   activating	   bgl	   and	   leuO),	   and	   GadE	   (acid	   stress	   response).	   These	  
auxiliary	   regulators	   likewise	   belong	   to	   the	   FixJ/NarL	   transcription	   factor	   family	   and	   their	  
activity	  depends	  on	  RcsB.	  Previously,	  RcsB	  was	  demonstrated	  to	  interact	  with	  two	  additional	  
transcriptional	   regulators	  of	   the	  FixJ/NarL-­‐family,	  MatA	  (control	  of	   the	  Mat	  pili	  expression)	  
and	  DctR	  (encoded	  in	  the	  acid	  stress	  island).	  	  
In	  this	  work,	  determinants	  for	  transcriptional	  activation	  by	  RcsB	  homo-­‐	  and	  heterodimers	  
were	   analyzed.	   To	   this	   end,	   suitable	   reporter	   systems	   for	   RcsB	   homodimers	   and	   RcsB	  
heterodimers	  with	  RcsA,	  and	  MatA	  were	  established.	  The	  results	  show	  that	  MatA	  requires	  
RcsB	  as	  a	  dimerization	  partner	  for	  activating	  the	  matA	  promoter	  of	  UPEC	  strain	  CFT073	  and	  
that	  activation	  is	  independent	  of	  RcsB	  phosphorylation.	  In	  addition,	  it	  was	  shown	  that	  MatA-­‐
RcsB	   is	   able	   to	   repress	   the	   motility	   of	   E.	  coli	   K-­‐12.	   Moreover,	   the	   results	   confirmed	   that	  
transcriptional	   activation	   by	   RcsA-­‐RcsB	   and	   RcsB-­‐RcsB	   is	   phosphorylation	   dependent.	   This	  
work	   also	   identified	   particular	   residues	   of	   the	   RcsB	   receiver	   domain	   being	   relevant	   for	  
transcriptional	   activation	   by	   a	   specific	   dimer	   where	   RcsB	   homodimers	   and	   RcsA-­‐RcsB	  
heterodimers	   that	   are	   depending	   on	   RcsB	   phosphorylation	   possess	   the	   most	   similar	  
properties.	   All	   relevant	   amino	   acids	   are	   located	   close	   to	   the	   active	   site,	   suggesting	   an	  
important	   role	   for	   the	   structural	   change	   that	   is	   elicited	   by	   phosphorylation.	   Finally,	   data	  
respective	  the	  mechanism	  of	  transcriptional	  activation,	  suggest	  that	  at	  some	  promoters	  BglJ-­‐




1.   Introduction	  
Bacteria	   are	   highly	   adaptive	   organisms	   with	   a	   large	   number	   of	   genes	   and	   pathways	   that	  
allow	  exploiting	  a	  plenty	  of	  different	  environments.	  The	  central	  element	  of	  adaptation	  to	  a	  
particular	  environment	  is	  the	  ability	  to	  modulate	  the	  expression	  of	  a	  gene	  subset	  in	  response	  
to	   specific	   signals	   (Stephenson	   et	   al.,	   2000).	   This	   response	   requires	   signal	   transduction	  
systems	   for	   recognition	   and	   interpretation	   of	   signals,	   and	   the	   conversion	   of	   these	   signals	  
resulting	   in	   a	   specific	   transcriptional	   regulation.	   For	   this	   purpose	   bacteria	   possess	   two-­‐
component	   signal	   transduction	   systems	   (TCS)	   that	   sense	   environmental	   stimuli	   and	   adjust	  
the	  expression	  of	  specific	  genes	  appropriately.	  Two-­‐component	  systems	  can	  also	  be	  found	  in	  
eukaryotic	   organisms	   (Stock	   et	   al.,	   2000).	   A	   typical	   two-­‐component	   system	   consists	   of	   a	  
sensor	  histidine	  kinase	  (HK)	  with	  an	  input	  and	  phosphorylation	  domain	  as	  well	  as	  a	  response	  
regulator	   (RR)	  with	  an	  N-­‐terminal	   receiver	  domain	  and	  a	  C-­‐terminal	  output	  domain.	  Signal	  
sensing	  by	  the	  input	  domain	  of	  the	  sensor	  histidine	  kinase	  triggers	  its	  autophosphorylation	  
at	   a	   conserved	   histidine	   residue.	   From	   this	   histidine	   residue	   the	   phosphoryl	   group	   is	  
transferred	   to	   a	   conserved	   aspartate	   residue	   within	   the	   receiver	   domain	   of	   its	   cognate	  
response	   regulator,	  whose	  phosphorylation	  affects	   its	  output	   function	   (Stock	   et	  al.,	   2000).	  
Response	   regulators	   exist	   presumably	   in	   equilibrium	   between	   active	   and	   inactive	   state,	  
while	   phosphorylation	   favors	   the	   active	   conformation	   and	   shifts	   the	   balance	   (Stock	   et	   al.,	  
2000).	   Beside	   prototypical	   two-­‐component	   systems,	   a	   variety	   of	   bacteria	   possess	   more	  
complex	   two-­‐component	   systems.	   One	   more	   complex	   two-­‐component	   system	   is	   the	   Rcs	  
phosphorelay	  (Rcs	  =	  Regulator	  of	  capsule	  synthesis)	  in	  Escherichia	  coli	  and	  other	  members	  of	  
the	   Enterobacteriaceae,	  whose	   response	   regulator	   is	  RcsB.	  RcsB	   is	  a	  versatile	   transcription	  
factor	  possessing	  the	  rare	  feature	  of	  homo-­‐	  and	  heterodimerization	  with	  auxiliary	  regulators.	  
RcsB	   is	   involved	   in	  many	   regulatory	   networks	   related	   to	  motility,	   cell	   division	   and	   various	  
stress	   responses	   (Majdalani	   &	   Gottesman,	   2005).	   In	   this	   work	   the	   determinants	   of	  
transcriptional	  activation	  by	  RcsB	  are	  analyzed.	  
	   	  
4	  
	  
1.1.  The	  Rcs	  phosphorelay	  and	  its	  cognate	  response	  regulator	  RcsB	  
The	   Rcs	   phosphorelay	   (Figure	   1)	   is	   a	   complex	   two-­‐component	   signal	   transduction	   system	  
that	  was	  originally	   identified	  as	  a	   regulatory	  system	  of	  colanic	  acid	  capsule	  biosynthesis	   in	  
Escherichia	   coli	   (Gottesman	   et	  al.,	   1985).	  Nowadays	   the	  Rcs	   system	   is	   recognized	  as	  a	   key	  
regulator	  of	  motility,	  biofilm	  formation,	  and	  various	  stress	  responses	  in	  Enterobacteriaceae	  
and	  plays	  an	   important	  role	   in	  the	  control	  of	   lifestyle	  transition	  from	  a	  planktonic	  cell	   to	  a	  
sessile	   cell	   in	   a	   biofilm	   (Evans	   et	   al.,	   2013,	   Farris	   et	   al.,	   2010,	   Laubacher	   &	   Ades,	   2008,	  
Majdalani	   &	   Gottesman,	   2005).	   In	   many	   bacterial	   pathogens	   the	   Rcs	   phosphorelay	   is	  
involved	   in	   controlling	   expression	  of	   virulence	  determinants.	   In	   enterohemorrhagic	  E.	   coli,	  
for	   example,	   the	   Rcs	   system	   controls	   expression	   of	   genes	   at	   the	   locus	   of	   enterocyte	  
effacement	   (LEE)	   that	  promote	  attachment	   to	  host	   cells	   (Tobe	   et	   al.,	   2005).	   In	  Salmonella	  
enterica	  serovar	  Typhimurium	  the	  Rcs	  system	  regulates	  the	  Salmonella	  pathogenicity	  island	  
2	   (SPI-­‐2)	   encoding	   a	   type	  III	   secretion	   system	   to	   transfer	   effector	   proteins	   into	   host	   cells	  
(Wang	   et	   al.,	   2007).	   In	   addition,	   the	   Rcs	   system	   has	   been	   implicated	   in	   pathogenicity	   in	  
Yersinia	  enterocolitica,	  Erwinia	  amylovora	  and	  other	  pathogens	  (Hinchliffe	  et	  al.,	  2008,	  Wang	  
et	   al.,	   2009,	   Majdalani	   &	   Gottesman,	   2005).	   The	   Rcs	   phosphorelay	   consists	   of	   the	   inner	  
membrane-­‐bound	   histidine	   kinase	   RcsC	   and	   the	   response	   regulator	   RcsB	   (Figure	   1).	   In	  
addition	   to	   these	   two	   components,	   the	  Rcs	   system	  possesses	   the	   inner	  membrane-­‐bound	  
phosphotransfer	   protein	   RcsD,	   the	   outer-­‐membrane	   lipoprotein	   RcsF	   and	   the	   inner	  
membrane	   protein	   IgaA	   (YrfF)	   (Figure	   1)	   (Cho	   et	   al.,	   2014,	   Castanie-­‐Cornet	   et	   al.,	   2006,	  
Majdalani	   &	   Gottesman,	   2005).	   The	   core	   proteins	   RcsB,	   RcsC	   and	   RcsD	   are	   encoded	   at	   a	  
single	   locus	   of	   the	   E.	   coli	   genome.	   The	   genes	   rcsD	   and	   rcsB	   form	   an	   operon	   which	   is	  
immediately	   adjacent	   to	   rcsC	   but	   in	   a	   convergent	   orientation	   (Majdalani	   &	   Gottesman,	  
2005).	  Rcs-­‐inducing	  conditions	  are,	  predominantly,	  perturbations	  of	  the	  cell	  wall	  and	  outer	  
membrane	  by	   impaired	   lipopolysaccharide	  (LPS)	  synthesis	   through	  deletion	  of	  rfaD	   (Parker	  
et	   al.,	   1992)	   and	   galU	   (Girgis	   et	   al.,	   2007),	   outer	   membrane	   protein	   (OMP)	   misfolding	  
through	   deletion	   of	   surA	   (Castanie-­‐Cornet	   et	   al.,	   2006),	   and	   antibiotic-­‐mediated	  
peptidoglycan	  stress	  by	  β-­‐lactam	  antibiotics	  such	  as	  amdinocillin	  (Laubacher	  &	  Ades,	  2008).	  
The	  lipoprotein	  RcsF	  is	  involved	  in	  sensing	  these	  perturbations	  and	  activating	  signaling,	  while	  




Figure	  1.	  Model	  of	  activation	  and	  phosphotransfer	  of	  the	  Rcs	  phosphorelay	  
The	  lipoprotein	  RcsF	  is	  translocated	  from	  the	  inner	  membrane	  (IM)	  to	  the	  outer	  membrane	  (OM)	  by	  
LolA	  (dashed	  arrows).	  At	  the	  OM	  RcsF	  binds	  BamA	  which	  funnels	  it	  to	  OmpA	  (dashed	  arrows).	  OmpA	  
displays	  RcsF	  to	  the	  cell	  surface.	  By	  defects	  of	  the	  Lol	  system	  or	  the	  Bam	  machinery,	  RcsF	  interacts	  
with	  IgaA	  inducing	  the	  autophosphorylation	  activity	  of	  the	  histidine	  kinase	  domain	  (H)	  of	  RcsC.	  The	  
phosphotransfer	  of	  the	  active	  system	  is	  indicated	  by	  curved	  black	  arrows.	  From	  the	  histidine	  kinase	  
domain,	   the	   phosphoryl	   group	   is	   transferred	   to	   the	   receiver	   domain	   (D)	   of	   RcsC,	   to	   the	   histidine	  
phosphotransfer	  protein	  RcsD	  and	   in	   turn	   to	   the	   receiver	  domain	  of	   the	   response	   regulator	  RcsB.	  
RcsB	  can	  also	  be	  phosphorylated	  unspecifically	  by	  acetyl	  phosphate	  (AcP)	  which	  is	  removed	  by	  the	  
phosphatase	  activity	  of	   the	  uninduced	  Rcs	   system	   in	   reversible	  phosphotransfer	  direction	   (dashed	  
curved	  arrow).	  
	  
Both	   RcsF	   and	   IgaA	   are	   acting	   upstream	   of	   RcsC	   and	   RcsD	   (Figure	   1)	   (Laubacher	   &	   Ades,	  
2008,	  Evans	  et	  al.,	  2013,	  Cho	  et	  al.,	  2014).	  On	  a	  molecular	   level,	  RcsF	  monitors	   lipoprotein	  
transport	   through	   the	   periplasm	   and	   the	   β-­‐barrel	   assembly.	   The	   chaperone	   LolA	   escorts	  
lipoproteins	  including	  RcsF	  from	  the	  inner	  to	  the	  outer	  membrane	  (Figure	  1).	  Defective	  LolA-­‐
mediated	  transport	  causes	  RcsF	  accumulation	  at	  the	  inner	  membrane	  what	  activates	  the	  Rcs	  
system	   through	   IgaA	   which	   in	   turn	   induces	   lolA	   expression	   (Tao	   et	   al.,	   2012,	   Cho	   et	   al.,	  
2014).	   At	   the	   outer	  membrane,	   RcsF	  monitors	   the	   β-­‐barrel	   assembly	  machinery	   (Bam)	   by	  
interacting	  with	  BamA.	  Active	  BamA	  funnels	  RcsF	  to	  the	  outer	  membrane	  porin	  OmpA	  that	  
exposes	  RcsF	   to	   the	   cell	   surface	   (Figure	  1)	   (Cho	   et	  al.,	   2014).	  Disruption	  of	   this	  machinery	  
results	   in	   RcsF	   accumulation	   in	   the	   periplasm	  where	   RcsF	   can	   activate	   the	   Rcs	   system	   by	  
interaction	   with	   IgaA	   (Cho	   et	   al.,	   2014).	   Both	   RcsC	   and	   RcsD	   are	   anchored	   to	   the	   inner	  
membrane	  and	  exhibit	  a	  cytoplasmic	  part	  (Figure	  1).	  The	  cytoplasmic	  part	  of	  RcsC	  includes	  a	  
sensor	   kinase	   domain	  which	   is	   autophosphorylated	   at	   a	   conserved	   histidine	   residue	   upon	  
activation	   of	   the	   signaling	   cascade.	   From	   this	   histidine,	   the	   phosphate	   is	   transferred	   to	   a	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conserved	   aspartate	   residue	   within	   the	   receiver	   domain	   of	   RcsC.	   In	   the	   next	   step	   of	   the	  
phosphorelay	  cascade	   the	  phosphate	   is	   transferred	   to	  a	  conserved	  histidine	   residue	   in	   the	  
histidine-­‐phosphotransfer	  domain	  of	  RcsD,	  and	   from	  there	   to	   the	   receiver	  domain	  of	  RcsB	  
(Majdalani	   &	   Gottesman,	   2005).	   Notably,	   in	   the	   absence	   of	   a	   stimulus,	   RcsB	   can	   be	  
phosphorylated	   by	   acetyl-­‐phosphate	   as	   a	   phosphoryl	   group	   donor	   (Figure	   1)	   (Hu	   et	   al.,	  
2013).	   RcsC	   and	  RcsD	  have	   a	   phosphatase	   activity	   to	   remove	   the	  phosphate	   from	  RcsB	   in	  
reversible	   phosphotransfer	   reactions	   (Figure	   1)	   (Majdalani	   et	   al.,	   2002,	   Majdalani	   et	   al.,	  
2005).	  	  
The	  complexity	  of	  the	  output	  that	  is	  generated	  by	  the	  Rcs	  phosphorelay	  via	  the	  response	  
regulator	   RcsB	   is	   likewise	   high	   and	   involves	   additional	   protein	   components.	   RcsB	   is	   a	   216	  
amino	  acid	  protein	  with	  an	  N-­‐terminal	  receiver	  domain	  containing	  the	  phosphorylation	  site	  
(D56)	   and	   a	   C-­‐terminal	  DNA	  binding	   domain	   (Henikoff	   et	   al.,	   1990,	  Gao	   et	   al.,	   2007).	   The	  
receiver	  domain	  comprises	  residues	  5	  to	  124	  and	  the	  DNA-­‐binding	  domain	  residues	  144	  to	  
209	  with	  a	  FixJ/NarL-­‐type	  typical	  helix-­‐turn-­‐helix-­‐DNA-­‐binding	  motif	  (HTH)	  from	  residue	  151	  
to	   194	   (Majdalani	   &	   Gottesman,	   2005,	   Pristovsek	   et	   al.,	   2003).	   As	   canonical	   bacterial	  
response	   regulators,	   RcsB	   can	   regulate	   target	   genes	   as	   a	   homodimer	   (Majdalani	   &	  
Gottesman,	  2005).	  Dependent	  on	  phosphorylation,	  RcsB	  activates	   transcription	  of	  multiple	  
loci	  including	  rprA,	  encoding	  the	  small	  regulatory	  RNA	  RprA,	  the	  cell	  division	  genes	  ftsZ	  and	  
ftsA,	   bdm	   coding	   for	   a	   protein	   involved	   in	   biofilm	   formation,	   as	   well	   as	   osmB	   and	   osmC,	  
encoding	   an	   osmotically	   inducible	   lipoprotein	   and	   peroxidase	   (Majdalani	   &	   Gottesman,	  
2005,	  Francez-­‐Charlot	  et	  al.,	  2005).	  RcsB	  binding	  sites,	  that	  were	  mapped	  for	  osmC	  and	  bdm	  
locate	   just	   upstream	  of	   the	   -­‐35	   promoter	   region,	   probably	   requiring	   interaction	  with	   RNA	  
polymerase	   for	   activation	   (Sturny	   et	   al.,	   2003,	   Francez-­‐Charlot	   et	   al.,	   2005,	   Majdalani	   &	  
Gottesman,	  2005).	  	  
Strikingly,	   in	   addition	   to	   forming	   homodimers,	   RcsB	   interacts	   with	   auxiliary	  
transcriptional	  regulators	  including	  RcsA,	  GadE,	  BglJ,	  MatA,	  and	  DctR	  that	  likewise	  exhibit	  a	  
DNA-­‐binding	  domain	  of	   the	  FixJ/NarL-­‐type	  (Majdalani	  &	  Gottesman,	  2005,	  Castanie-­‐Cornet	  
et	   al.,	   2010,	   Venkatesh	   et	   al.,	   2010,	   Fabisch,	   2008).	   The	   interactions	   of	   RcsB	   with	   the	  
auxiliary	  partners	  alter	  the	  DNA-­‐binding	  specificity	  (Venkatesh	  et	  al.,	  2010,	  Castanie-­‐Cornet	  
et	  al.,	  2010,	  Wehland	  &	  Bernhard,	  2000)	  and	   thus	  extend	   the	   regulatory	   repertoire	  of	   the	  
Rcs	  system	  to	  the	  control	  of	  multiple	  loci	  related	  to	  motility	  and	  biofilm	  formation,	  various	  
stress	   responses,	   cell	   surface	   components,	   and	   additional	   functions	   (Majdalani	   &	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Gottesman,	   2005,	   Clarke,	   2010).	   Although	   heterodimerization	   of	   response	   regulators	   is	   a	  
common	   feature	   in	   Eukaryotes,	   it	   is	   very	   rare	   in	   bacteria.	   To	   date,	   the	   only	   described	  
example	  for	  heterodimerization	  of	  bacterial	  response	  regulators	  beside	  RcsB	  are	  BldM	  and	  
WhiI	   in	   the	  filamentous	  bacteria	  Streptomyces	   (Al-­‐Bassam	  et	  al.,	  2014).	  Notably,	  BldM	  and	  
WhiI	  likewise	  belong	  to	  the	  FixJ/NarL	  family	  of	  transcriptional	  regulators.	  
	  
1.2.  Auxiliary	  regulators	  of	  RcsB	  belong	  to	  the	  FixJ/NarL-­‐family	  
E.	   coli	   has	   18	  proteins	  with	   a	   FixJ/NarL-­‐type	   typical	  HTH-­‐motif,	   of	  which	  RcsA,	  GadE,	   BglJ,	  
MatA	  and	  DctR	  were	  shown	  to	  interact	  with	  RcsB	  (Fabisch,	  2008).	  Their	  targets	  and	  cellular	  
roles	  are	   summarized	   in	  Table	  1	  and	   their	   relations	   in	  Figure	  2.	  RcsA	   is	  a	  207	  amino	  acids	  
long	   protein	   whose	   intracellular	   concentration	   is	   generally	   low.	   The	   amount	   of	   the	   RcsA	  
protein	  is	  limited	  by	  its	  rapid	  degradation	  by	  Lon,	  an	  ATP-­‐dependent	  protease	  (Stout	  et	  al.,	  
1991).	  Moreover,	  the	  expression	  of	  rcsA	  is	  repressed	  by	  HNS	  (Sledjeski	  &	  Gottesman,	  1995).	  
However,	   RcsA	   was	   reported	   to	   activate	   its	   own	   expression	   together	   with	   RcsB	   (Ebel	   &	  
Trempy,	  1999,	  Wehland	  &	  Bernhard,	  2000).	  The	  small	  RNA	  DsrA	  was	  found	  to	  activate	  rcsA	  
expression	   by	   anti-­‐silencing	  HNS	   repression	   (Sledjeski	  &	  Gottesman,	   1995).	   Together	  with	  
RcsB,	  RcsA	  activates	  expression	  of	  loci	  such	  as	  the	  cps/wza	  gene	  cluster	  and	  yjb	  operon	  for	  
exopolysaccharide	  production,	  or	   rcsA	   expression	   itself	   (Stout	   et	  al.,	   1991,	   Ferrieres	   et	  al.,	  
2007).	   The	   flhDC	  operon	  encoding	   the	   flagella	  master	   regulator	   is	   repressed	  by	  RcsA-­‐RcsB	  
(Soutourina	  &	  Bertin,	  2003,	  Francez-­‐Charlot	  et	  al.,	  2003).	  RcsA-­‐RcsB	  heterodimers	  regulate	  
their	  targets	  by	  binding	  a	  specific	  DNA	  sequence,	  called	  RcsAB	  box,	  which	  is	  located	  around	  
100	  bp	  upstream	  of	  the	  transcription	  start	  site	  of	  wza	  as	  well	  as	  rcsA	  and	  downstream	  of	  the	  
promoter	  of	  flhDC	  (Wehland	  &	  Bernhard,	  2000,	  Francez-­‐Charlot	  et	  al.,	  2003).	  The	  activity	  of	  
the	  RcsA-­‐RcsB	  heterodimer	  depends	  on	  phosphorylation	  of	  RcsB	   (Majdalani	  &	  Gottesman,	  
2005).	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Table	  1.	  Cellular	  roles	  of	  RcsB	  homo-­‐	  and	  heterodimers	  
Transcription	  factor	   Role	   Target	  genes1	   Source	  
RcsB/RcsB	   cell	  division,	  biofilm	  





(Carballes	  et	  al.,	  1999,	  
Francez-­‐Charlot	  et	  al.,	  2005,	  
Sturny	  et	  al.,	  2003,	  Majdalani	  
et	  al.,	  2002,	  Castanie-­‐Cornet	  
et	  al.,	  2010)	  
RcsA2/RcsB	   capsule	  production	   wza,	  rcsA,	  
flhDC,	  csg	  
(Stout	  &	  Gottesman,	  1990,	  
Ebel	  &	  Trempy,	  1999,	  
Francez-­‐Charlot	  et	  al.,	  2003,	  
Vianney	  et	  al.,	  2005)	  
BglJ2/RcsB	   pleiotropic	  role	   bgl,	  leuO,	  
other	  targets	  
(Venkatesh	  et	  al.,	  2010,	  
Stratmann	  et	  al.,	  2012,	  
Salscheider	  et	  al.,	  2013)	  
GadE2/RcsB	   acid	  stress	  resistance	   gadA/BC	   (Castanie-­‐Cornet	  et	  al.,	  2010)	  
MatA2/RcsB	   fimbriae	   mat,	  flhDC	   (Lehti	  et	  al.,	  2012b,	  Lehti	  et	  
al.,	  2012a,	  Lehti	  et	  al.,	  2013)	  
DctR2/RcsB	   acid	  stress?	   ?	   (Masuda	  &	  Church,	  2003)	  
1activated	  targets	  in	  green,	  repressed	  targets	  in	  red	  
2HNS	  repressed	  
	  
BglJ	  is	  a	  225	  amino	  acid	  transcriptional	  regulator	  that	  is	  encoded	  in	  an	  operon	  together	  with	  
YjjQ,	  another	  transcription	  factor	  belonging	  to	  the	  FixJ/NarL-­‐family	  (Stratmann	  et	  al.,	  2008).	  
Notably,	  YjjQ	  was	  also	  identified	  as	  a	  transcriptional	  repressor	  of	  the	  flhDC	  operon	  and	  other	  
targets	  (Wiebe	  et	  al.,	  2015).	  Expression	  of	  yjjQ-­‐bglJ	  is	  repressed	  by	  HNS	  and	  activated	  by	  the	  
LysR-­‐type	   transcription	   factor	   LeuO	   that	   antagonizes	  HNS-­‐mediated	   repression	   (Stratmann	  
et	   al.,	   2008).	   Interestingly,	   BglJ-­‐RcsB	   heterodimers	   in	   turn	   activate	   leuO	   expression	   and	  
hence	  BglJ	  and	  LeuO	  form	  a	  small	  regulatory	  network	  (Stratmann	  et	  al.,	  2012).	  Furthermore,	  
BglJ-­‐RcsB	   activates	   expression	   of	   the	   bgl	   operon,	   encoding	   proteins	   for	   the	   uptake	   and	  
utilization	  of	   aryl-­‐β,D-­‐glucosides	   and	  more	   than	  10	   additional	   loci	   (Venkatesh	   et	   al.,	   2010,	  
Stratmann	  et	  al.,	  2012,	  Salscheider	  et	  al.,	  2013).	  For	  regulation	  of	  expression,	  BglJ-­‐RcsB	  was	  
proposed	   to	  act	   in	   the	  context	  of	   the	  promoter	  as	  a	   class	   I	   activator	   interacting	  with	  RNA	  
polymerase	  or	  as	  an	  HNS	  antagonist.	  At	  the	  bgl	  promoter	  BglJ-­‐RcsB	  acts	  synergistically	  with	  
CRP	   (Salscheider	  et	  al.,	  2013).	  Moreover,	  a	  consensus	  DNA-­‐binding	  motif	  was	  defined	  that	  
suggested	   a	   DNA	   phasing-­‐	   and	   orientation-­‐dependent	   positioning	   of	   the	   BglJ-­‐RcsB	  
heterodimer	   in	   relation	   to	   the	   transcription	   start	   site	   which	   varies	   with	   the	   promoter	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(Salscheider	  et	  al.,	  2013).	  Unlike	  RcsA-­‐RcsB,	  the	  activity	  of	  BglJ-­‐RcsB	  is	  independent	  of	  RcsB	  
phosphorylation	  (Venkatesh	  et	  al.,	  2010,	  Stratmann	  et	  al.,	  2012).	  	  
	  
Figure	  2.	  Targets	  of	  RcsB	  homo-­‐	  and	  heterodimers	  in	  E.	  coli.	  
RcsB	   homodimers	   activate	   ftsAZ,	   bdm,	   osmC,	   osmB,	   and	   rprA.	   RcsA-­‐RcsB	   activates	  wza,	   rcsA	   and	  
represses	  csg	  and	  flhDC.	  MatA-­‐RcsB	  activates	  mat	  in	  NMEC	  and	  represses	  flhDC.	  BglJ-­‐RcsB	  activates	  
several	  loci	  including	  bgl	  and	  leuO.	  GadE-­‐RcsB	  activates	  gadA	  and	  gadBC.	  Direct	  targets	  of	  DctR-­‐RcsB	  
are	  unknown.	  
	  
GadE,	  the	  central	  activator	  of	  glutamate-­‐dependent	  acid	  resistance,	  is	  encoded	  by	  the	  gadE-­‐
mdtEF	   operon	   located	   within	   the	   acid	   fitness	   island.	   GadE’s	   expression	   is	   negatively	  
regulated	  by	  HNS	  (Tucker	  et	  al.,	  2002,	  Tramonti	  et	  al.,	  2008,	  Sayed	  &	  Foster,	  2009).	  Together	  
with	   RcsB,	   GadE	   activates	   the	   expression	   of	   the	   gadA/BC	   genes	   in	   a	   phosphorylation	  
independent	   manner	   by	   binding	   the	   GAD	   box	   located	   around	   -­‐60	   bp	   upstream	   of	   the	  
transcription	  start.	  The	  genes	  gadA	  and	  gadB	  encode	  glutamate	  decarboxylases	  conferring	  
resistance	   to	   extreme	   acidic	   conditions.	   Interestingly,	   phosphorylated	   RcsB	   represses	  
expression	   of	   gadA	   as	   a	   homodimer	   by	   binding	   to	   a	   site	   upstream	   of	   the	   -­‐10	   promoter	  
element	  (Castanie-­‐Cornet	  et	  al.,	  2010).	  
In	  a	  systematic	  approach,	  interaction	  of	  RcsB	  with	  all	  other	  18	  FixJ/NarL-­‐type	  proteins	  
in	  E.	  coli	  K-­‐12	  was	  previously	  investigated	  (Fabisch,	  2008).	  These	  heterodimerization	  studies	  
using	  the	  bacterial	  LexA-­‐based	  two-­‐hybrid	  system	  (Dmitrova	  et	  al.,	  1998)	  revealed	  MatA	  and	  
DctR	   as	   further	   interaction	   partners	   of	   RcsB	   (Fabisch,	   2008).	   Notably,	   all	   FixJ/NarL-­‐type	  
proteins	  (except	  GadE	  and	  EvgA)	  that	  form	  heterodimers	  with	  RcsB	  do	  not	  form	  homodimers	  
and	   vice	   versa	   (Fabisch,	   2008).	   The	   one/two-­‐	   hybrid	   analyses	   for	   EvgA	   showed	  
homodimerization	   as	   well	   as	   heterodimerization	   with	   RcsB.	   For	   GadE	   neither	   homo-­‐	   nor	  
heterodimerization	   was	   detected	   under	   standard	   conditions,	   possibly	   due	   to	   acid-­‐stress	  
dependent	  dimerization	  behavior	  (Fabisch,	  2008).	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MatA	  (also	  termed	  EcpR)	  is	  a	  196	  amino	  acids	  long	  transcriptional	  regulator	  encoded	  
as	  the	  first	  gene	  of	  the	  common	  mat	  fimbria	  operon	  (Lehti	  et	  al.,	  2012a).	  Mat	  fimbriae	  are	  a	  
common	  colonization	  factor	  promoting	  biofilm	  formation	  as	  well	  as	  bacterial	  adherence	  to	  
epithelial	  cells	  (Lehti	  et	  al.,	  2010,	  Lehti	  et	  al.,	  2012b).	  MatA	  is	  the	  key	  activator	  of	  this	  operon	  
in	   newborn	   meningitis-­‐associated	   E.	   coli	   (NMEC)	   and	   enterohemorrhagic	   E.	   coli	   (EHEC)	  
although	   the	  mat	   operon	   remains	   cryptic	   in	   the	   non-­‐pathogenic	   E.	   coli	   K-­‐12	   and	   strains	  
belonging	  to	  the	  lineages	  A	  and	  B1	  (Martinez-­‐Santos	  et	  al.,	  2012,	  Lehti	  et	  al.,	  2012a,	  Lehti	  et	  
al.,	  2012b,	  Lehti	  et	  al.,	  2013).	  In	  NMEC	  and	  other	  E.	  coli	  strains	  belonging	  to	  the	  lineages	  B2,	  
D,	  and	  E,	  MatA	  forms	  a	  positive	  autoregulatory	  circuit	  (Lehti	  et	  al.,	  2013).	  However,	  also	  the	  
MatA	  protein	  of	  E.	  coli	  K-­‐12	  strain	  MG1655	  is	  fully	  functional	  (Lehti	  et	  al.,	  2013).	  In	  addition	  
to	  MatA,	  RcsB	  is	  required	  to	  activate	  mat	  expression	  in	  NMEC	  (Lehti	  et	  al.,	  2012a,	  Lehti	  et	  al.,	  
2012b).	  Notably,	  the	  mat	  operon	  is	  repressed	  by	  HNS	  (Lehti	  et	  al.,	  2012b,	  Lehti	  et	  al.,	  2013).	  
The	  flhDC	  operon	   is	  under	  negative	  control	  of	  MatA	  and	  hence	  the	   importance	  of	  MatA	   in	  
the	  transition	  from	  planktonic	  to	  adhesive	  lifestyle	  is	  discussed	  (Lehti	  et	  al.,	  2012a).	  	  
DctR	   is	   a	   176	   amino	   acids	   long	   predicted	   transcriptional	   regulator	   encoded	   in	   the	   slp-­‐
dctR	  operon	  whose	  expression	  is	  likewise	  repressed	  by	  HNS	  (Krin	  et	  al.,	  2010).	  The	  gene	  dctR	  
is	   a	  member	   of	   the	  E.	  coli	   acid	   fitness	   island	   (AFI)	   and	   its	   expression	   is	   activated	  by	   YdeO	  
(Mates	  et	  al.,	  2007,	  Masuda	  &	  Church,	  2003).	  	  Deletion	  of	  slp-­‐dctR	  abolishes	  YdeO-­‐induced	  
acid	  resistance	  (Masuda	  &	  Church,	  2003).	  Slp	  and	  DctR	  were	  implicated	  in	  protection	  against	  
metabolic	   end	   products	   under	   acidic	   conditions,	   however	   a	   direct	   target	   of	   DctR	   as	   a	  
transcriptional	  regulator	  is	  not	  known	  (Mates	  et	  al.,	  2007,	  Yamanaka	  et	  al.,	  2014).	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1.3.  Aims	  of	  this	  thesis	  
For	   the	   viability	   of	   bacteria	   it	   is	   essential	   to	   fine-­‐tune	   gene	   expression	   according	   to	   the	  
environmental	  conditions.	  RcsB	  has	  the	  unique	  feature	  to	  interact	  with	  several	  auxiliary	  co-­‐
regulators	  and	  is	  able	  to	  activate	  and	  repress	  targets	  dependent	  on	  interaction	  partner	  and	  
phosphorylation	   state.	   These	   different	   modes	   of	   regulation	   by	   RcsB	   imply	   specific	  
recognition	   mechanisms	   between	   RcsB	   and	   auxiliary	   regulators.	   Thus,	   RcsB	   is	   a	   versatile	  
transcription	   factor	   being	   involved	   in	  many	   regulatory	   networks	   that	   contribute	   to	   adjust	  
gene	  expression	   in	   response	   to	  environmental	   conditions.	  So	   far	   the	  specific	  determinants	  
for	  transcriptional	  activation	  by	  RcsB	  are	  poorly	  understood.	  The	  aims	  of	  this	  work	  were:	  	  
	  
•   To	  study	  a	  potential	  heterodimer	  formation	  of	  FixJ/NarL-­‐type	  transcription	  factors	  
•   To	   further	   characterize	   the	   RcsB	   regulon	   by	   identification	   of	   putative	   targets	   of	  
MatA-­‐RcsB	  and	  DctR-­‐RcsB	  heterodimers	  	  
•   To	   establish	   reporter	   systems	   to	   analyze	   transcriptional	   regulation	   by	   RcsB	   homo-­‐	  
and	  heterodimers	  
•   To	   study	   the	   phosphorylation	   dependence	   of	   RcsB	   for	   activity	   of	   specific	  
heterodimers	  
•   To	   identify	   particular	   amino	   acid	   residues	  within	   RcsB	  which	   are	   important	   for	   the	  
activity	  of	  RcsB	  as	  well	  as	  residues	  which	  are	  crucial	  for	  specific	  interaction	  with	  only	  
one	  or	  a	  subset	  of	  the	  partners	  
•   To	  study	  the	  mechanism	  of	  transcriptional	  activation	  by	  BglJ-­‐RcsB	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2.   Results	  
To	  address	  the	  aims	  of	  this	  work,	  I	  applied	  following	  approaches:	  
•   Analysis	  of	  heterodimer	  formation	  by	  bacterial	  LexA-­‐based	  two-­‐hybrid	  system	  
•   Search	  for	  MatA	  and	  DctR	  targets	  by	  microarray	  analysis	  
•   Analysis	  of	  MatA-­‐RcsB	  effect	  on	  motility	  on	  soft	  agar	  plates	  
•   Reporter	  construction	  by	  fusion	  of	  known	  target	  promoters	  to	  lacZ	  
•   Analysis	   of	   the	   activity	   of	   RcsB	   mutants	   as	   homo-­‐	   and	   heterodimers	   by	  
β-­‐galactosidase	  assays	  using	  the	  established	  reporter	  systems	  
•   Stability	  test	  of	  RcsB	  mutants	  by	  western	  blotting	  
•   Interaction	  analysis	  of	  RcsB	  mutants	  by	  strep-­‐protein	  interaction	  experiment	  
•   BglJ-­‐RcsB-­‐RNA	  polymerase	  interaction	  studies	  by	  a	  bacterial	  two-­‐hybrid	  system	  as	  
well	  as	  overexpression	  of	  the	  RNA	  polymerase	  α	  subunit	  +	  mutants	  
	  
2.1.  Homo-­‐	  and	  heterodimer	  formation	  of	  RcsB	  
The	   FixJ/NarL-­‐type	   transcriptional	   regulator	   RcsB	   is	   known	   to	   interact	   with	   auxiliary	  
regulators	  such	  as	  RcsA,	  BglJ	  and	  GadE	  which	  also	  belong	  to	  the	  FixJ/NarL	  family	  (Majdalani	  
&	   Gottesman,	   2005,	   Castanie-­‐Cornet	   et	   al.,	   2010,	   Venkatesh	   et	   al.,	   2010).	   In	   previous	  
studies,	  homo-­‐	  and	  heterodimerization	  of	  RcsB	  was	  analyzed	  using	  the	  bacterial	  LexA-­‐based	  
one/two-­‐hybrid	   system	   (Dmitrova	   et	   al.,	   1998).	   The	   one-­‐hybrid	   reporter	   for	   examining	  
homodimer	   formation	  consists	  of	   the	  native	  sulA	  promoter	   (+/+)	   fused	  to	   lacZ	   (Figure	  3A).	  
Only	   homodimers	   of	   proteins	   fused	   to	   the	   wild-­‐type	   DNA-­‐binding	   domain	   of	   the	   LexA	  
repressor	   are	   able	   to	   bind	   to	   the	   lexA	   operator	   and	   repress	   PsulA	   lacZ	   expression.	   For	  
analyzing	  heterodimer	  formation,	  the	  sulA	  promoter	  carries	  a	  hybrid	   lexA	  operator	  (408/+)	  
with	  a	  mutation	  in	  one	  half-­‐site	  (Figure	  3B).	  Only	  heterodimers	  in	  which	  one	  partner	  is	  fused	  
to	   the	   LexA	   wild-­‐type	   DNA-­‐binding	   domain	   and	   the	   other	   partner	   is	   fused	   to	   the	   LexA408	  
mutant	   DNA-­‐binding	   domain	   are	   able	   to	   bind	   the	   hybrid	   operator	   and	   repress	   PsulA	   lacZ	  




Figure	  3.	  Homo-­‐	  and	  heterodimer	  formation	  by	  RcsB,	  BglJ,	  RcsA,	  MatA	  and	  DctR.	  	  
(A)	  In	  the	  LexA-­‐based	  one/two-­‐hybrid	  system,	  the	  sulA	  promoter	  lacZ	  fusion	  with	  the	  wild-­‐type	  LexA	  
+/+	  operator	  was	  used	  to	  analyze	  homodimerization.	  For	  analysis	  of	  homodimerization,	  a	  fusion	  of	  
the	   respective	   protein	   to	   the	  wild-­‐type	   LexA	   DNA-­‐binding	   domain	  was	   expressed	   from	   a	   plasmid	  
under	  the	  control	  of	  the	  IPTG-­‐inducible	  lacUV5	  promoter	  (PUV5).	  (B)	  The	  sulA	  promoter	   lacZ	  reporter	  
fusion	   with	   a	   hybrid	   lexA	   408/+	   operator	   served	   as	   a	   reporter	   for	   heterodimerization.	   For	  
heterodimerization	  analysis,	  fusions	  of	  one	  protein	  to	  the	  wild-­‐type	  LexA	  DNA-­‐binding	  domain	  and	  
the	   potential	   interaction	   partner	   fused	   to	   the	   LexA408	   mutant	   DNA-­‐binding	   domain	   were	   co-­‐
expressed	  from	  compatible	  plasmids.	  (C)	  Summary	  of	  the	  results	  for	  heterodimer	  formation	  by	  RcsB,	  
BglJ.	   The	   fold	   repression	   of	   the	   lexAop408/+	   sulA	   promoter	   lacZ	   fusion	   is	   a	   measure	   of	  
heterodimerization,	   and	   was	   calculated	   by	   dividing	   the	   expression	   levels	   (values	   given	   in	   smaller	  
font	   size)	   of	   the	  PsulA	   lacZ	   reporter	   that	  were	   obtained	  without	   and	  with	   induction	   of	   the	   LexA-­‐
fusion	   proteins.	   For	   analyzing	   heterodimer	   formation	   of	   RcsA,	   MatA,	   and	   DctR	   with	   each	   other,	  
strains	   S3440	   (ΔrcsB)	   was	   co-­‐transformed	   with	   plasmids	   encoding	   for	   LexAWT-­‐X	   and	   LexA408-­‐Y	  
fusions,	  respectively.	  The	  following	  plasmids	  were	  used:	  pKEMK4	  (LexAWT-­‐MatA),	  pKEMK1	  (LexAWT-­‐
DctR),	  as	  well	  as	  pKEDP59	  (LexA408-­‐MatA)	  and	  pKEDP60	  (LexA408-­‐RcsA).	  The	  cultures	  were	  grown	  in	  
LB	   supplemented	   with	   antibiotics	   in	   the	   presence	   and	   absence	   of	   IPTG	   to	   an	   OD600	   of	   0.5.	   (D)	  
Summary	  of	  homodimer	   formation	  of	  RcsB,	  BglJ,	  RcsA,	  MatA	  and	  DctR.	  The	   fold	   repression	  of	   the	  
sulA	   promoter	   lacZ	   fusion	   with	   the	   lexA	   operator	   (lexAop+/+)	   is	   a	   measure	   of	   homodimerization.	  
Values	  indicated	  with	  a	  are	  taken	  from	  (Venkatesh	  et	  al.,	  2010).	  Unpublished	  laboratory	  results	  are	  




Previous	   analyses	   using	   the	   LexA-­‐based	   two-­‐hybrid	   system	   (Dmitrova	   et	   al.,	   1998)	  
demonstrated	   an	   interaction	   of	   RcsB	   also	   with	   MatA,	   and	   DctR,	   respectively	   (Figure	   3C)	  
(Fabisch,	  2008).	  Analyses	  using	  the	  LexA-­‐based	  one-­‐hybrid	  system	  demonstrated	  that	  these	  
interaction	   partners	   of	   RcsB	   partners	   do	   not	   form	   homodimers	   (Figure	   3D).	   Since	   RcsB	  
interacts	  with	  RcsA,	  BglJ,	  MatA,	  and	  DctR,	   these	  proteins	  may	   form	  heterodimers	   in	  other	  
combinations	   as	  well.	   In	   previous	   experiments,	   heterodimer	   formation	   between	   BglJ	  with	  
RcsA,	  MatA,	  or	  DctR,	  respectively,	  was	  not	  observed	  (Figure	  3C)	  (Dreck,	  2013).	  Here	  I	  tested	  
heterodimer	  formation	  between	  RcsA	  and	  MatA,	  or	  DctR,	  respectively,	  and	  between	  MatA	  
and	  DctR	  using	  the	  bacterial	  LexA-­‐based	  two	  hybrid	  system.	  	  
The	   two-­‐hybrid	   assays	   for	   heterodimer	   formation	   of	   RcsA,	   MatA	   and	   DctR	   were	  
conducted	   in	   a	  ΔrcsB	   background	   strain	   carrying	   the	   sulA	   408/+	  hybrid	  promoter	   fused	   to	  
lacZ.	  This	  strain	  (S3440)	  was	  co-­‐transformed	  with	  a	  plasmid	  harboring	  RcsA	  or	  MatA	  fused	  to	  
the	   LexA408	   DNA-­‐binding	   domain	   together	   with	   a	   plasmid	   harboring	   one	   of	   the	   other	  
FixJ/NarL-­‐type	  proteins	  MatA	  or	  DctR	   fused	   to	   the	  wild-­‐type	   LexAWT	  DNA-­‐binding	  domain.	  
Neither	  the	  co-­‐induction	  of	  LexA408-­‐RcsA	  with	  LexAWT-­‐MatA	  or	  LexAWT-­‐DctR,	  respectively,	  nor	  
the	  co-­‐induction	  of	  LexA408-­‐MatA	  with	  LexAWT-­‐DctR	  resulted	  in	  a	  repression,	  suggesting	  that	  
RcsA,	  MatA	  and	  DctR	  do	  not	  form	  heterodimers	  with	  each	  other	  (Figure	  3C).	  Taken	  together,	  
these	   data	   combined	  with	   the	   previous	   findings	   show	   that	   RcsB	   forms	   heterodimers	  with	  
RcsA,	  BglJ,	  MatA,	   and	  DctR,	   and	   that	   these	   interaction	  partners	  neither	   form	  homodimers	  
nor	  heterodimers	  with	  each	  other.	  
	  
2.2.  Establishment	  of	  reporter	  systems	  
To	   study	   the	   regulatory	   effect	   of	   RcsB	   homo-­‐	   and	   heterodimers,	   appropriate	   reporter	  
systems	  for	  RcsB-­‐RcsB,	  RcsA-­‐RcsB,	  MatA-­‐RcsB	  and	  DctR-­‐RcsB	  remained	  to	  be	  established.	  To	  
this	  end,	   the	  promoter	  regions	  of	  specific	   targets	  were	   fused	  to	   lacZ,	   integrated,	  and	  their	  
activation	   tested	   in	  different	   strain	  backgrounds.	  Given	   that	   for	  MatA	  and	  DctR	  no	   targets	  
are	   known	   in	   E.	   coli	   K-­‐12,	   I	   performed	   a	  Microarray	   analysis.	   Furthermore,	   I	   investigated	  
whether	  transcriptional	  activation	  by	  RcsB	  homodimers	  or	  heterodimers	  with	  RcsA,	  BglJ,	  and	  
MatA	   depends	   on	   RcsB	   phosphorylation.	   For	   this,	   I	   expressed	   wild-­‐type	   RcsB	   or	   mutants	  
D56E,	   D56N,	   and	   D56A	   in	   the	   appropriate	   reporter	   strains.	   RcsB-­‐D56E	   mimics	  
phosphorylated	   RcsB,	   and	   RcsB-­‐D56N	   and	   -­‐D56A	  mimic	   non-­‐phosphorylated	   inactive	   RcsB	  
(Scharf,	  2010).	  In	  all	  reporter	  strains,	  the	  chromosomal	  lacZ	  gene	  was	  deleted.	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2.2.1.   RcsB-­‐RcsB	  activates	  PrprA	  in	  a	  phosphorylation	  dependent	  manner	  
For	  analyzing	  the	  RcsB	  homodimer	  activity,	  first	  a	  PftsA	  lacZ	  fusion	  was	  tested	  as	  a	  reporter.	  
This	   fusion,	  which	  was	   constructed	  before,	   comprises	   the	  promoter	   region	   (-­‐70	   to	  +30)	  of	  
the	   cell	   division	   gene	   ftsA	   that	   is	   activated	   by	   RcsB	   (Carballes	   et	   al.,	   1999),	   fused	   to	   the	  
reporter	  gene	  lacZ	  (constructed	  by	  Öztürk,	  Figure	  4A).	  Previously,	  this	  reporter	  was	  tested	  in	  
ΔrcsB	   ΔlacZ	   strain	   T818	   (Öztürk,	   2010).	   This	   strain	   was	   transformed	   with	   empty	   plasmid	  
pKESK22	  or	  plasmids	   expressing	  wild-­‐type	  RcsB	   and	  mutants	  D56E,	  D56N,	  D56A,	  or	  M88A	  
(pKETS6,	   pKETS7,	   pKETS8,	   pKES235	   and	   pKES232)	   and	   β-­‐galactosidase	   activities	   were	  
determined.	  RcsB-­‐D56E	  mimics	  phosphorylated	  RcsB,	  and	  RcsB-­‐D56N	  and	  -­‐D56A	  mimic	  non-­‐
phosphorylated	   inactive	  RcsB	  (Scharf,	  2010).	   In	  RcsB	  mutant	  M88A,	  methionine	  at	  position	  
88	  is	  replaced	  by	  alanine.	  At	  this	  position,	  response	  regulators	  except	  for	  RcsB	  carry	  usually	  a	  
conserved	  small	  residue	  such	  as	  alanine	  or	  glycine	  (Bourret,	  2010).	  Compared	  to	  the	  empty	  
vector	  control,	  the	  plasmidically	  expressed	  wild-­‐type	  rcsB	  did	  not	  activate	  the	  ftsA	  promotor	  
(Öztürk,	   Figure	   4B).	   The	   finding	  may	   be	   due	   to	   non-­‐induced	   Rcs	   signaling	   resulting	   in	   an	  
equilibrium	  shift	  to	  unphosphorylated	  RcsB	  in	  the	  cytoplasm.	  Accordingly,	  the	  RcsB	  mutant	  
D56A,	  mimicking	   inactive	  RcsB,	  did	  not	  activate	  the	  promoter	  and	  RcsB-­‐D56N	  only	  slightly.	  
RcsB-­‐D56E,	  mimicking	  phosphorylated	  RcsB,	  as	  well	  as	  RcsB-­‐M88A,	  activated	  the	  promoter	  




Figure	  4.	  Analysis	  of	  the	  PftsA	  lacZ	  reporter	  in	  different	  strain	  backgrounds	  
(A)	  The	  ftsA	  promoter	  region	  from	  -­‐70	  to	  +30	  relative	  to	  the	  transcription	  start	  site	  was	  fused	  to	  lacZ	  
on	  plasmid	  pKES243	  and	  integrated	  into	  the	  attB	  site	  of	  the	  chromosome	  of	  different	  strains.	  These	  
reporter	  strains	  were	  transformed	  with	  empty	  plasmid	  pKESK22	  (pCtrl),	  wild-­‐type	  RcsB	  (pKETS6)	  or	  
RcsB-­‐mutants	   D56E,	   D56N,	   D56A	   and	  M88A	   (pKETS7,	   pKETS8,	   pKES235,	   and	   pKES232)	   expressing	  
plasmids	  and	  reporter	  expression	   levels	  were	  determined.	  (B)	  PftsA	   lacZ	  expression	   levels	   in	  ΔrcsB	  
ΔlacZ	  strain	  T818,	  ΔrcsBCD	  ΔlacZ	  strain	  T868	  and	  ΔrcsB	  ΔlacZ	  rfaD::mTn-­‐cat	  strain	  T866.	  Cultures	  for	  
β-­‐galactosidase	  assays	  were	  grown	  in	  LB	  medium	  to	  an	  OD600	  of	  0.5,	  supplemented	  with	  1	  mM	  IPTG	  
and	   25	   µg/ml	   of	   kanamycin.	   Values	   obtained	   for	   ΔrcsB	   strain	   (indicated	   with	   1)	   are	   unpublished	  
laboratory	  results	  from	  Öztürk,	  2010.	  
	  
	  
Based	  on	  these	  previous	  results,	  I	  constructed	  two	  PftsA	  lacZ	  reporter	  strains	  to	  potentially	  
increase	  RcsB	  phosphorylation.	  The	  first	  reporter	  strain	  ΔrcsBCD	  ΔlacZ	  (T868)	  lacks	  both	  the	  
sensor	  kinase	  RcsC	  and	  the	  phosphotransfer	  protein	  RcsD	  to	  avoid	  RcsB	  dephosphorylation	  
by	  the	  Rcs	  system.	  In	  the	  second	  reporter	  strain	  ΔrcsB	  ΔlacZ	  rfaD::mTn10-­‐cat	  (T866),	  rfaD	  is	  
mutated	  by	   transposon	   insertion.	  Mutation	  of	   rfaD	  which	   is	   involved	   in	   lipopolysaccharide	  
(LPS)	   synthesis	   (Pegues	   et	   al.,	   1990)	  was	   reported	   to	   activate	   Rcs	   signaling	   (Parker	   et	   al.,	  
1992).	  Each	  reporter	  strain	  was	  transformed	  with	  an	  empty	  plasmid	  or	  plasmids	  expressing	  
wild-­‐type	  RcsB	  and	  mutants	  D56E,	  D56N,	  D56A,	  or	  M88A	  and	  β-­‐galactosidase	  activities	  were	  
determined.	  In	  the	  ΔrcsBCD	  ΔlacZ	  strain,	  wild-­‐type	  RcsB	  activated	  expression	  approximately	  
2-­‐fold	   to	   61	   units	   compared	   to	   the	   empty	   vector	   control	   with	   27	   units	   (Figure	   4B).	   RcsB	  
mutants	   D56E	   and	  M88A	   activated	   PftsA	   lacZ	   up	   to	   155	   units	   and	   291	   units,	   respectively	  
(Figure	   4B).	   RcsB	  mutant	   D56N	   activated	   expression	   only	   slightly	  with	   46	   units	   and	   RcsB-­‐
D56A	  did	  not	  activate	  PftsA	  lacZ	  expression	  (Figure	  4B).	  In	  the	  ΔrcsB	  ΔlacZ	  rfaD::mTn10-­‐cat	  
strain	  wild-­‐type	  RcsB	  only	   slightly	  activated	  expression	   from	  28	  units	   for	   the	  empty	  vector	  
control	  to	  40	  units	  (Figure	  4B).	  RcsB	  mutants	  D56E	  and	  M88A	  activated	  the	  PftsA	  lacZ	  up	  to	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176	  units	  and	  189	  units,	   respectively.	  RcsB	  mutant	  D56N	  activated	  expression	  only	  slightly	  
with	  40	  units	  and	  RcsB-­‐D56A	  did	  not	  activate	  PftsA	   lacZ	  expression	   (Figure	  4B).	   In	  none	  of	  
the	   three	   reporter	   strain	   backgrounds	   the	   PftsA	   lacZ	   expression	   was	   more	   than	  
approximately	   2-­‐fold	   upregulated	   by	   wild-­‐type	   RcsB	   and	   around	   6-­‐fold	   by	   RcsB-­‐D56E	  
compared	  to	  the	  control.	  Thus	  the	  PftsA	  lacZ	  fusion	  did	  not	  prove	  to	  be	  optimal	  for	  further	  
analyses	  and	  a	  reporter	  was	  needed	  which	  is	  strongly	  activated	  by	  wild-­‐type	  RcsB	  that	  allows	  
distinguishing	  smaller	  differences.	  	  
Therefore	   the	   promoter	   of	   rprA	   (-­‐124	   to	   +4)	   encoding	   the	   small	   RNA	   RprA	  whose	  
expression	  is	  activated	  by	  RcsB	  (Majdalani	  et	  al.,	  2002)	  was	  fused	  to	  the	  lacZ	  reporter	  gene	  
and	   this	   construct	   was	   integrated	   into	   the	   chromosome	   of	   different	   strain	   backgrounds	  
(Figure	  5A).	  
	  
Figure	  5.	  PrprA	  lacZ	  as	  a	  reporter	  for	  studying	  activation	  by	  RcsB	  
(A)	  The	   rprA	  promoter	   region	   from	   -­‐142	   to	  +4	   relative	   to	   the	   transcription	   start	   site	  was	   fused	   to	  
lacZ	  on	  plasmid	  pKES299	  and	   integrated	   into	  the	  attB	   site	  of	   the	  chromosome.	   (B)	  The	  expression	  
levels	   of	   the	   PrprA	   lacZ	   reporter	   were	   determined	   in	   rcsB+	   ΔlacZ	   strain	   T2023,	   rcsB+	  ΔgalU	   ΔlacZ	  
strain	  T2041,	  and	  ΔrcsB	  ΔlacZ	  strain	  T1052.	  For	  complementation,	  rcsB	  was	  expressed	  from	  plasmid	  
pKETS6.	   RcsB	   derivatives	   D56E,	   D56N,	   D56A	   and	  M88A	   from	   plasmids	   pKETS7,	   pKETS8,	   pKES235,	  
and	  pKES232,	  respectively.	  Empty	  cloning	  vector	  pKESK22	  served	  as	  control	   (pCtrl).	  Cultures	   for	  β-­‐
galactosidase	   assays	  were	   grown	   in	   LB	  medium	   to	   an	  OD600	   of	   0.5,	   if	   transformed	   supplemented	  
with	  1	  mM	  IPTG	  and	  25	  µg/ml	  of	  kanamycin.	  
	  
In	  the	  rcsB+	  strain	  T2023	  the	  PrprA	  lacZ	  expression	  was	  poorly	  activated	  (7	  units,	  Figure	  5B).	  
In	   a	   ΔgalU	   strain	   that	   cannot	   produce	   UDP-­‐D-­‐glucose,	   the	   Rcs	   system	   is	   constitutively	  
activated	   (Girgis	   et	   al.,	   2007).	   Deletion	   of	  galU	   in	   the	   rcsB+	   background	   (T2041)	   activated	  
PrprA	   lacZ	   expression	   up	   to	   39	   units	   (Figure	   5B).	   In	   the	   ΔrcsB	   strain	   (T1052)	   PrprA	   lacZ	  
expression	   is	   very	   low	   (2	   units,	   Figure	   5B)	   and	   when	   transformed	   with	   control	   plasmid	  
pKESK22	  completely	  off	  (<1	  unit,	  Figure	  5B).	  Complementation	  of	  ΔrcsB	  strain	  with	  wild-­‐type	  
rcsB	  (pKETS6)	  induced	  PrprA	  lacZ	  expression	  up	  to	  52	  units	  (Figure	  5B).	  RcsB	  mutants	  D56E	  
and	  M88A	   activated	   the	   promoter	   up	   to	   100	   units	   and	   109	   units,	   respectively,	   and	   RcsB	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derivative	  D56N	  and	  D56A	  activated	  the	  rprA	  promoter	  up	  to	  65	  and	  35	  units,	  respectively.	  
This	   lower	   activity	   for	   the	   inactive	   RcsB-­‐D56A	   mutant	   confirms	   an	   at	   least	   partial	  
phosphorylation	  dependent	  activation.	  Although	  activation	  of	  PrprA	  by	  RcsB	  homodimers	  is	  
phosphorylation	  dependent,	   the	  complementation	  with	  wild-­‐type	   rcsB	   partially	  overcomes	  
the	  requirement	  for	  induction	  of	  the	  Rcs	  signaling	  cascade.	  In	  the	  ΔrcsB	  strain,	  plasmidically	  
expressed	  wild-­‐type	  RcsB	  activates	  the	  PrprA	  more	  than	  50-­‐fold	  and	  RcsB-­‐D56E	  more	  than	  
100-­‐fold	   compared	   to	   the	   control	   plasmid,	   allowing	   to	   distinguish	   also	   small	   differences.	  
Taken	  together,	  the	  PrprA	  lacZ	  reporter	  in	  the	  ΔrcsB	  strain	  proved	  to	  be	  appropriate	  for	  the	  
analysis	   of	   transcriptional	   activation	   by	   RcsB	   and	   mutants.	   The	   results	   also	   confirmed	   a	  
phosphorylation	  dependent	  activation	  by	  RcsB	  homodimers.	  
2.2.2.   RcsA-­‐RcsB	  activates	  Pwza	  in	  a	  phosphorylation	  dependent	  manner	  
To	  analyze	  the	  activity	  of	  RcsA-­‐RcsB	  heterodimers,	  a	  Pwza	  lacZ	  reporter	  was	  constructed	  and	  
analyzed	   in	  various	  strain	  backgrounds,	  each	  carrying	  a	   lacZ	  deletion.	  For	   this	  purpose	   the	  
wza	   promoter	   (-­‐202	   to	   +346)	   was	   fused	   to	   lacZ,	   and	   integrated	   into	   the	   attB	   site	   of	   the	  
chromosome.	  The	  promoter	  is	  derived	  from	  the	  wza-­‐wca	  gene	  cluster	  of	  capsule	  production	  
that	  is	  activated	  by	  RcsA-­‐RcsB	  in	  a	  phosphorylation	  dependent	  manner	  (Gupte	  et	  al.,	  1997,	  
Majdalani	   &	   Gottesman,	   2005).	   This	   Pwza	   lacZ	   reporter	   was	   tested	   in	   a	   ΔrcsB	   strain	  
background.	   Since	   the	  activation	  of	  Pwza	  was	   reported	   to	  be	  phosphorylation	  dependent,	  
the	  Pwza	  lacZ	  reporter	  was	  also	  tested	  in	  a	  ΔrcsBCD	  strain	  background	  lacking	  RcsC	  and	  RcsD	  
to	  avoid	  RcsB	  dephosphorylation	  by	  the	  Rcs	  system	  as	  well	  as	  a	  ΔrcsB	  rfaD::mTn10-­‐cat	  strain	  
background	  with	  an	  rfaD	  mutation	  which	  is	  supposed	  to	  activate	  the	  Rcs	  system.	  Expression	  
of	  rcsA	   is	  repressed	  by	  HNS	  and	  autoregulated	  by	  RcsA-­‐RcsB	  (Sledjeski	  &	  Gottesman,	  1995,	  
Majdalani	  &	  Gottesman,	  2005)	  and	  the	  intracellular	  RcsA	  concentration	  is	  low	  because	  RcsA	  
is	  a	   target	  of	   the	  Lon	  protease	   (Torres-­‐Cabassa	  &	  Gottesman,	  1987).	  This	   is	  why	   in	  certain	  
strains	   the	  native	  rcsA	  promoter	  was	   replaced	  by	   the	  strong	  phage	  λ	  PL	  promoter	  or	  weak	  
P16	   promoter	   causing	   constitutive	   expression	   and	   avoiding	   HNS	   repression	   as	   well	   as	  
circumventing	   autoregulation.	  Overall	   the	   Pwza	   lacZ	   reporter	  was	   tested	   in	   strains	  with	   a	  




Figure	  6.	  Pwza	  lacZ	  as	  a	  reporter	  for	  studying	  activation	  by	  RcsA-­‐RcsB	  
(A)	  The	  wza	  promoter	  region	  from	  -­‐202	  to	  +346	  relative	  to	  the	  transcription	  start	  site	  was	  fused	  to	  
lacZ	  on	  plasmid	  pKES260	  and	   integrated	   into	  the	  attB	  site	  of	  the	  chromosome	  of	  different	  strains.	  
These	   reporter	   strains	   were	   transformed	   with	   empty	   plasmid	   pKESK22	   (pCtrl),	   RcsB	   wild-­‐type	  
(pKETS6)	   or	   RcsB-­‐mutants	   D56E	   and	   M88A	   (pKETS7,	   pKES232)	   expressing	   plasmids	   and	   reporter	  
expression	  levels	  were	  determined.	  Cultures	  for	  β-­‐galactosidase	  assays	  were	  grown	  in	  LB	  medium	  to	  
an	  OD600	  of	  0.5,	  if	  transformed	  supplemented	  with	  1	  mM	  IPTG	  and	  25	  µg/ml	  of	  kanamycin.	  (B)	  Pwza	  
lacZ	   expression	   levels	   in	   ΔrcsB	   ΔlacZ	   strain	   T864,	   ΔrcsBCD	   ΔlacZ	   strain	   T921	   and	   ΔrcsB	   ΔlacZ	  
rfaD::mTn-­‐cat	   strain	   T919.	   (C)	   Pwza	   lacZ	   expression	   levels	   in	   ΔrcsB	   ΔlacZ	   rcsAP16	   strain	   T929	   and	  
ΔrcsBCD	   ΔlacZ	   rcsAP16	   strain	   T979.	   (D)	   Expression	   levels	   of	   the	   Pwza	   lacZ	   reporter	   in	   rcsB+	   ΔlacZ	  
rcsAPL	   strain	   T2039,	   rcsB+	   ΔgalU	   ΔlacZ	   rcsAPL	   strain	   T2045,	   ΔrcsBCD	   ΔlacZ	   rcsAPL	   strain	   T963,	   and	  
ΔrcsB	  ΔlacZ	  rcsAPL	  strain	  T927.	  RcsB	  and	  derivatives	  D56E,	  D56N,	  D56A,	  and	  M88A	  were	  expressed	  




Each	  reporter	  strain	  was	   transformed	  with	  empty	  plasmid	  pKESK22	  or	  plasmids	  expressing	  
wild-­‐type	   RcsB	   (pKETS6)	   and	   mutants	   D56E,	   D56N,	   D56A,	   and	   M88A	   (pKETS7,	   pKETS8,	  
pKES235,	   pKES232)	   and	   the	   reporter	   expression	  was	  measured	   by	   β-­‐galactosidase	   assays.	  
The	  results	  are	  summarized	  in	  Figure	  6.	  In	  strains	  with	  the	  native	  rcsA	  promoter	  (ΔrcsB	  strain	  
T864,	   ΔrcsBCD	   strain	   T921	   and	   ΔrcsB	   rfaD::mTn-­‐cat	   strain	   T919,	   Figure	   6B),	   the	   reporter	  
expression	   levels	   upon	   complementation	  with	  wild-­‐type	   rcsB	  were	   not	   significantly	   higher	  
compared	  to	  the	  control.	  In	  strains	  with	  rcsA	  under	  the	  control	  of	  the	  weak	  constitutive	  P16	  
promoter	   (ΔrcsB	   P16-­‐rcsA	   strain	   T929	   and	   ΔrcsBCD	   P16-­‐rcsA	   strain	   T979),	   the	   reporter	  
expression	   levels	   upon	   complementation	   with	   wild-­‐type	   rcsB	   were	   also	   not	   significantly	  
higher	   compared	   to	   the	   control	   (Figure	   6C),	   similar	   to	   the	   strains	   with	   the	   native	   rcsA	  
promoter.	  RcsB	  mutants	  D56E	  and	  M88A	  activated	  the	  promoter	  strongly	  in	  the	  strains	  with	  
native	   rcsA	   promoter	   and	   the	   weak	   constitutive	   P16	   promoter	   (Figure	   6B	   and	   C).	  
Interestingly,	   the	   activation	   by	   RcsB-­‐D56E	   and	   M88A	   was	   higher	   in	   the	   strains	   with	   the	  
native	  rcsA	  promoter	  compared	  to	  the	  strains	  with	  constitutive	  rcsA	  expression	  controlled	  by	  
P16	  (Figure	  6B	  and	  C).	  This	  can	  be	  explained	  by	  autoinduction	  of	  the	  native	  rcsA	  promoter.	  In	  
the	  rcsB+	  PL-­‐rcsA	  strain	  T2039	  Pwza	  lacZ	  was	  strongly	  activated	  compared	  to	  the	  rcsB+	  strain	  
(217	  units	  and	  1	  unit,	  Figure	  6D).	  Activation	  of	  the	  Rcs	  system	  by	  deletion	  of	  galU	  in	  the	  rcsB+	  
background	   (T2042)	   did	   not	   strongly	   activate	   Pwza	   lacZ	   expression	   (5	   units,	   Figure	   6D).	  
Deletion	  of	  galU	  in	  the	  rcsB+	  PL-­‐rcsA	  background	  (T2045)	  induced	  Pwza	  lacZ	  expression	  up	  to	  
287	   units	   (Figure	   6D).	   In	   the	   ΔrcsBCD	   PL-­‐rcsA	   strain	   T963,	   plasmidic	   wild-­‐type	   RcsB	  
expression	   activated	   expression	   223-­‐fold	   compared	   to	   the	   untransformed	   strain	   and	   the	  
strain	  harboring	  an	  empty	  plasmid	   (223	  versus	  1	  units,	  Figure	  6D).	  RcsB	  mutant	  D56N	  and	  
D56A	   activated	   Pwza	   lacZ	   up	   to	   153	   and	   20	   units,	   and	   RcsB	   mutants	   D56E	   and	   M88A	  
activated	   the	   promoter	   up	   to	   328	   units	   and	   343	   units,	   respectively	   (Figure	   6D).	   The	   low	  
activity	   of	   the	   RcsB-­‐D56A	   mutant	   compared	   to	   wild-­‐type	   RcsB	   demonstrates	   the	   RcsB	  
phosphorylation	  dependence	  of	  transcriptional	  activation	  by	  RcsA-­‐RcsB.	  	  
When	   rcsA	   is	   constitutively	   expressed	   under	   PL	   control	   in	   the	   presence	   of	   RcsB,	  
capsule	  production	  is	  activated	  and	  colonies	  of	  the	  strains	  exhibit	  a	  mucoid	  phenotype	  on	  LB	  
plates	  (Figure	  7,	  middle	  photo).	   In	  a	  ΔrcsB	  strain	  constitutive	  rcsA	  expression	  is	  not	  able	  to	  
induce	   the	  mucoid	  phenotype,	   confirming	   that	   capsule	  production	  depends	  on	  both,	  RcsA	  
and	  RcsB	  (Figure	  7,	  right	  photo).	  Since	  induction	  of	  Rcs	  signaling	  by	  deletion	  of	  galU	   in	  the	  
wild-­‐type	   background	   is	   not	   sufficient	   to	   activate	   Pwza,	  we	   continued	   our	   experiments	   in	  
21	  
	  
ΔrcsBCD	  ΔlacZ	  PL-­‐rcsA	  reporter	  strain	  T963,	  although	  a	  ΔrcsB	  PL-­‐rcsA	   reporter	  strain	   (T927)	  
yielded	   comparable	   results	   (Figure	   6D).	   Collectively,	   RcsA-­‐RcsB	   activates	   Pwza	   in	   a	  
phosphorylation	  dependent	  fashion.	  
	  
Figure	  7.	  The	  mucoid	  phenotype	  depends	  on	  
RcsB	  and	  RcsA.	  
E.	  coli	  wt	  strain	  S4197	  (left)	  and	  PL-­‐rcsA	  strain	  
T2039	  (middle)	  and	  ΔrcsB	  PL-­‐rcsA	  strain	  T927	  
(right).	   Only	   the	   presence	   of	   RcsA	   together	  
with	   RcsB	   is	   able	   to	   induce	   the	   mucoid	  
phenotype	  (middle	  photo).	  
	  
2.2.3.   BglJ-­‐RcsB	  reporter	  system	  
A	  reporter	  system	  for	  analyzing	  BglJ-­‐RcsB	  has	  already	  been	  established.	  The	   leuO	  promoter	  
was	   fused	   to	   lacZ	   and	   chromosomally	   integrated	   in	   a	   ΔrcsB	  bglJC	   ΔlacZ	   strain,	   in	  which	   a	  
miniTn10	   transposon	   was	   inserted	   in	   yjjQ	   leading	   to	   constitutive	   expression	   of	   bglJ	  
(Stratmann	  et	  al.,	  2012).	  	  The	  yjjQ-­‐bglJ	  operon	  is	  usually	  repressed	  by	  HNS	  (Stratmann	  et	  al.,	  
2008).	  
2.2.4.   MatA-­‐RcsB	  activates	  PmatCFT073	  in	  a	  phosphorylation	  independent	  manner	  
Two-­‐hybrid	   results	   suggested	   that	   the	   DNA-­‐binding	   transcriptional	   regulator	  MatA	   (EcpR)	  
forms	  heterodimers	  with	  RcsB	  whereas	  it	  does	  not	  form	  homodimers.	  It	  was	  recently	  shown	  
that	  activation	  of	  the	  HNS	  repressed	  mat	  operon	  by	  MatA	  in	  NMEC	  strain	  IHE3034	  and	  other	  
E.	  coli	  strains	  depends	  on	  the	  specific	  sequence	  of	  the	  mat	  regulatory	  region.	  This	  sequence	  
of	  the	  regulatory	  region	  is	  divergent	  between	  the	  E.	  coli	  lineages	  B2,	  D,	  and	  E	  as	  compared	  to	  
the	  A	   and	  B1	   lineages,	  while	   the	   nucleotide	   sequence	  of	   the	  matABCDEF	   coding	   region	   is	  
highly	  conserved	  among	  all	  E.	  coli	  strains	  (Lehti	  et	  al.,	  2013).	  To	  establish	  a	  suitable	  reporter	  
system	  for	  studying	  MatA-­‐RcsB	  activity	  in	  E.	  coli	  K-­‐12,	  I	  first	  performed	  a	  microarray	  analysis.	  
However,	  the	  analysis	  did	  not	  reveal	  any	  specific	  target	  locus	  of	  MatA	  in	  E.	  coli	  K-­‐12.	  The	  ten	  
highest	  upregulated	  loci	  are	  summarized	  in	  Table	  2.	  According	  to	  the	  average	  fluorescence	  
intensities	   the	   expression	   of	   these	   loci	   is	   low	   and	   the	   results	   might	   be	   unspecific.	   The	  
average	   intensities	   of	   three	   housekeeping	   genes	   rrsA,	   ihfB	   and	   rpoD	   detected	   in	   this	  
microarray	  analysis	  are	  listed	  in	  Table	  2	  as	  reference.	  	  	  	  




Table	  2.	  Summary	  of	  MatA	  microarray	  analysis	  results	  






3866477-­‐3866882	   <<	   ibpB	   3866469-­‐3866897	   small	  heat	  shock	  protein	   7.5	   8.97/11.97	  
1460475-­‐1460889	   >>	   paaI	   1460471-­‐1460893	   phenylacetyl-­‐CoA	  
thioesterase	  
5.5	   7.89/10.30	  
1459157-­‐1460454	   >>	   paaH	   1459054-­‐1460481	   3-­‐hydroxyadipyl-­‐CoA	  
dehydrogenase	  
4.2	   8.56/10.55	  
1460988-­‐1462030	   >>	   paaJ	   1460893-­‐1462098	   β-­‐ketoadipyl-­‐CoA	  
thiolase	  
3.8	   9.16/11.03	  
2794269-­‐2795549	   >>	   gabP	   2794253-­‐2795653	   aminobutyrate	  
transporter	  
3.3	   7.04/8.69	  
310109-­‐310657	   >>	   matB	   310084-­‐310671	   Mat	  fibrillin	  subunit	   3.2	   7.82/9.48	  
1826119-­‐1826877	   <<	   ydjS	   1825955-­‐1826923	   succinylglutamate	  
desuccinylase	  
3.2	   8.10/9.89	  
3703015-­‐3703486	   <<	   dppD	   3702865-­‐3703848	   dipeptide	  transporter	   3.2	   9.16/10.79	  
2793213-­‐2793315	   >>	   gabT	   2792735-­‐2794015	   aminobutyrate	  
aminotransferase	  
3.0	   8.52/9.92	  
14273-­‐15112	   >>	   dnaJ	   14168-­‐15298	   chaperone	   2.9	   11.69/13.25	  
	  
housekeeping	  genes	  
224773-­‐224815	   >>	   rrsH	   223771-­‐225312	   16S	  ribosomal	  RNA	   1.0	   15.23/15.23	  
963844-­‐964109	   >>	   ihfB	   963051-­‐963335	   integration	  host	  factor,	  
β	  subunit	  
1.0	   12.86/12.90	  
3213085-­‐3213830	   >>	   rpoD	   3211069-­‐3212910	   RNA	  polymerase,	  σ70	   1.5	   12.37/12.93	  
Summary	  of	  the	  ten	  highest	  MatA-­‐regulated	  loci	  (p	  value	  <	  0.05).	  
a	  Positions	  of	  probes	  and	  genes	  are	  given	  as	  coordinates	  of	  U0096.3	  genome.	  
b	  ‘dir’	  describes	  the	  orientation	  of	  the	  probe	  (<<	  for	  lower	  strand,	  >>	  for	  upper	  strand).	  
c	  Average	  intensities	  of	  the	  strain	  harboring	  control	  (left)	  or	  MatA	  expressing	  plasmid	  (right)	  	  
	  
Therefore,	  I	  constructed	  a	  lacZ	  fusion	  of	  the	  mat	  promoter	  and	  regulatory	  region	  from	  UPEC	  
strain	  CFT073	  encompassing	  position	  -­‐552	  to	  +68	  relative	  to	  the	  T1	  transcription	  start	  site,	  
similar	  to	  a	  NMEC	  matA	  promoter	  reporter	  gene	  fusion	  described	  before	  (Lehti	  et	  al.,	  2013).	  
The	   NMEC	   strain	   IHE3034	   and	   the	   UPEC	   strains	   CFT073	   both	   belong	   to	   the	   same	  
phylogenetic	  B2	  subgroup	  of	  E.coli	  (Lehti	  et	  al.,	  2013),	  and	  accordingly,	  the	  matA	  upstream	  
region	  of	  strains	  IHE	  3034	  and	  CFT073	  exhibit	  an	  almost	  identical	  nucleotide	  sequence	  while	  




Figure	   8.	   Sequence	   alignment	   of	  matA	   upstream	   region	   of	   E.	   coli	   strains	   IHE3034,	   CFT073	   and	  
MG1655.	  	  
Three	   different	   promoters	   with	   transcriptional	   start	   sites	   (T1,	   T2,	   T3)	   as	   well	   as	   the	   -­‐35	   and	   -­‐10	  
promoter	  elements	  are	  indicated.	  The	  main	  promoter	  P2	  contains	  an	  RcsAB	  box	  (Lehti	  et	  al.,	  2013).	  
Nucleotides	   that	   differ	   from	   the	   IHE3034	   sequence	   are	   indicated	   in	   red.	   For	   the	   reporter	   the	  




Here,	  I	  used	  the	  PmatACFT073	   lacZ	  reporter	  to	  test	  regulation	  by	  RcsB	  and	  MatA	  (Figure	  9A).	  
This	   reporter	  was	   integrated	   into	   the	   chromosome	  of	   rcsB+	   strain	   (T1749)	  and	  an	   isogenic	  
ΔrcsB	   strain	   (T1747)	   as	  well	   as	   in	   isogenic	   PL-­‐matA	  and	   PL-­‐matA	  ΔrcsB	   strains	   background	  
(T1986	  and	  T1987).	  In	  the	  two	  latter	  strains	  the	  native	  HNS	  repressed	  mat	  promoter	  in	  the	  K-­‐
12	   genome	   was	   replaced	   by	   the	   phage	   λ	   PL	   promoter	   causing	   constitutive	   expression	   of	  
matA.	  The	  PmatACFT073	  lacZ	  fusion	  exhibited	  basal	  expression	  levels	  of	  167	  units	  in	  the	  rcsB+	  
strain,	   i.e.	   in	   the	   presence	   of	   RcsB,	   in	  which	   chromosomal	  matA	   	   is	   not	   expressed	   (strain	  
T1749)	   (Figure	   9B).	   In	   the	   presence	   of	   MatA	   and	   RcsB	   (PL-­‐matA	   rcsB+	   strain	   T1986)	   the	  
expression	   level	   of	   the	   PmatACFT073	   lacZ	   reporter	   increased	   to	   1367	   units	   (Figure	   9B).	  
However,	  upon	  expression	  of	  matA	  (allele	  PL-­‐matA)	  in	  the	  ΔrcsB	  strain	  (T1987)	  the	  activity	  of	  
24	  
	  
the	  Pmat	  lacZ	  reporter	  was	  very	  low	  (89	  units,	  Figure	  9B).	  Complementation	  of	  this	  PL-­‐matA	  
ΔrcsB	  strain	  with	  rcsB	  using	  plasmid	  pKETS6	  triggered	  an	  increase	  of	  Pmat	  lacZ	  expression	  to	  
2468	  units	  (Figure	  9B).	  Similar	  results	  were	  obtained	  for	  rcsB+	  strain	  T1749	  and	  ΔrcsB	  strain	  
with	   MatA	   expressed	   from	   plasmid	   pKEDP51	   (Figure	   9B).	   Taken	   together,	   the	   results	  
demonstrate	   that	   both	   proteins	  MatA	   and	   RcsB	   are	   required	   for	   activating	   the	  matACFT073	  
promoter	  indicating	  that	  a	  MatA-­‐RcsB	  heterodimer	  activates	  the	  mat	  promoter.	  
Next,	  I	  assessed	  whether	  activation	  by	  MatA-­‐RcsB	  depends	  on	  RcsB	  phosphorylation.	  
To	   this	   end,	   the	   reporter	   strain	   T1987	   (PL-­‐matA	   ΔrcsB)	   was	   transformed	   with	   a	   plasmid	  
encoding	   RcsB-­‐D56E	   (pKETS7)	   mimicking	   phosphorylated	   RcsB	   and	   RcsB-­‐D56A	   (pKES235)	  
that	  mimics	   the	   non-­‐phosphorylated	   inactive	   RcsB	   (Scharf,	   2010).	   Upon	   complementation	  
with	   rcsB-­‐D56E	   and	   rcsB-­‐D56A	   the	   expression	   levels	   were	   3207	   units	   and	   2177	   units,	  
respectively	   (Figure	   9B).	   The	   moderate	   difference	   in	   activation	   of	   Pmat	   by	   the	   RcsB-­‐D56	  
mutants	   and	   wild-­‐type	   RcsB	   (2468	   units)	   suggest	   that	   transcriptional	   activation	   of	   the	  
matACFT073	   promoter	   by	   MatA-­‐RcsB	   heterodimers	   is	   only	   weakly	   dependent	   on	   RcsB	  
phosphorylation.	   These	   results	   are	   in	   accordance	   with	   expression	   studies	   in	   NMEC	   strain	  
IHE3034,	  where	   deletion	   of	   the	   Rcs	   phosphorelay	   genes	   rcsC	   and	   rcsD	   did	   not	   affect	  mat	  




Figure	  9.	  MatA-­‐RcsB	  activates	  the	  matACFT073	  promoter.	  
(A)	  The	  matACFT073	  promoter	   region	   from	  -­‐552	   to	  +68	   relative	   to	   the	  T1	   transcription	   start	   site	  was	  
fused	   to	   lacZ	   on	   plasmid	   pKEDP49	   and	   integrated	   into	   the	   attB	   site	   of	   the	   chromosome.	   (B)	   The	  
expression	  levels	  of	  the	  PmatACFT073	  lacZ	  reporter	  were	  determined	  in	  rcsB+	  ΔlacZ	  strain	  T1749,	  ΔrcsB	  
ΔlacZ	   strain	   T1747,	   PL-­‐matA	   rcsB+	   ΔlacZ	   strain	   T1986	   and	   PL-­‐matA	   ΔrcsB	   ΔlacZ	   strain	   T1987.	   For	  
complementation,	  rcsB	  was	  expressed	  from	  plasmid	  pKETS6.	  RcsB	  derivatives	  D56E,	  D56N,	  and	  D56A	  
were	   expressed	   from	   plasmids	   pKETS7,	   pKETS8	   and	   pKES235,	   respectively.	   Empty	   vector	   pKESK22	  
serves	   as	   control	   (pCtrl).	   MatA	   was	   expressed	   from	   plasmid	   pKEDP51	   (pMatA).	   Cultures	   for	   β-­‐
galactosidase	  assays	  were	  grown	  in	  LB	  medium	  to	  an	  OD600	  of	  0.5,	  if	  necessary	  supplemented	  with	  1	  
mM	  IPTG	  and	  50	  µg	  ml-­‐1	  of	  ampicillin	  and/or	  25	  µg/ml	  of	  kanamycin.	  
	  
Recently	   it	  was	   shown	   that	  ectopic	  expression	  of	  matA	   impairs	   the	   swimming	  behavior	  of	  
E.	  coli	   strains	   IHE3034	   (NMEC)	   and	  MG1655	   (K-­‐12)	   presumably	   by	   repression	   of	   the	   flhDC	  
operon	  encoding	  the	  master	  regulator	  of	  flagella	  synthesis	  FlhD4C2	  (Lehti	  et	  al.,	  2012a).	  Here,	  
I	  tested	  whether	  this	  repression	  of	  motility	  by	  ectopically	  expressed	  MatA	  depends	  on	  RcsB.	  
To	  this	  end,	  3	  µl	  of	  an	  overnight	  culture	  of	  motile	  E.	  coli	  K-­‐12	  rcsB+	  strain	  T1241	  was	  spotted	  
to	  the	  center	  of	  a	  soft	  agar	  plate	   (0.2	  %	  agar),	  and	  the	  motility	  radius	  was	  measured	  after	  
growth	   of	   5	   hours	   at	   37°C.	   The	   motility	   radius	   of	   the	   rcsB+	   K-­‐12	   strain	   T1241	   was	  
approximately	   16	   mm	   (Figure	   10).	   When	   this	   strain	   was	   transformed	   with	   a	   plasmid	  
expressing	  matA	   under	   control	   of	   the	   tac	   promoter	   (pKEDP30),	   its	   motility	   on	   soft	   agar	  
plates	  supplemented	  with	  0.2	  mM	  IPTG	  was	  completely	  abolished	  (Figure	  10).	  The	  motility	  of	  
an	   isogenic	  ΔrcsB	   strain	   (U89)	  was	   similar	   to	   the	   rcsB+	   strain	   (16	  mm,	   Figure	  10),	   and	   this	  
ΔrcsB	  strain	  remained	  motile	  upon	  additional	  expression	  of	  matA	  (18	  mm,	  Figure	  10).	  These	  
data	   demonstrate	   that	   inhibition	  of	  motility	   by	  MatA	   requires	  RcsB,	   indicating	   that	  MatA-­‐





Figure	  10.	  MatA-­‐RcsB	  inhibits	  motility.	  
Motility	  of	  rcsB+	  strain	  T1241	  and	  ΔrcsB	  strain	  U89	  and	  of	  transformants	  of	  these	  strains	  ectopically	  
expressing	   MatA	   under	   the	   control	   of	   Ptac	   (pKEDP30)	   was	   determined.	   Overnight	   cultures	   were	  
grown	  in	  LB	  medium,	  if	  transformed	  supplemented	  with	  1	  mM	  IPTG	  and	  25	  µg	  ml-­‐1	  kanamycin.	  3	  µl	  
of	  each	  culture	  was	  spotted	  on	  the	  center	  of	  a	  0.2	  %	  soft	  agar	  plate	  containing	  0.2	  mM	  IPTG	  and	  25	  
µg	  ml-­‐1	  kanamycin	  for	  transformants,	  and	  the	  plates	  were	  incubated	  at	  37°C	  for	  5	  hours.	  The	  plates	  
were	   scanned	   and	   the	   motility	   radii	   that	   are	   indicated	   by	   arrows	   were	   measured.	   Image	   scale:	  
Reduced	  by	  1:4	  of	  original	  size.	  
	  
2.2.5.   Search	  for	  potential	  DctR	  targets	  
Our	   two-­‐hybrid	   analyses	   identified	   DctR	   as	   a	   further	   FixJ/NarL-­‐type	   protein	   that	   interacts	  
with	  RcsB	  (Fabisch,	  2008).	  Gene	  dctR	  (yhiF)	  presumably	  forms	  an	  operon	  with	  the	  upstream	  
gene	   slp	   encoding	   a	   lipoprotein	   (Tucker	   et	   al.,	   2003).	   Both	   DctR	   and	   Slp	   play	   a	   role	   in	  
protection	   against	   organic-­‐acids	   that	   are	   metabolic	   end	   products	   under	   acidic	   conditions	  
(Mates	   et	  al.,	   2007).	   The	  expression	  of	  slp-­‐dctR	   is	   activated	  by	  YdeO,	  a	   regulator	  of	  genes	  
involved	   in	   the	  cellular	   response	  to	  acid	  resistance	  (Masuda	  &	  Church,	  2003).	  However,	  as	  
no	  target	  locus	  of	  DctR	  is	  known	  (Mates	  et	  al.,	  2007),	  to	  analyze	  the	  relevance	  of	  the	  DctR-­‐
RcsB	  protein	  interaction	  in	  gene	  regulation	  I	  first	  needed	  to	  identify	  a	  DctR	  target.	  For	  this	  I	  
performed	   a	   microarray	   analysis	   and	   compared	   the	   transcriptome	   of	   E.	  coli	   K-­‐12	   strain	  
BW30270	   harboring	   a	   plasmid	   encoding	   DctR	   under	   control	   of	   the	   IPTG	   inducible	   tac	  
promoter	  (pKEDP31)	  to	  the	  same	  strain	  harboring	  vector	  pKESK22	  as	  control.	  The	  expression	  
of	  dctR	  was	  induced	  by	  addition	  of	  IPTG	  for	  30	  minutes	  in	  the	  exponential	  growth	  phase.	  The	  
transcript	  analysis	   revealed	   that	  57	   loci	  were	  more	   than	  10-­‐fold	  upregulated	   (with	  p	  value	  
<	  0.05).	  At	  ten	  of	  these	  57	  loci,	  the	  microarray	  probe	  set	  mapped	  within	  an	  annotated	  gene	  
(Table	   3).	   However,	   the	   expression	   of	   these	   ten	   targets	   is	   low	   according	   to	   the	   average	  
intensities.	  The	  average	  fluorescence	  intensities	  were	  in	  the	  range	  of	  6.85	  for	  ypjC	  and	  8.39	  
for	  yaiV	  upon	  DctR	  expression	  (see	  Table	  3).	  The	  average	  intensities	  of	  three	  housekeeping	  




Table	  3.	  DctR	  upregulated	  loci	  determined	  by	  microarray	  analysis	  






3657577-­‐3658135	   <<	   arrS	   3657986-­‐3658054	   small	  regulatory	  RNA	   18.4	   3.78/7.82	  
4260607-­‐4261264	   >>	   yjbM	   4260599-­‐4261306	   predicted	  protein	   16.0	   3.94/7.70	  
2991310-­‐2991759	   >>	   ygeG	   2991268-­‐2991759	   predicted	  chaperone	   14.0	   4.18/7.84	  
2990556-­‐2990915	   >>	   ygeF	   2990554-­‐2991043	   hypothetical	  protein	   13.9	   4.27/7.96	  
2784529-­‐2784724	   <<	   ypjC	   2783638-­‐2785011	   pseudo	   13.5	   3.46/6.85	  
4250967-­‐4252274	   >>	   yjbI	   4250703-­‐4252283	   pseudo	   13.4	   4.77/8.28	  
1096019-­‐1096776	   >>	   ycdU	   1095843-­‐1096829	   predicted	  inner	  
membrane	  protein	  
12.9	   4.51/8.05	  
394477-­‐395129	   >>	   yaiV	   394506-­‐395129	   predicted	  DNA-­‐binding	  
transcriptional	  regulator	  
10.4	   5.12/8.39	  
2989936-­‐2990345	   <<	   yqeK	   2989935-­‐2990360	   hypothetical	  protein	   10.3	   3.78/6.96	  
3633574-­‐3634438	   <<	   yhiL	   3632852-­‐3634458	   pseudo	   10.3	   4.67/7.74	  
	  
housekeeping	  genes	  
224773-­‐224815	   >>	   rrsH	   223771-­‐225312	   16S	  ribosomal	  RNA	   1.0	   15.23/15.20	  
963844-­‐964109	   >>	   ihfB	   963051-­‐963335	   integration	  host	  factor,	  
β	  subunit	  
1.0	   12.86/12.86	  
3213085-­‐3213830	   >>	   rpoD	   3211069-­‐3212910	   RNA	  polymerase,	  σ70	   1.4	   12.37/12.79	  
Summary	  of	  all	  significantly	  DctR-­‐regulated	  loci	  (>	  10-­‐fold,	  p	  value	  <	  0.05).	  
a	  Positions	  of	  probes	  and	  genes	  are	  given	  as	  coordinates	  of	  U0096.3	  genome.	  
b	  ‘dir’	  describes	  the	  orientation	  of	  the	  probe	  (<<	  for	  lower	  strand,	  >>	  for	  upper	  strand).	  
c	  Average	  intensities	  of	  the	  strain	  harboring	  control	  (left)	  or	  DctR	  expressing	  plasmid	  (right)	  	  
	  
Of	   these	   10	   loci	   I	   selected	   six	   loci	   (ycdU,	   ygeF,	   ygeG,	   yjbI,	   yjbM,	   ypjC)	   to	   validate	   the	  
microarray	  data	  by	  qRT-­‐PCR.	  None	  of	   the	  six	   targets	  was	  significantly	  upregulated	  by	  DctR	  
under	  the	  same	  growth	  conditions.	  Since	  DctR	  is	  encoded	  in	  an	  acid	  stress	   island,	  the	  qRT-­‐
PCR	  experiment	  was	   repeated	  with	  RNA	  obtained	   from	   transformants	   that	  were	  grown	   in	  
acidic	  conditions	  (LB	  MES	  pH	  5.5,	  supplemented	  with	  1	  mM	  IPTG	  for	  30	  minutes).	  Loci	  ygeF,	  
ycdU	   and	   yjbM	   exhibited	   an	   around	   10-­‐fold,	   5-­‐fold,	   and	   2.5-­‐fold	   upregulation	   by	   DctR,	  
respectively,	  when	   bacteria	  were	   grown	   at	   pH	   5.5	   but	   not	  when	   grown	   at	   pH	   7.0	   (Figure	  
11A).	   The	   expression	   of	   loci	   ygeG,	   yjbI,	   and	   ypjC	   was	   not	   upregulated	   in	   the	   presence	   of	  
DctR,	   neither	   in	   bacteria	   grown	   at	   pH	   7	   nor	   at	   pH	   5.5.	   Loci	   ygeF	   and	   ycdU	   were	   further	  
analyzed	  by	  qPCR	  (Figure	  11B).	  For	  this,	  RNA	  was	  isolated	  from	  rcsB+	  strain	  S3974	  and	  ΔrcsB	  
strain	   T73,	   harboring	   either	   control	   vector	   pBAD24	   or	   DctR	   expression	   vector	   pKEDP57	  
grown	   at	   pH	   5.5.	   However,	   the	   determined	   fold	   change	   was	   unspecific	   and	   the	   absolute	  
expression	  levels	  reflected	  by	  the	  Ct	  values	  were	  very	  low	  (Figure	  11B).	  The	  effect	  of	  DctR	  on	  
ygeF	  expression	  was	  also	  analyzed	  by	  β-­‐galactosidase	  assays.	  For	  this,	  the	  promoter	  region	  
of	  ygeF	   (-­‐193	  to	  +12	  rel.	  to	  start	  codon)	  was	  fused	  to	   lacZ	  on	  pKEDP61	  and	  integrated	  into	  
the	  chromosome	  of	  ΔlacZ	  strain	  (resulting	  T2017)	  and	  ΔlacZ	  PL-­‐dctR	  strain	  (resulting	  T2016).	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The	  lacZ	  data	  showed	  no	  differences	  of	  PygeF	  activation	  upon	  dctR	  expression,	  neither	  at	  pH	  
7.0	   nor	   at	   pH	   5.5.	   In	   addition,	   the	   effect	   of	   DctR	   on	   arrS	   expression	   was	   analyzed	   by	   β-­‐
galactosidase	  assays.	   The	  expression	  of	   gene	  arrS	   encoding	   the	  69	  nt	   long	   small	  RNA	  ArrS	  
(Aiso	   et	  al.,	   2011)	  was	  not	  analyzed	  by	  qPCR	  because	  of	   its	   short	   length	   it	  was	  difficult	   to	  
design	   an	   adequate	   primer	   pair.	   For	   the	   construction	   of	   the	   promoter	   lacZ	   fusion,	   the	  
promoter	   region	   of	   arrS	   (-­‐311	   to	   +10	   rel.	   to	   the	   transcription	   start)	   was	   fused	   to	   lacZ	  
resulting	  plasmid	  pKEDP52.	  The	  rcsB+	  ΔlacZ	  strain	  S4197	  and	  PL-­‐dctR	  rcsB+	  ΔlacZ	  strain	  T1841	  
were	   transformed	  with	   plasmid	   pKEDP52	   harboring	   ParrS	   lacZ	   and	   β-­‐galactosidase	   assays	  
were	   performed.	   The	   lacZ	   data	   showed	   no	   differences	   of	   ParrS	   activation	   upon	   dctR	  
expression,	  neither	  at	  pH	  7.0	  nor	  at	  pH	  5.5.	  Taken	  together,	  a	  certain	  target	  gene	  activated	  
by	  DctR	  could	  not	  be	  identified	  in	  E.	  coli	  K-­‐12.	  
	  
Figure	  11.	  Influence	  of	  DctR	  and	  pH	  on	  expression.	  
qRT-­‐PCR	  analysis	  of	  chromosomal	  loci	  expression.	  Cultures	  were	  inoculated	  in	  LB-­‐MES	  (pH	  5.5)	  and	  
LB-­‐MOPS	  (pH	  7.0)	  supplemented	  with	  25	  µg	  ml-­‐1	  kanamycin	  or	  50	  µg	  ml-­‐1	  of	  ampicillin	  to	  an	  OD600	  of	  
0.05	  for	  exponential	  growth.	  At	  an	  OD600	  of	  0.3	  IPTG	  was	  added	  to	  a	  final	  concentration	  of	  1	  mM	  and	  
cultures	  were	  grown	  for	  additional	  30	  min.	  For	  first-­‐strand	  cDNA	  synthesis,	  random	  hexameric	  DNA	  
oligonucleotides	  were	  used.	  Quantitative	  PCR	  was	  performed	  using	  serial	  dilutions	  of	  cDNA	  and	  loci	  
specific	  primers.	  Ct	  values	  were	  normalized	  to	  rpoD	  expression	  determined	  with	  primers	  T247	  and	  
T248.	   (A)	   RNA	  was	   isolated	   from	   cultures	   of	   strain	   S3839	   (rcsB+),	   harboring	   either	   control	   vector	  
pKESK22	  (-­‐DctR)	  or	  DctR	  expression	  vector	  pKEDP31	  (DctR).	  Expression	  level	  is	  given	  as	  fold-­‐change	  
compared	  with	   the	  wild-­‐type	  control	   (S3839	  harboring	  pKESK22)	  grown	  at	  pH	  5.5.	  Rel.	  expression	  
indicates	  values	  of	  1	  experiment.	  (B)	  RNA	  was	  isolated	  from	  cultures	  of	  rcsB+	  strain	  S3974	  and	  ΔrcsB	  
strain	   T73,	   harboring	   either	   control	   vector	   pBAD24	   (pCtrl)	   or	   DctR	   expression	   vector	   pKEDP57	  
(pDctR)	  grown	  at	  pH	  5.5	  in	  LB-­‐MES	  supplemented	  with	  50	  µg	  ml-­‐1	  of	  ampicillin	  and	  0.2	  %	  arabinose.	  
Expression	  level	  is	  given	  as	  fold-­‐change	  compared	  with	  the	  control	  (S3974	  harboring	  pBAD24).	  Rel.	  




2.2.6.   Triple	  reporter	  system	  
To	   find	  single	  amino	  acid	   substitutions	  within	  RcsB	   that	  potentially	   impair	   interaction	  with	  
specific	  partners,	  so	  far	  a	  plasmid	  expressing	  randomly	  mutated	  rcsB	  was	  transformed	  into	  a	  
ΔrcsB	  ΔlacZ	  bglJC	  reporter	  strain	  carrying	  the	  BglJ-­‐RcsB	  activated	  leuO	  promoter	  fused	  to	  lacZ	  
(T572).	  The	  transformants	  were	  screened	  on	  X-­‐gal	   indicator	  plates,	  and	  clones	  exhibiting	  a	  
Lac-­‐negative	   phenotype	  were	   characterized.	   These	   RcsB	  mutants	  were	   then	   characterized	  
for	   transcriptional	   activation	   of	   targets	   that	   are	   activated	   by	   RcsA-­‐RcsB	   and	   RcsB-­‐RcsB,	  
respectively.	   For	   improving	   the	  efficiency	  of	   this	   screen,	   I	  designed	  a	   triple	   reporter	   strain	  
with	   features	   that	   allow	   for	   analysis	   of	   transcriptional	   activation	   by	   RcsB-­‐RcsB,	   RcsA-­‐RcsB	  
and	  BglJ-­‐RcsB	  in	  the	  same	  strain.	  	  
In	  this	  ΔrcsB	  ΔlacZ	  strain	  rcsA	   is	  constitutively	  expressed	  under	  the	  control	  of	  the	  PL	  
promoter.	   RcsA,	   together	   with	   plasmid	   provided	   RcsB,	   activates	   colonic	   acid	   capsule	  
production,	   and	   the	   cells	   become	   mucoid	   (Gupte	   et	   al.,	   1997).	   The	   bglJ	   gene	   is	   as	   well	  
constitutively	   expressed	   and	   with	   a	   functional	   version	   of	   RcsB,	   BglJ-­‐RcsB	   heterodimers	  
activate	  expression	  of	  the	  bgl	  operon	  (Venkatesh	  et	  al.,	  2010)	  and	  the	  colonies	  exhibit	   the	  
Bgl	   positive	   phenotype	   on	   BTB	   salicin	   indicator	   plates.	   The	   third	   feature	   of	   this	   triple	  
reporter	   strain	   is	   the	   integrated	   PrprA	   lacZ	   fusion	   which	   is	   activated	   by	   RcsB-­‐RcsB	  
homodimers	   that	   allows	   screening	   for	   the	   Lac	   phenotype	   on	   X-­‐gal	   indicator	   plates.	   The	  
relevant	  genotype	  of	  this	  triple	  reporter	  strain	  (T1751)	  is	  shown	  in	  Figure	  12A.	  	  
	  
Figure	  12.	  Triple	  reporter	  system	  for	  RcsB	  mutagenesis	  screen	  
(A)	  Relevant	  phenotype	  of	  the	  triple	  reporter	  strain	  T1751.	  The	  PrprA	   lacZ	  fusion	  is	  integrated	  into	  
the	  attB	  site	  of	  a	  ΔrcsB	  ΔlacZ	  strain	  with	  rcsA	  under	  the	  control	  of	  the	  constitutive	  PL	  promoter	  and	  
expressing	  bglJ	  constitutively.	  (B)	  Phenotypic	  assay	  of	  strain	  T1751	  transformed	  with	  empty	  vector	  
(pKESK22)	  or	  vectors	  expressing	  wild-­‐type	  RcsB	  and	  mutants	  D56E	  and	  D56A	  (pKETS6,	  pKETS7,	  and	  
pKES235)	  on	  BTB	  salicin	  plates	  (kanamycin,	  IPTG)	  and	  on	  (C)	  X-­‐gal	  plates	  (kanamycin,	  IPTG).	  
	  
	  
For	   testing	   this	   reporter	   system,	   strain	  T1751	  was	   transformed	  either	  with	  empty	  plasmid	  
pKESK22	   or	   plasmids	   expressing	   wild-­‐type	   RcsB	   and	   mutants	   D56E	   and	   D56A	   (pKETS6,	  
pKETS7	  and	  pKES235)	  and	  the	  transformants	  were	  plated	  on	  BTB	  salicin	  plates	  (Figure	  12B)	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and	   LB	   X-­‐gal	   plates	   (Figure	   12C)	   both	   containing	   kanamycin	   for	   selection	   and	   IPTG	   for	  
induction	  of	  rcsB	  expression.	  In	  the	  absence	  of	  RcsB	  (empty	  vector	  pKESK22),	  colonies	  of	  the	  
reporter	   strain	   exhibited	   the	   Bgl	   negative	   (transparent	   colonies)	   and	   Lac	   negative	   (white	  
colonies)	  phenotype	  with	  non-­‐mucoid	  colonies,	  indicating	  that	  neither	  expression	  of	  bgl	  nor	  
of	  the	   lacZ	  reporter	  and	  the	  capsule	  genes	  was	  induced.	  Upon	  complementation	  with	  wild-­‐
type	  rcsB	  or	  derivatives	  D56E	  or	  D56A,	  all	  transformants	  showed	  the	  Bgl	  phenotype	  on	  BTB	  
salicin	  plates	  (yellow	  colonies,	  Figure	  12B),	  indicating	  that	  expression	  of	  bgl	  was	  induced	  by	  
BglJ-­‐RcsB	   and	   that	   induction	   is	   independent	   on	   RcsB	   phosphorylation.	   Upon	  
complementation	   with	   wild-­‐type	   rcsB	   or	   derivatives,	   all	   transformants	   exhibited	   a	   Lac	  
positive	  phenotype	  on	  X-­‐gal	  plates,	  albeit	  only	  slightly	  (light	  blue	  colonies,	  Figure	  12C).	  Wild-­‐
type	   RcsB	   and	   RcsB-­‐D56E	   but	   not	   RcsB-­‐D56A	   were	   able	   to	   induce	   a	   mucoid	   phenotype,	  
indicating	  that	  capsule	  gene	  expression	  is	  induced	  by	  RcsA-­‐RcsB	  in	  an	  RcsB	  phosphorylation	  
dependent	  manner	   (Figure	   12B	   and	  C).	   Taken	   together,	   this	   phenotypic	   screening	   reflects	  
the	   results	   obtained	   by	   β-­‐galactosidase	   assays,	   in	   detail	   the	   RcsB	   phosphorylation	  
independence	   for	   transcriptional	   activation	   by	   BglJ-­‐RcsB	   and	   the	   distinct	   RcsB	  
phosphorylation	   dependence	   for	   transcriptional	   activation	   by	   RcsA-­‐RcsB.	   However,	   the	   at	  
least	   partly	   RcsB	   phosphorylation	   dependence	   of	   transcriptional	   activation	   by	   RcsB	  
homodimers	   that	   was	   found	   in	   the	   β-­‐galactosidase	   assays	   is	   indistinguishable	   in	   the	  
phenotypic	  assay.	  Summarized	  this	  triple	  reporter	   is	  a	  suitable	  tool	  for	  performing	  random	  
mutagenesis	   screens	   for	   RcsB	  mutants	   that	   impair	   the	   activity	   of	   BglJ-­‐RcsB,	   RcsA-­‐RcsB	   or	  
RcsB-­‐RcsB,	  nevertheless	  the	  effect	  of	  the	  RcsB	  mutants	  on	  transcriptional	  activation	  needs	  to	  
be	   further	   studied	   by	   quantitative	   methods	   such	   as	   β-­‐galactosidase	   assays.	   Notably,	   the	  
results	   show	   that	   RcsB	   homodimers	   as	  well	   as	   RcsA-­‐RcsB	   and	   BglJ-­‐RcsB	   heterodimers	   are	  
simultaneously	  active,	  suggesting	  that	  RcsB	  forms	  homodimers	  and	  heterodimers	  with	  BglJ	  
and	  RcsA	  at	  the	  same	  time,	  when	  BglJ	  and	  RcsA	  are	  present	  in	  the	  cell.	  	  
	   	  
31	  
	  
2.3.  Relevance	  of	  particular	  residues	  of	  RcsB	  for	  specific	  RcsB	  dimers	  
Our	   results	   demonstrated	   that	   MatA-­‐RcsB	   heterodimers	   are	   active	   independent	   of	   RcsB	  
phosphorylation,	   as	   shown	  previously	   for	  BglJ-­‐RcsB	   (Venkatesh	   et	   al.,	   2010,	   Salscheider	   et	  
al.,	   2013).	   In	   contrast,	   the	   activity	   of	   RcsA-­‐RcsB	   heterodimers	   and	   RcsB	   homodimers	   is	  
phosphorylation-­‐dependent	   (Majdalani	   &	   Gottesman,	   2005,	   Clarke,	   2010).	   To	   study	   the	  
determinants	   for	   transcriptional	   activation	   by	   RcsB	   homo-­‐	   and	   heterodimers,	   I	   identified	  
particular	   residues	   of	   RcsB	   being	   relevant	   for	   transcriptional	   activation	   in	   the	   context	   of	  
interaction	  partner.	  For	  this,	  RcsB	  mutants	  were	  specifically	  constructed	  or	   isolated	  from	  a	  
mutagenesis	  screen	  and	  tested	  in	  the	  appropriate	  reporter	  systems.	  
2.3.1.   	  Identification	  of	  relevant	  amino	  acids	  within	  RcsB	  
To	  identify	  particular	  amino	  acids	  of	  RcsB	  that	  are	  important	  for	  its	  activity	  together	  
with	  the	  auxiliary	  proteins,	  a	  construction	  of	  RcsB	  mutants	  as	  well	  as	  a	  random	  mutagenesis	  
screen	   was	   performed	   in	   which	   31	   RcsB	   residues	   were	   replaced	   obtaining	   36	   different	  
mutants.	   These	   RcsB	   residues	   were	   selected	   as	   follows:	   (1)	   By	   a	   bioinformatics	   based	  
analysis	  in	  which	  38	  RcsB	  protein	  sequences	  from	  various	  Proteobacteria	  were	  aligned	  (Kay	  
Hofmann,	  Milteny	  Biotech),	   presumably	   surface-­‐exposed	  amino	  acids	  were	   chosen.	   In	   this	  
analysis,	   the	   amino	   acid	   residues	   I14,	   Y64,	   D66,	   R76,	   H77,	   and	   M88	   were	   presumed	   as	  
notably	  surface	  exposed	  (Figure	  13C).	  (2)	  By	  a	  comparison	  of	  RcsB	  with	  conserved	  features	  
of	   response	   regulators,	   amino	   acids	   of	   the	   highly	   conserved	   active	   quintet	  which	   includes	  
D56,	  D11,	  T87,	  and	  K109	  were	  chosen	  (Bourret,	  2010).	  (3)	  In	  addition	  the	  highly	  conserved	  
and	  presumably	  structurally	  important	  residues	  P60	  and	  G67	  were	  selected	  (Figure	  13A).	  (4)	  
Residues	  K180	  and	   S184	   (Figure	  13E)	  were	   selected	  because	  of	   their	   location	   in	   the	  DNA-­‐
recognition	  helix	  α9	  from	  which	  K180	  was	  shown	  to	  be	  critical	  for	  DNA-­‐binding	  activity	  (Thao	  
et	   al.,	   2010).	   (5)	   Residues	   I199	   and	   N203	   (Figure	   13E)	   are	   located	   in	   helix	   α10	   of	   the	   C-­‐
terminal	  domain	  which	  is	   involved	  in	  dimerization	  of	  the	  NarL	  C-­‐terminal	  domain	  (Maris	  et	  
al.,	  2002).	  (6)	  On	  the	  basis	  of	  a	  structure	  prediction	  (see	  below),	  presumably	  surface	  exposed	  
residues	  of	  the	  α4-­‐β5-­‐α5	  surface	  that	  has	  been	  defined	  as	  dimerization	  interface	  in	  response	  
regulators	   of	   the	   PhoB-­‐type,	  were	   chosen	   (Gao	  &	   Stock,	   2010,	   Bourret,	   2010).	   This	   group	  
comprises	  residues	  L95,	  S96,	  L99,	  D100,	  E104,	  I106,	  L108,	  T114,	  D115	  and	  K118	  (Figure	  13B).	  
(7)	   In	  a	  non-­‐saturated	   random	  mutagenesis	   screen	   for	   inactive	  RcsB	  mutants,	  D11G,	  L41P,	  




Figure	  13.	  Structural	  model	  of	  the	  receiver	  domain	  of	  RcsB.	  
Structural	   model	   of	   the	   receiver	   domain	   and	   DNA-­‐binding	   domain	   of	   RcsB.	   The	   model	   of	   the	  
receiver	  domain	  was	  predicted	  by	  the	  PHYRE2	  server	  (Kelley	  &	  Sternberg,	  2009)	  on	  the	  basis	  of	  the	  
crystal	  structure	  of	  NarL	  (Schnell	  et	  al.,	  2008).	  The	  phosphorylation	  site	  is	  marked	  in	  blue.	  The	  DNA-­‐
binding	  domain	  was	  solved	  for	  RcsB	  of	  Erwinia	  amylovora	  (Pristovsek	  et	  al.,	  2003).	  Mutated	  residues	  
are	  marked	  in	  red.	  (A)	  Top	  view	  on	  the	  active	  site	  with	  active	  quintet	  and	  highly	  conserved	  residues	  
indicated.	  The	  α	  helices	  are	   labelled	   from	  1-­‐5.	   (B)	  Side	  view	  on	   the	  α4-­‐β5-­‐α5-­‐surface	  with	  surface	  
exposed	  amino	  acids	  indicated.	  (C)	  Top	  view	  on	  the	  active	  site	  with	  amino	  acids	  indicated	  that	  were	  
predicted	   to	  be	   surface	  exposed	  by	  bioinformatics	  based	  analysis.	   (D)	   Top	  view	  on	   the	  active	   site	  
with	   amino	   acids	   being	   found	   in	   a	   random	   mutagenesis	   screen.	   (E)	   RcsB	   DNA-­‐binding	   domain.	  




Receiver	   domains	   of	   two-­‐component	   response	   regulators	   typically	   exhibit	   a	   (βα)5	  
topology	  with	   five	  parallel	  β	   sheets	   in	   the	  center	   surrounded	  by	   two	  α	  helices	  on	   the	  one	  
and	  three	  on	  the	  other	  side	  (Bourret,	  2010).	  The	  structure	  of	  the	  RcsB	  receiver	  domain	  has	  
not	   been	   solved.	   Therefore,	   I	   used	   the	   PHYRE2	   server	   (Kelley	   et	   al.,	   2015)	   to	   predict	   a	  
structural	  model	  of	   the	  RcsB	   receiver	  domain	  on	   the	  basis	  of	   the	  crystal	   structure	  of	  NarL	  
(Schnell	   et	   al.,	   2008),	   comprising	   residues	   1-­‐125	   (Figure	   13A-­‐D).	   The	   structural	   model	  
suggests	   that	   in	  RcsB,	   the	  active	  quintet	  group	  comprises	   the	  amino	  acid	  residue	  D56	  that	  
can	  become	  phosphorylated,	  as	  well	  as	  D10,	  D11,	  T87,	  M88	  and	  K109.	  Of	   these	   the	   three	  
aspartate	  residues	  D10,	  D11,	  and	  D56	  presumably	  coordinate	  the	  metal	  ion	  that	  is	  essential	  
for	  the	  phosphoryl	  group	  chemistry	  and	  hence	  for	  receiver	  domain	  function	  (Bourret,	  2010).	  
Interestingly,	   at	   the	   position	   corresponding	   to	   methionine	   residue	   88	   in	   RcsB,	   in	   other	  
bacterial	   response	   regulators	   there	   is	   often	   a	   small	   amino	   acid	   such	   as	   alanine	   or	   glycine	  
conserved	   (Bourret,	   2010).	   Additional	   conserved	   residues	  within	   the	   receiver	   domains	   are	  
amino	  acids	  P60	  and	  G67	  (Figure	  13A).	  The	  structure	  of	  the	  DNA-­‐binding	  domain	  was	  solved	  
for	   RcsB	   derived	   from	   Erwinia	   amylovora	   comprising	   amino	   acids	   129-­‐215	   by	   NMR	  
spectroscopy	  (Pristovsek	  et	  al.,	  2003).	  Helices	  α8	  and	  α9	  (residues	  151-­‐194)	  were	  identified	  
as	  the	  central	  HTH	  DNA-­‐binding	  motif	  which	  is	  stabilized	  by	  helix	  α7	  (Pristovsek	  et	  al.,	  2003).	  
According	   to	   their	   possible	   function,	   the	  RcsB	  mutants	   can	  be	  divided	   into	   five	   groups	  
with	  exchanged	  amino	  acids	  (i)	  belonging	  to	  the	  active	  quintet	  of	  the	  receiver	  domain	  (D56,	  
D11,	  T87,	  K109),	  (ii)	  being	  highly	  conserved	  within	  receiver	  domains	  of	  response	  regulators	  
(P60,	  G67,	  M88),	  (iii)	  being	  surface	  exposed	  on	  α-­‐helices	  or	  β-­‐sheets	  (I14,	  R76,	  H77,	  L95,	  S96,	  
L99,	  D100,	   E104,	   I106,	   L108,	   T114,	  D115,	   K118),	   (iv)	   other	   residues	   being	   non-­‐exposed	   or	  
located	  within	  loops	  (L41,	  S58,	  D62,	  Y64,	  D66,	  V98),	  and	  (v)	  residues	  within	  the	  DNA-­‐binding	  
domain	  (F162,	  K180,	  S184,	  I199,	  N203).	  
2.3.2.   	  The	  relevance	  of	  particular	  residues	  of	  RcsB	  varies	  with	  its	  interaction	  partner	  
The	  results	  demonstrated	  that	  the	  phosphorylation	  dependence	  of	  RcsB	  for	  transcriptional	  
activation	  varies	  with	  its	  interaction	  partner.	  Phosphorylation	  of	  response	  regulators	  at	  the	  
conserved	  aspartic	  acid	  residue	  is	  considered	  to	  induce	  a	  structural	  change	  that	  stabilizes	  the	  
active	  form	  (Gao	  &	  Stock,	  2010)	  and	  affects	  the	  α4-­‐β5-­‐α5	  surface	  that	  has	  been	  defined	  as	  
dimerization	  interface	  of	  PhoB-­‐type	  response	  regulators	  (Gao	  &	  Stock,	  2010,	  Bourret,	  2010).	  
Helix	   α1	   has	   been	   identified	   as	   dimerization	   surface	   in	   NarL-­‐type	   response	   regulators	  
(Trajtenberg	  et	  al.,	  2014).	  The	  finding	  that	  some	  RcsB-­‐heterodimers	  are	  active	  independent	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of	   RcsB-­‐phosphorylation	   suggests	   that	   for	   these,	   the	   phosphorylation-­‐induced	   structural	  
change	   is	  not	   important	   indicating	   that	   they	   interact	  differently	  or	   that	   the	  active	   form	  of	  
that	  particular	  heterodimer	   is	  more	  stable.	  Here	   I	  analyzed	   if	  particular	  amino	  acids	  of	   the	  
receiver	  domain	  of	  RcsB	  are	   important	   for	   its	   activity	   together	  with	   the	  auxiliary	  proteins.	  
The	   RcsB	   mutants	   were	   analyzed	   in	   reporter	   strains	   with	   PrprA	   lacZ	   (T1052)	   for	   RcsB	  
homodimer	  activity,	  Pwza	  lacZ	  (T963)	  for	  RcsA-­‐RcsB	  activity,	  PleuO	  lacZ	  (T572)	  for	  BglJ-­‐RcsB	  
activity	   and	   PmatA	   lacZ	   (T1987)	   for	   MatA-­‐RcsB	   activity.	   These	   reporter	   strains	   were	  
transformed	  with	   low-­‐copy	  plasmids	  coding	  for	  wild-­‐type	  RcsB	  and	  mutants.	  To	  allow	  data	  
comparison	   the	   expression	   levels	   directed	   by	   the	   respective	   lacZ	   reporter	   fusions	   were	  
standardized	  to	  those	  obtained	   in	  presence	  of	  the	  active	  RcsB	  derivative	  D56E	  which	  were	  
defined	   as	   100	  %.	   A	   brief	   summary	   of	   the	   data	   obtained	   for	   (i)	   active	   quintet,	   (ii)	   highly	  
conserved	  and	  (iii)	  α/β-­‐surface	  exposed	  residues	  is	  as	  follows	  (Figure	  14).	  First,	  mutation	  of	  
residues	  of	  the	  active	  quintet	  including	  D56,	  D11,	  T87,	  and	  K109	  has	  the	  highest	  impact	  on	  
the	  phosphorylation	  dependent	  RcsA-­‐RcsB	  heterodimer	  and	  on	  RcsB.	  Among	  these	  mutants	  
only	  K109A	  has	  strong	  impact	  on	  BglJ-­‐RcsB	  and	  MatA-­‐RcsB.	  Second,	  of	  the	  three	  mutants	  of	  
conserved	   amino	   acid	   residues	   P60A,	   G67A,	   and	   M88A	   the	   latter	   (M88A)	   results	   in	   high	  
activity	  of	  all	  RcsB	  homo-­‐/heterodimers.	   In	  other	  response	  regulators	  a	  small	  amino	  acid	   is	  
highly	   conserved	   at	   position	  M88	   (Bourret,	   2010).	   The	  M88A	  mutation	   may	   stabilize	   the	  
active	  conformation	  of	  RcsB.	  G67A	  has	  a	  strong	   impact	  on	  RcsB,	  RcsA-­‐RcsB,	  and	  BglJ-­‐RcsB,	  
but	   not	   on	  MatA-­‐RcsB,	   while	   P60A	   affects	   only	   the	   phosphorylation	   dependent	   RcsB	   and	  
RcsA-­‐RcsB.	  Third,	  mutation	  of	  the	  presumably	  α/β-­‐surface	  exposed	  residues	  that	  are	  located	  
close	   to	   the	   phosphorylation	   site	   (including	   L95A,	   I106A,	   L108A,	   and	   D115A)	   reduce	   the	  
activity	   of	   RcsB	   and	   RcsA-­‐RcsB	   and	   have	   little	   to	   no	   impact	   on	   BglJ-­‐RcsB	   and	  MatA-­‐RcsB.	  
Mutation	  of	  I14	  to	  alanine	  renders	  all	  dimers	  inactive	  (Figure	  14).	  Residue	  I14	  is	  located	  on	  α	  
helix	  1	  which	  has	  been	   identified	  as	  dimerization	  surface	   in	  NarL-­‐type	   response	   regulators	  
(Trajtenberg	  et	  al.,	  2014).	  The	  data	   suggest	   that	  α	  helix	  1	  may	  constitute	   the	  dimerization	  
interface	  in	  RcsB.	  The	  results	  obtained	  for	  (iv)	  other	  residues	  being	  non-­‐surface	  exposed	  on	  
α-­‐helices	   or	   located	   in	   loops	   are	   as	   follows:	   The	   majority	   of	   mutations	   abolishes	   or	  
significantly	   impairs	   the	   activity	   of	   RcsB	   homodimers	   or	   heterodimers	   with	   RcsA	   or	   BglJ,	  
while	   those	  mutants	   tested	   for	  MatA-­‐RcsB	  did	  not	  have	  an	  effect	   (Figure	  14).	  D66A	  has	   a	  






Figure	   14.	   Effects	   of	   active	   site,	   α/β-­‐surface	   exposed,	   and	   other	   residues	   on	   transcriptional	  
activation.	  
Each	  strain	  was	  transformed	  with	  empty	  plasmid	  pKESK22	  or	  plasmids	  expressing	  RcsB-­‐wild-­‐type	  and	  
–mutants	   (pKETS6-­‐8,	   pKES229-­‐235,	   pKES271-­‐275,	   pKESL111-­‐120,	   pKEDP41,	   pKEDP43-­‐47)	   and	   β-­‐
galactosidase	  activities	  were	  determined.	  The	  values	  obtained	  for	  RcsB-­‐D56E	  were	  defined	  as	  100	  %.	  
The	   phosphorylation	   site	   is	   marked	   with	   P.	   Cultures	   for	   β-­‐galactosidase	   assays	   were	   grown	   in	   LB	  
medium	   to	   an	  OD600	   of	   0.5	   supplemented	  with	   1	  mM	   IPTG	   and	   25	   µg	  ml-­‐1	   of	   kanamycin.	   (A)	   Test	  
system	  for	  monitoring	  the	  activity	  of	  RcsB	  mutants	  for	  RcsB	  homodimers:	  rprA	  promoter	  lacZ	  fusion	  
integrated	   into	  attB	   site	   in	   a	   ΔrcsB	   ΔlacZ	   background	   (T1052).	   (B)	   Test	   system	   for	   analyzing	   RcsA-­‐
RcsB:	  wza	  promoter	   lacZ	   fusion	   in	  ΔrcsBCD	  ΔlacZ	  PL-­‐rcsA	  background	  expressing	   rcsA	  constitutively	  
(T963).	   (C)	   Test	   system	   for	   BglJ-­‐RcsB:	   leuO	   promoter	   lacZ	   fusion	   in	   ΔrcsB	   ΔlacZ	   bglJC	   background	  
expressing	  bglJ	  constitutively	  (T572).	  (D)	  Test	  system	  for	  MatA-­‐RcsB:	  matACFT73	  promoter	  lacZ	  fusion	  
in	  ΔrcsB	  ΔlacZ	  PL-­‐matA	  background	  expressing	  matA	  constitutively	  (T1987).	  a	  Values	  are	  taken	  from	  
Stratmann	  et	  al.	  2012.	   b	  Values	   for	   L95A,	  S96A,	   L99A,	  D100A,	  E104A,	   I106A,	   L108A,	  T114A,	  D115A,	  





The	  results	  obtained	  for	  (v)	  residues	  within	  the	  DNA-­‐binding	  domain	  are	  briefly	  summarized	  
below	   (Figure	   15).	   The	   vast	   majority	   of	   mutations	   completely	   abolishes	   or	   significantly	  
impairs	   the	   activity	   of	   RcsB	   homodimers	   or	   heterodimers	  with	   RcsA	  or	   BglJ.	   K180A,	   being	  
located	  within	  α9	  of	  the	  DNA	  binding	  domain	  completely	  abolishes	  activity	  of	  all	  dimers.	  Its	  
location	  is	  in	  the	  HTH	  motif	  close	  to	  the	  turn	  to	  α8	  and	  hence	  presumably	  affects	  the	  DNA-­‐
binding	  ability	  of	  RcsB.	  Mutated	  F162,	  found	  in	  the	  mutagenesis	  screen	  as	  F162C	  and	  F162S	  
completely	  abolishes	  activity	  of	  all	  tested	  dimers.	  F162	  is	  located	  at	  α7	  that	  is	  important	  for	  
stabilizing	   the	  HTH	  motif	  α8	  and	  α9	  by	  hydrophobic	   interaction	   (Figure	  13E).	   The	  mutants	  
putatively	  disturb	  the	  integrity	  of	  the	  HTH	  motif.	  
Taken	   together,	  RcsB	  homodimers	  and	  RcsA-­‐RcsB	  heterodimers	   that	  are	  depending	  
on	   RcsB	   phosphorylation	   possess	   the	  most	   similar	   properties.	   According	   to	   the	   structural	  
model	   (Figure	  13)	  all	  mutations	   located	   in	   the	  receiver	  domain	  that	   reduce	  or	   impair	   their	  
activity	  are	  located	  in	  close	  vicinity	  to	  the	  active	  site	  supporting	  the	  predicted	  model.	  These	  
residues	   are	   presumably	   important	   for	   the	   structural	   change	   that	   is	   elicited	   by	  
phosphorylation.	   Therefore	   the	   active	   conformation	   of	   RcsB	   is	   likely	   essential	   for	  
transcriptional	  activation	  by	  RcsB	  homodimers	  and	  heterodimers	  with	  RcsA.	  Interestingly,	  all	  
residues	  found	  by	  the	  random	  mutagenesis	  screen	  with	  the	  exception	  of	  F162C	  and	  F162S	  
are	  also	  close	  to	  the	  active	  site.	  For	  the	  activity	  of	  BglJ-­‐RcsB	  dimers	  amino	  acid	  G67	  plays	  a	  
crucial	   role	  and	  K109	  a	  partial	   role,	  whereas	   for	   the	  activity	  of	  MatA-­‐RcsB	  only	  amino	  acid	  
K109	  is	  important.	  K109	  and	  other	  amino	  acids	  being	  important	  for	  the	  activity	  of	  all	  dimers	  
may	   be	   crucial	   for	   the	   structure.	   K180	   is	  most	   probably	   crucial	   for	   DNA-­‐binding.	   Another	  
possibility	  for	  inactive	  RcsB	  mutants	  is	  reduced	  protein	  stability	  due	  to	  improper	  folding	  and	  
rapid	  degradation	  which	  was	  addressed	  with	  a	  chloramphenicol	  chase	  experiment	  (see	  next	  
section).	  Summarized,	  these	  results	  underscore	  the	  model	  that	  transcriptional	  regulation	  of	  
RcsB	  homodimer	  and	  RcsA-­‐RcsB	  heterodimer	   targets	  depends	  on	  Rcs	   signaling	   induced	  by	  






Figure	  15.	  Effects	  of	  residues	  in	  DNA-­‐binding	  domain	  on	  transcriptional	  activation.	  	  
Each	   strain	  was	   transformed	  with	   empty	   plasmid	   pKESK22	   or	   plasmids	   expressing	   RcsB-­‐wild-­‐type	  
and	   –mutants	   (pKETS6,	   pKES276-­‐279,	   pKEDP40,	   pKEDP42)	   and	   β-­‐galactosidase	   activities	  
determined.	   Values	   of	   bars	  marked	  with	   1	   are	   taken	   from	   Stratmann	   et	   al.	   2012.	   Cultures	   for	   β-­‐
galactosidase	  assays	  were	  grown	   in	  LB	  medium	  to	  an	  OD600	  of	  0.5	  supplemented	  with	  1	  mM	  IPTG	  
and	  25	  µg	  ml-­‐1	  of	  kanamycin.	  Analysis	  of	  RcsA-­‐RcsB	  in	  reporter	  strain	  T1052,	  of	  RcsA-­‐RcsB	  in	  strain	  
T963,	  of	  BglJ-­‐RcsB	  in	  strain	  T572,	  and	  of	  MatA-­‐RcsB	  in	  strain	  T1987.	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2.4.  Expression	  and	  stability	  of	  RcsB	  mutants	  
The	  expression	  analyses	  using	  the	  lacZ	  reporters	  showed	  that	  several	  RcsB	  mutants	  were	  not	  
able	  to	  activate	  gene	  expression	  as	  homodimers	  as	  well	  as	  heterodimers	  to	  the	  same	  extent	  
as	   wild-­‐type	   RcsB.	   The	   amino	   acid	   substitutions	   within	   RcsB	   could	   potentially	   influence	  
correct	   folding	  of	   the	  mutant	  proteins	   leading	   to	   reduced	  stability	  by	  degradation.	  To	   find	  
out,	  whether	   these	  RcsB	  mutants	   are	   instable	  and	   rapidly	  degraded,	   in	   a	   chloramphenicol	  
chase	  experiment	  the	  protein	  stability	  was	  analyzed.	  To	  this	  end,	  plasmids	  were	  constructed	  
for	   IPTG	   inducible	   expression	   of	   C-­‐terminally	   HA-­‐tagged	   RcsB	  mutants	   (Figure	   16A).	  With	  
these	  plasmids	  ΔrcsB	  strain	  T21	  was	  transformed	  and	  cultures	  of	  these	  transformants	  were	  
grown	  without	  induction	  of	  rcsBHA	  expression.	  At	  OD600	  of	  0.3	  the	  first	  samples	  were	  taken.	  
At	   the	   same	   time	   the	  expression	  was	   induced	  by	  adding	   IPTG	   (1	  mM	   final	   concentration).	  
The	   second	   sample	   was	   taken	   30	   minutes	   after	   induction.	   Immediately	   thereafter,	  
chloramphenicol	   (200	   μg/ml)	   was	   added	   to	   inhibit	   protein	   synthesis.	   After	   further	   30	  
minutes	   the	   third	  sample	  was	   taken.	  The	  samples	  were	  analyzed	  by	  western	  blot	  analysis.	  
The	  results	  demonstrate	  that	  all	  proteins	  were	  expressed	  to	  comparable	  amounts.	  However,	  
the	  stability	  of	  the	  K109A	  mutant	  was	  reduced	  in	  comparison	  to	  the	  wild-­‐type	  (Figure	  16B).	  
The	   K109A	  mutant	   was	   inactive	   in	   all	   tested	   reporter	   systems	   for	   RcsB	   homodimers	   and	  
heterodimers	  with	  RcsA,	  BglJ	  and	  MatA.	  According	  to	  the	  structure	  prediction	  (Figure	  13A),	  
K109	  resides	  in	  the	  center	  of	  the	  receiver	  domain	  and	  hence	  could	  play	  an	  important	  role	  for	  




Figure	  16.	  Stability	  assays	  of	  RcsB	  and	  its	  mutants	  by	  western	  blot	  analysis.	  
(A)	  Features	  and	  list	  of	  plasmids	  expressing	  HA	  tagged	  wild-­‐type	  RcsB	  and	  mutants.	  (B)	  The	  plasmidic	  
expression	  of	  HA	  tagged	  RcsB	  or	  HA	  tagged	  RcsB	  mutants	  (pKEAP38,	  pKEDP1-­‐9)	  was	  induced	  by	  IPTG	  
and	  inhibited	  by	  chloramphenicol.	  Thus,	  the	  stability	  of	  the	  RcsB	  protein	  and	  its	  mutants	  should	  be	  
monitored.	   Samples	   were	   taken	   before	   induction	   (-­‐	  IPTG,	   -­‐	  cm),	   30	   minutes	   after	   induction	  
(+	  IPTG,	   -­‐	  cm)	   and	   30	   minutes	   after	   inhibition	   by	   chloramphenicol	   (+	  IPTG,	   +	  cm).	   For	   the	   empty	  
vector	  control	  no	  HA	  tagged	  protein	  could	  be	  detected.	  For	  the	  RcsB	  wild-­‐type	  and	  its	  mutants,	  no	  or	  
very	  weak	  bands	  appear	  for	  the	  samples	  taken	  from	  cultures	  without	  IPTG	  induction	  of	  expression.	  
The	   difference	   of	   the	   intensity	   between	   the	   bands	   obtained	   from	   cultures	   after	   IPTG	   induction	   (+	  
IPTG,	  -­‐	  cm)	  and	  after	  inhibition	  of	  protein	  synthesis	  (+	  IPTG,	  +	  cm)	  give	  information	  about	  the	  stability	  
of	  each	  RcsB	  mutant.	  For	  the	  RcsB	  mutant	  K109A,	  the	  (+	  IPTG,	  +	  cm)	  band	  is	  weaker	  than	  the	  (+	  IPTG,	  
-­‐	  cm)	  band,	  indicating	  that	  this	  RcsB	  mutant	  exhibits	  a	  reduced	  stability.	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2.5.  Protein-­‐protein	  interaction	  of	  RcsB	  mutants	  
To	  analyze	  whether	  the	  mutant	  RcsB	  proteins	  are	  still	  able	  to	   interact	  with	  each	  other	  and	  
with	   the	   co-­‐regulators	   RcsA	   as	   well	   as	   BglJ	   and	   form	   stable	   homo-­‐	   and	   heterodimers,	  
respectively,	   the	   SPINE	   method	   (Strep-­‐Protein-­‐Interaction-­‐Experiment)	   was	   applied	  
(Herzberg	  et	  al.,	  2007).	  For	  this	  purpose,	  two	  different	  expression	  vectors	  were	  transformed	  
into	  strain	  T73	  (ΔrcsB).	  One	  contained	  an	  HA-­‐tagged	  RcsB	  version,	  the	  other	  one	  the	  Strep-­‐
tagged	   interaction	   partner	   RcsB,	   BglJ,	   or	   RcsA	   (Figure	   17A).	   In	   brief,	   exponential	   cultures	  
(1000	  ml	  	   LB	   medium	   containing	   ampicillin	   and	   kanamycin)	   were	   inoculated	   from	   a	   fresh	  
overnight	  culture	  and	  grown	  to	  an	  OD600	  =	  0.8	  and	  at	  this	  point	  the	  expression	  of	  the	  Strep-­‐	  
and	  HA-­‐tagged	  proteins	  were	  induced	  by	  adding	  IPTG	  (1	  mM	  final	  concentration).	  One	  hour	  
after	  induction	  of	  protein	  synthesis,	  the	  crosslinking	  agent	  formaldehyde	  was	  added,	  which	  
stabilizes	   the	   interactome,	   i.e.	   all	   interacting	   proteins	   including	   those	   being	   tagged,	   are	  
crosslinked.	   A	   protein	   lysate	   obtained	   from	   these	   cultures	   was	   applied	   on	   a	   Strep-­‐tactin	  
gravity	   flow	  column,	   thereby	  the	  Strep-­‐tagged	  RcsB	  protein	  and	  consequently	   the	  putative	  
HA-­‐tagged	   interaction	   partner	   were	   purified.	   The	   eluate	   was	   boiled	   for	   reversion	   of	   the	  
crosslinks	  and	  analyzed	  by	  western	  blot	  (Figure	  17).	  Figure	  17A	  shows	  the	  results	  for	  analysis	  
of	  RcsB-­‐RcsB	   interaction.	  All	  RcsB	  mutants	   seem	   to	   interact	  with	  each	  other.	  Also	   the	  HA-­‐
tagged	  RcsB-­‐D56A	  mutant	  that	  mimics	   inactive	  RcsB	  was	  detected	   in	  the	  eluate,	   indicating	  
that	   the	   dimerization	   behavior	   of	   RcsB	   is	   phosphorylation	   independent.	   However	   the	  
quantification	  of	  the	  interaction	  turned	  out	  to	  be	  difficult.	  The	  interaction	  between	  BglJ	  and	  
RcsB	  for	  specific	  RcsB	  mutants	  could	  also	  be	  shown	  by	  the	  SPINE	  method.	  Therefore	  Strep-­‐
tagged	  RcsB	  or	  RcsB	  mutants,	   respectively,	  were	  plasmidically	   expressed	   together	  with	   an	  
HA-­‐tagged	   BglJ	   (Figure	   17B)	   in	   the	   strain	   T175	   (ΔrcsΒ	   ΔyjjP-­‐yjjQ-­‐bglJ)	   under	   the	   same	  
conditions	   as	   for	   RcsB-­‐RcsB	   homomers.	   The	   protein	   lysates	   obtained	   from	   these	   cultures	  
were	  purified	  on	  a	   strep	   tactin	   columns,	  potential	   crosslinking	  between	  BglJ-­‐HA	  and	  RcsB-­‐
Strep	   was	   reversed	   by	   boiling	   and	   analyzed	   by	   western	   blot	   analysis.	   In	   the	   control	  
experiment,	  at	  which	  BglJ-­‐HA	  is	  expressed	  in	  the	  absence	  of	  RcsB-­‐Strep,	  BglJ-­‐HA	  can	  only	  be	  
detected	  in	  the	  lysate	  but	  not	  in	  the	  eluate,	  indicating	  that	  BglJ-­‐HA	  is	  indeed	  purified	  via	  the	  
interaction	   with	   RcsB-­‐Strep	   (Figure	   17B).	   However,	   the	   interaction	   appears	   to	   be	   weaker	  




Figure	  17.	  RcsB	  protein	  interaction	  studies	  by	  SPINE.	  
Features	  of	  plasmids	  and	  western	  blots	  of	  protein	  lysate	  and	  eluate	  obtained	  from	  SPINE	  analyses.	  
Each	  western	  blot	  was	  developed	  with	  rat	  anti-­‐HA	  as	  primary	  and	  fluorescence	   labeled	  anti	   rat	  as	  
secondary	   antibody.	   The	   Strep-­‐tagged	   proteins	   were	   visualized	   with	   Strep-­‐MAB-­‐HRP-­‐conjugate	  
antibodies	   via	   chemiluminescence.	   (A)	   For	   analyzing	   RcsB-­‐RcsB	   interaction,	   RcsB-­‐Strep	   expressing	  
plasmids	  pKEDP10-­‐21	  and	  RcsB-­‐HA	  expressing	  plasmids	  pKEAP38,	  pKEAP43-­‐44,	  and	  pKEDP1-­‐9	  were	  
used.	   RcsB-­‐Strep	   and	   RcsB-­‐HA	   were	   expressed	   in	   strain	   T73	   (ΔrcsΒ).	   (B)	   For	   analyzing	   BglJ-­‐RcsB	  
interaction,	  RcsB-­‐Strep	   (pKEDP10-­‐21)	  and	  BglJ-­‐HA	   (pKERV12)	  were	  expressed	   in	  strain	  T175	   (ΔrcsΒ	  
ΔyjjP-­‐yjjQ-­‐bglJ).	   (C)	   For	   analyzing	   RcsA-­‐RcsB	   interaction,	   RcsB-­‐Strep	   and	   RcsA-­‐HA	   (pKEDP36)	   were	  
expressed	  in	  strain	  T1338	  (ΔrcsΒ	  ΔrcsA).	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This	  observation	  might	  be	  due	  to	  BglJ-­‐HA	  forming	  inclusion	  bodies	  upon	  high	  overexpression	  
resulting	   in	   growth	   defects.	   On	   pKERV12	   the	   native	   RBS	   of	   BglJ	   is	   replaced	   by	   an	   epsilon	  
element	   and	   Shine-­‐Dalgarno	   sequence	   (εSD)	   enhancing	   protein	   synthesis	   initiation	   (Figure	  
17B).	  For	  RcsA-­‐RcsB	  interaction,	  HA-­‐tagged	  RcsA	  was	  expressed	  together	  with	  Strep-­‐tagged	  
RcsB	  and	   its	  mutants	  under	   the	   same	  conditions	   as	   for	  RcsB-­‐RcsB	  homomers.	   The	  protein	  
lysates	  obtained	  from	  these	  cultures	  were	  also	  purified	  on	  a	  strep	  tactin	  columns,	  potential	  
crosslinking	   between	   RcsA	   and	   RcsB	   reversed	   by	   boiling	   and	   analyzed	   by	   western	   blot	  
analysis.	  Only	   two	  weak	  RcsA	  bands	  could	  be	  seen	   in	   the	  anti-­‐HA	   immunostained	  western	  
blot	   for	   the	   eluate	   (Figure	   17C).	   The	   interaction	   between	   RcsA	   and	   RcsB	   appears	   to	   be	  
weaker	  than	  for	  BglJ-­‐RcsB.	  The	  fact	  that	   in	  the	  RcsA-­‐RcsB	   interaction	  experiment	  no	  bands	  
could	  be	  detected	   -­‐	  neither	   for	  RcsB-­‐D56E-­‐Strep	  nor	   for	  RcsA-­‐HA	   tested	  with	  RcsB-­‐D56E	  –	  
may	  be	  caused	  by	  a	  difficulty	  in	  pelleting	  the	  cultures.	  RcsA-­‐RcsB	  activates	  expression	  of	  the	  
capsule	   genes	   causing	   a	   mucoid	   phenotype	   of	   colonies	   on	   plates.	   Pellets	   obtained	   by	  
centrifugation	  of	   liquid	  cultures	  immediately	  resuspended	  in	  the	  remaining	  medium.	  Taken	  
together,	  for	  assessing	  a	  protein-­‐protein	  interaction	  between	  RcsB-­‐Strep	  and	  RcsB-­‐HA,	  BglJ-­‐
HA,	  and	  RcsA-­‐HA,	  SPINE	  proves	  to	  be	  difficult.	  
2.6.  Mechanism	  of	  transcriptional	  activation	  
In	   recent	   studies,	   the	   mechanism	   of	   activation	   by	   BglJ-­‐RcsB	   of	   several	   target	   genes	   was	  
analyzed.	  Therefore	  the	  BglJ-­‐RcsB	  binding	  site	  was	  mapped	  at	  several	   loci	  and	  a	  consensus	  
sequence	  motif	  was	  proposed.	  It	  was	  suggested	  that	  activation	  by	  BglJ-­‐RcsB	  is	  DNA	  phasing	  
dependent	   at	   some	   loci,	   such	   as	   it	   was	   shown	   for	   PmolR	   and	   proposed	   for	   PynbA	  
(Salscheider	  et	  al.,	  2013).	  As	  activation	  of	  several	  promoters	  by	  BglJ-­‐RcsB	  is	  DNA	  helical	  turn	  
dependent,	  BglJ-­‐RcsB	  might	  interact	  with	  RNA	  polymerase.	  To	  study	  a	  potential	   interaction	  
between	  BglJ-­‐RcsB	  and	  RNA	  polymerase,	   I	   followed	  two	  approaches	  as	   follows:	  A	  bacterial	  
two-­‐hybrid	  system	  and	  the	  overexpression	  of	  the	  RNA	  polymerase	  α	  subunit.	  
2.6.1.   Interaction	  studies	  of	  RcsB	  with	  RNA	  polymerase	  by	  a	  bacterial	  two-­‐hybrid	  system	  
Interaction	  of	  RcsB	  with	   the	  alpha	   subunit	  of	  RNA	  polymerase	  was	   tested	  with	  a	  bacterial	  
two-­‐hybrid	  system	  (Dove	  &	  Hochschild,	  2004).	  In	  this	  system,	  either	  the	  RcsB-­‐HTH	  domain	  or	  
the	  whole	   RcsB	  was	   fused	   to	   the	   cI	   domain	   of	   phage	   λ	   (plasmids	   pKEKD23,	   pKEDP38	   and	  
pKEDP39,	  Figure	  18B).	  The	  λ	  cI	  domain	  binds	  to	  the	  λ	  operator	  being	  located	  62	  bp	  upstream	  
of	  the	  transcription	  start	  of	  the	  reporter	  construct	  in	  strain	  S3773	  (Figure	  18A).	  Transcription	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of	  the	  lacZ	  reporter	  gene	  is	  only	  induced	  if	  there	  are	  direct	  contacts	  between	  RcsB	  or	  RcsB-­‐
HTH,	  respectively,	  and	  the	  αCTD	  domain	  of	  the	  RNA	  polymerase	  (Figure	  18A).	  As	  a	  positive	  
control	  served	  the	  plasmids	  pAC	  λcI-­‐β	  831-­‐1057,	  encoding	  for	  a	  fusion	  of	  amino	  acids	  831–
1057	   of	   RNA	   polymerase	   β	   subunit	   to	   λcI	   under	   PlacUV5	   control,	   and	   pBR	   α-­‐σ70	   D581G,	  
encoding	   for	   a	   fusion	   of	   amino	   acids	   528-­‐613	   of	   σ70	   (with	   a	   D581G	   substitution)	   to	   RNA	  
polymerase	  α-­‐subunit	   under	  PlacUV5	   control.	   Plasmids	  pAC	  λcI	   and	  pBR	  α(NTD)	   served	  as	  
negative	  control.	  Expression	  of	  both	  positive	  control	  plasmids	   is	  necessary	  for	  activation	  of	  
the	   promoter,	   mediated	   by	   λ	   cI	   binding	   to	   the	   λ	   operator	   and	   interacting	   with	   the	   RNA	  
polymerase.	   The	   positive	   control	   plasmids	   exhibited	   a	   transcriptional	   activation	   of	   the	  
reporter,	   with	   expression	   levels	   of	   245	   units	   uninduced	   and	   1246	   units	   induced	   (200	   μM	  
IPTG	   final	   concentration).	   The	   negative	   control	   plasmids	   resulted	   in	   81	   and	   106	   units,	  
respectively.	   In	  a	  second	  setup	  RcsB	  HTH	  was	   fused	   to	   the	  N-­‐terminal	  domain	   (αNTD)	  and	  
the	  αCTD	  was	  fused	  to	  λ	  cI	  (plasmids	  pKEKD24	  and	  pKEDP50,	  Figure	  18B).	  These	  constructs	  
were	  plasmidically	  expressed	  under	  the	  control	  of	  the	  lacUV	  promoter	  applying	  200	  µM	  IPTG	  
final	   concentration	   as	   well	   as	   without	   induction	   (Figure	   18C).	   Also	   varying	   IPTG	  
concentrations	   (from	   10	   µM	   to	   1	   mM)	   were	   tested.	   For	   none	   of	   the	   different	   setups	  
activation	  of	  the	  reporter	  promoter	  could	  be	  detected.	  Taken	  together,	  by	  this	  bacterial	  two-­‐





Figure	  18.	  Experimental	  setup,	  used	  plasmids	  and	  results	  for	  RcsB-­‐RNA	  polymerase	  interaction	  by	  
bacterial	  two-­‐hybrid	  analyses.	  
(A)	   Schematic	   overview	  of	   the	   bacterial	   two-­‐hybrid	   system.	   RcsB	   and	   RcsB	  HTH	   respectively	  were	  
fused	  to	  λ	  cI	  (top)	  or	  the	  αCTD	  was	  fused	  to	  λ	  cI	  and	  RcsB	  HTH	  to	  α	  NTD	  (bottom).	  If	  RcsB/RcsB	  HTH	  
and	   αCTD	   interact,	   the	   reporter	   gene	   lacZ	   is	   expressed	   and	   the	   β-­‐galactosidase	   activity	   can	   be	  
measured	  in	  reporter	  strain	  S3773.	  (B)	  Features	  of	  plasmids	  pKEKD23,	  pKEDP38,	  pKEDP39,	  pKEDP50	  
and	  pKEKD24	  used	  for	  the	  bacterial	  two-­‐hybrid	  experiment.	  All	  constructs	  were	  expressed	  under	  the	  
control	  of	  PUV5.	  (C)	  β-­‐galactosidase	  assay	  results	  in	  miller	  units	  for	  induction	  with	  200	  μM	  IPTG	  final	  
concentration.	   The	   induced	   positive	   control	   plasmids	   pAC	   λcI-­‐β	   831-­‐1057	   and	   pBR	   α-­‐σ70	   D581G	  
exhibited	   a	   promotor	   induction	   of	   1246	   units.	   Plasmids	   pAC	   λcI	   +	   pBR	   α(NTD)	   served	   as	   negative	  
control.	  For	  none	  of	  the	  different	  setups	  activation	  of	  the	  reporter	  promoter	  could	  be	  detected.	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2.6.2.   Overexpression	  of	  the	  RNA	  polymerase	  α	  subunit	  
In	  a	   second	  approach	   to	  analyze	  potential	  BglJ-­‐RcsB	   interaction	  with	  RNA	  polymerase,	   the	  
complete	  α	  subunit	  as	  well	  as	  a	  truncated	  version	  lacking	  the	  αCTD	  of	  the	  RNA	  polymerase	  
was	  plasmidically	  expressed.	  The	  idea	  of	  this	  approach	  is	  depicted	  in	  Figure	  19.	  If	  BglJ-­‐RcsB	  
interacts	   with	   the	   αCTD	   to	   activate	   certain	   promoters,	   the	   expression	   of	   a	   reporter	   gene	  
should	   be	   activated	   in	   case	   of	   overexpression	   of	   the	   wt	   α	   subunit	   (Figure	   19A).	  
Overexpression	  of	   the	  αNTD,	  a	   truncated	  version	   lacking	   the	  αCTD	  should	  reduce	  reporter	  
gene	   expression	   (Figure	   19B).	   Such	   mutant	   RNA	   polymerase	   holoenzymes	   are	   unable	   to	  
induce	  transcription	  activation	  by	  cAMP/CRP	  at	  some	  type	  I	  CRP-­‐dependent	  promoters,	  such	  
as	  lac	  and	  uxuAB	  (Igarashi	  et	  al.	  1991).	  	  
	  
	  
Figure	   19.	   Idea	   of	   overexpres-­‐
sing	   RNA	   polymerase	   α	   subunit	  
and	  αNTD	   in	   case	   of	   αCTD	  BglJ-­‐
RcsB	  interaction.	  
(A)	  Upon	  overexpression	  of	  wt	  α	  
subunit,	   the	   RNA	   polymerase	  
holoenzymes	  are	  able	  to	  activate	  
the	   promoter	   due	   to	   direct	  
contacts	  to	  BglJ-­‐RcsB.	  (B)	  If	  αNTD	  
is	   overexpressed,	   a	   given	   pro-­‐
portion	   of	   RNA	   polymerase	  
holoenzymes	  is	  lacking	  the	  αCTD.	  
The	  activation	  of	  the	  promoter	  is	  
impaired.	  
	  
For	  this	  approach	  the	  promoters	  of	  the	  HNS	  repressed	  genes	   leuO	  and	  yidL	   (Figure	  20C)	  as	  
well	  as	  of	  genes	  molR,	  ynbA	  (Figure	  20D)	  were	  analyzed.	  All	  four	  promoters	  were	  shown	  to	  
be	  a	  BglJ-­‐RcsB	  target	  (Salscheider	  et	  al.,	  2013).	  In	  addition,	  I	  analyzed	  PrprA,	  a	  promoter	  that	  
is	   activated	   by	   RcsB	   homodimers	   (Figure	   20B).	   Previous	   analyses	   demonstrated	   a	   phasing	  
dependent	   activation	  of	   the	  molR	   promoter	  by	  BglJ-­‐RcsB,	   and	   showed	  a	  BglJ-­‐RcsB	  binding	  
site	   in	   phase	   of	   the	   ynbA	  promoter.	   The	  BglJ-­‐RcsB	   binding	   site	   at	   the	   yidL	   promoter	   was	  
shown	  to	  be	  in	  reverse	  orientation	  and	  PyidL	  may	  not	  be	  activated	  by	  direct	  BglJ-­‐RcsB	  RNA	  
polymerase	  contacts	   (Salscheider	  et	  al.,	  2013).	  The	  reporter	  strains	  carried	  attB	   integrated	  
promoter	   lacZ	   fusions	   in	   a	   bglJC	   background.	   For	   the	   analyses,	   the	   appropriate	   reporter	  
strains	   were	   transformed	   with	   pBR	   derived	   high-­‐copy	   plasmids	   expressing	   wt	   α	   subunit	  
(pLAX185)	   or	   αNTD	   (pLAD235)	   under	   the	   control	   of	   the	   IPTG-­‐inducible	   lpp/lacUV	   tandem	  




Figure	  20.	  Effects	  of	  overexpression	  of	  the	  RNAP	  α	  subunit	  on	  different	  promoters.	  	  
(A)	   pBR	   derived	   high-­‐copy	   plasmids	   harboring	   full-­‐length	   rpoA	   (pLAX185)	   or	   the	   truncated	   αCTD	  
(pKEDP48)	  or	  αNTD	  (pLAD235)	  under	  the	  control	  of	  the	  IPTG-­‐inducible	  lpp/lacUV	  tandem	  promoter.	  
The	  reporter	  strains	  were	  transformed	  with	  these	  plasmids	  and	  cultures	  for	  β-­‐galactosidase	  assays	  
were	  grown	  in	  LB	  medium	  to	  an	  OD600	  of	  0.5	  optional	  supplemented	  with	  1	  mM	  IPTG	  and	  50	  µg	  ml-­‐1	  
of	   ampicillin.	   Untransformed	   reporter	   strains	   served	   as	   control.	   (B)	   Results	   for	   PrprA	   lacZ	   fusion	  
integrated	   into	   a	   ΔlacZ	   ΔgalU	   strain	   (T2043)	   for	   analyzing	   RNA	   polymerase	   interaction	  with	   RcsB	  
homodimers,	  (C)	  Results	  for	  PleuO	  and	  PyidL,	  both	  HNS	  repressed,	  fused	  to	  lacZ	  and	  integrated	  in	  a	  
ΔlacZ	   ΔleuO	   bglJC	   strain	   background	   (T570,	   T1474)	   (D)	   Results	   for	   PmolR	   lacZ	   and	   PynbA	   lacZ	  
integrated	   in	  a	  ΔlacZ	  ΔleuO	  bglJC	  strain	  background	  (T1441,	  T1326).	   (E)	  Results	   for	  PlacUV5	   (strain	  
S1906,	  negative	  control)	  and	  PlacO1-­‐20GCW	  (strain	  T46,	  positive	  control).	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Reporter	   strain	   S1906	   with	   PlacUV5	   lacZ	   served	   as	   negative	   control	   and	   strain	   T46	   with	  
PlacO1-­‐20GCW	   as	   positive	   control	   with	   CRP-­‐RNA	   polymerase	   interaction	   required	   for	  
expression	  (Figure	  20E).	  Cultures	  for	  β-­‐galactosidase	  assays	  were	  grown	  in	  LB	  medium	  to	  an	  
OD600	  of	  0.5	  supplemented	  with	  1	  mM	  IPTG	  and	  50	  µg	  ml-­‐1	  of	  ampicillin.	  	  
First,	   the	   rprA	   promoter	   that	   is	   activated	  by	  RcsB	  homodimers	  was	  analyzed.	   Since	  
activation	   of	   the	   rprA	   promoter	   is	   RcsB	   phosphorylation	   dependent,	   the	   analyses	   were	  
conducted	   in	   a	   ΔgalU	   strain.	   The	   results	   are	   shown	   in	   Figure	   20B.	   The	   expression	   levels	  
obtained	  for	  induced	  expression	  of	  full-­‐length	  and	  truncated	  α	  subunits	  were	  similar	  to	  the	  
control	  without	  plasmid.	  Consequently,	  a	  potential	  interaction	  between	  the	  RNA	  polymerase	  
α	   subunit	   and	   RcsB	   homodimers	   could	   not	   be	   shown	   for	   the	   rprA	   promoter.	   Next,	   the	  
promoters	  activated	  by	  BglJ-­‐RcsB	  were	  analyzed.	  Interestingly,	  at	  the	   leuO,	  molR,	  and	  ynbA	  
promoter	   the	   induction	  of	  wt	  α	  expression	   significantly	   reduced	   reporter	   gene	   expression	  
levels	   (Figure	   20C,	   D).	   Induction	   of	   αNTD	   expression	   causes	   reduced	   reporter	   gene	  
expression	  levels	  for	  the	  ynbA	  promoter	  compared	  to	  no	  induction.	  Surprisingly,	  the	  induced	  
expression	  of	  the	  wt	  α	  subunit	  caused	  a	  reduced	  reporter	  expression	  at	  the	  molR	  and	  ynbA	  
promoter;	  however,	  expression	  of	  the	  αNTD	  had	  no	  influence	  on	  the	  level	  of	  the	  control,	  at	  
least	  for	  PmolR.	  These	  findings	  contradict	  the	  initial	  hypothesis	  that	  overexpression	  of	  αNTD	  
lacking	   the	   αCTD	   should	   reduce	   the	   promoter	   activity	   if	   BglJ-­‐RcsB	   interacts	   with	   RNA	  
polymerase	  α	  subunit.	  Also	  the	  fact	  that	  the	  strain	  is	  merodiploid	  for	  rpoA	  (the	  chromosomal	  
rpoA	   is	   present)	   as	   the	   gene	   is	   essential	   for	   viability,	   does	   not	   fully	   explain	   the	   results,	  
although	  it	  could	  explain	  why	  the	  results	  obtained	  fοr	  overexpressing	  αNTD	  are	  on	  the	  same	  
level	   as	   the	   control	  without	   plasmid	   (Figure	   20D,	   top	   graph).	   The	   results	   obtained	   for	   the	  
molR	  promoter	   upon	   expression	   of	   wt	   α	   subunit,	   although	   unexpected,	   can	   indeed	   be	   in	  
accordance	  with	  the	   initial	  considerations.	   If	   the	  BglJ-­‐RcsB	  dimer	  binds	  to	  the	  αCTD	  before	  
the	   RNA	  polymerase	   holoenzyme	  binds	   to	   the	  molR	   promoter,	   overexpression	   of	   the	   full-­‐
length	  α	  subunit	  would	  outcompete	  RNA	  polymerase	  for	  interaction	  with	  BglJ-­‐RcsB	  and	  thus	  
reduce	  activation	  of	  the	  molR	  promoter	  (Figure	  21B).	  To	  test	  this	  hypothesis,	  I	  expressed	  the	  
αCTD	  (pKEDP48),	  a	  truncated	  version	  of	  the	  α	  subunit	  lacking	  αNTD.	  At	  PmolR,	  induced	  αCTD	  
overexpression	   activates	   the	   promoter	   on	   a	   similar	   level	   as	   α	  wt	   (Figure	   20D,	   top	   graph),	  
supporting	   the	   hypothesis	   of	   a	   pre-­‐recruitment	   mechanism.	   At	   PynbA,	   induced	   αCTD	  
overexpression	  also	  reduced	  promoter	  activation,	  although	  the	  effect	  was	   less	  strong	  than	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for	  wt	  α	  subunit	  (Figure	  20D,	  bottom	  graph).	  A	  model	  explaining	  these	  results	  is	  depicted	  in	  
Figure	  21A	  and	  B.	  
	  
	  
Figure	  21.	  Potential	  model	  of	  PmolR	  activation	  by	  BglJ-­‐RcsB.	  
(A)	  Although	  αNTD	  is	  plasmidically	  expressed,	  PmolR	  is	  activated	  by	  fully	  assembled	  RNA	  polymerase	  
with	   the	  α	   subunit	   being	  encoded	   in	   the	   chromosome.	   (B)	  Overexpressed	  α	   subunit	   or	  αCTD	  bind	  
BglJ-­‐RcsB	   in	  a	  pre-­‐recruitment	  mechanism	  and	  hinder	   fully	  assembled	  RNA	  polymerase	   to	   interact.	  
PmolR	   activation	   is	   decreased.	   (C)	   Overexpressed	   αCTD	  mutants	   have	   less	   ability	   to	   interact	   with	  
BglJ-­‐RcsB.	  The	  wild-­‐type	  RNA	  polymerase	  is	  able	  to	  activate	  PmolR.	  
	  
The	  results	  above	  indicated	  for	  PmolR	  a	  pre-­‐recruitment	  mechanism,	  in	  which	  the	  BglJ-­‐RcsB	  
dimer	   binds	   to	   the	   αCTD	   before	   the	   RNA	   polymerase	   holoenzyme	   binds	   to	   the	   molR	  
promoter.	  In	  this	  case,	  overexpression	  of	  the	  full-­‐length	  α	  subunit	  or	  its	  C-­‐terminal	  domain	  
would	   hinder	   the	   RNA	   polymerase	   holoenzyme	   for	   interaction	   with	   BglJ-­‐RcsB	   and	   thus	  
reduce	  activation	  of	  the	  molR	  promoter	  (Figure	  21B).	  To	  test	  this	  hypothesis,	  I	  repeated	  the	  
analyses	  with	  plasmidically	  expressing	  different	  αCTD	  mutants.	  Each	  αCTD	  mutant	  carried	  a	  
single	   alanine	   substitution	   of	   residues	   belonging	   to	   the	   287	   determinant	   that	   were	  
previously	   shown	   to	   contact	   CRP	   during	   class	   I	   and	   class	   II	   CRP-­‐dependent	   transcription	  
(Savery	   et	   al.,	   1998,	   Savery	   et	   al.,	   2002).	   The	   location	   of	   residues	   belonging	   to	   the	   287	  
determinant	  is	  indicated	  in	  Figure	  22A	  and	  a	  list	  of	  plasmids	  harboring	  the	  αCTD	  mutants	  is	  
given	  in	  Figure	  22B.	  In	  case	  of	  a	  pre-­‐recruitment	  mechanism,	  reduced	  contacts	  between	  BglJ-­‐
RcsB	   and	   ectopically	   expressed	   αCTD	   mutants	   would	   not	   hinder	   the	   RNA	   polymerase	  
holoenzyme	   for	   interaction	   with	   BglJ-­‐RcsB	   anymore.	   Consequently,	   in	   case	   of	   expressing	  
αCTD	   mutants,	   reporter	   gene	   expression	   should	   increase	   compared	   to	   wild-­‐type	   αCTD	  
(Figure	   22C).	   Here,	   I	   tested	   PmolR	   and	   PynbA,	   each	   having	   the	   BglJ-­‐RcsB	   binding	   site	   in	  
phase,	  as	  well	  as	  PyidL	  as	  a	  control	  with	  the	  BglJ-­‐RcsB	  binding	  site	  in	  reverse	  orientation.	  To	  
this	   end,	   the	   appropriate	   reporter	   strains	  were	   transformed	  with	   plasmids	   expressing	   the	  
αCTD	   mutants	   T285A,	   E286A,	   V287A,	   E288A,	   L290A,	   G315A,	   R317A,	   and	   L318A.	   The	   β-­‐
galactosidase	   activities	   were	   determined	   without	   induction	   and	   with	   IPTG	   induction.	   The	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results	  are	  summarized	   in	  Figure	  22C-­‐E.	  The	  statistical	   significance	  was	  calculated	   for	  each	  
αCTD	  mutant	  compared	  to	  wild-­‐type	  αCTD	  upon	  induction.	  Activation	  of	  PmolR	  and	  PynbA	  
was	   significantly	  higher	  upon	  expression	  of	   each	  αCTD	  mutant	   compared	   to	   the	  wild-­‐type	  
αCTD	  (gray	  bars,	  Figure	  22C	  and	  D).	  Activation	  of	  PyidL	  was	  similar	   for	  expression	  of	  αCTD	  
mutants	  or	  wild-­‐type	  αCTD	  (gray	  bars,	  Figure	  22E).	  These	  results	  are	  in	  agreement	  with	  the	  
initial	   hypothesis	   in	   which	   wild-­‐type	   αCTD	   hinders	   RNA	   polymerase	   holoenzyme	   for	  
interaction	  with	  BglJ-­‐RcsB	  at	  PmolR	  and	  PynbA.	  Mutant	  αCTD	  proteins	  bind	  BglJ-­‐RcsB	  with	  
less	  affinity,	  the	  steric	  hindrance	  is	  reduced	  and	  PmolR	  as	  well	  as	  PynbA	  activation	  is	  higher.	  
Taken	  together,	   these	  results	  support	   the	  model	   for	  PmolR	  and	  PynbA	  activation	  by	  direct	  




Figure	  22.	  Effects	  of	  overexpression	  of	  αCTD	  mutants	  on	  PmolR,	  PynbA,	  and	  PyidL.	  
(A)	  Structure	  of	  the	  αCTD	  with	  residues	  belonging	  to	  the	  287	  determinant	  indicated.	  The	  structure	  
of	   the	   E.	   coli	   αCTD	   was	   solved	   by	   X-­‐ray	   crystallography	   comprising	   amino	   acids	   245-­‐329	   (Lara-­‐
Gonzalez	   et	   al.,	   2010).	   (B)	  pBR	  derived	  high-­‐copy	  plasmids	  harboring	  αCTD	   (pKEDP48)	  or	  mutants	  
T285A,	  E286A,	  V287A,	  E288A,	  L290A,	  G315A,	  R317A,	  and	  L318A	  (pKEDP62-­‐69)	  under	  the	  control	  of	  
the	   IPTG-­‐inducible	   lpp/lacUV	  tandem	  promoter.	  The	  reporter	  strains	  were	  transformed	  with	  these	  
plasmids	   and	   cultures	   for	   β-­‐galactosidase	   assays	   were	   grown	   in	   LB	   medium	   to	   an	   OD600	   of	   0.5	  
supplemented	  with	  50	  µg	  ml-­‐1	  ampicillin	  and	  1	  mM	  IPTG	  in	  case	  of	  induction.	  (C)	  Results	  for	  PmolR	  
lacZ	   integrated	   in	   a	   ΔlacZ	   ΔleuO	   bglJC	   strain	   background	   (T1441).	   (D)	   Results	   for	   PynbA	   lacZ	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integrated	  in	  a	  ΔlacZ	  ΔleuO	  bglJC	  strain	  background	  (T1326).	  (E)	  Results	  for	  PyidL	  fused	  to	   lacZ	  and	  
integrated	  in	  a	  ΔlacZ	  ΔleuO	  bglJC	  strain	  background	  (T1474).	  Displayed	  values	  are	  means	  ±	  SD.	  The	  
significance	  was	  calculated	  for	  each	  mutant	  compared	  to	  αCTD	  upon	  IPTG	  induction	  with	  *p	  <	  0.05;	  




3.   Discussion	  
The	   Rcs	   phosphorelay	   is	   a	   key	   regulator	   of	  motility,	   biofilm	   formation,	   and	   various	   stress	  
responses	  and	  its	  complex	  output	  is	  governed	  by	  the	  response	  regulator	  RcsB	  (Majdalani	  &	  
Gottesman,	  2005).	  Since	  RcsB	  is	  involved	  in	  the	  regulation	  of	  these	  highly	  energy-­‐consuming	  
processes,	   its	   output	   function	   has	   to	   be	   tightly	   regulated.	   Hence,	   the	   activity	   of	   RcsB	   is	  
controlled	  on	  different	  levels:	  On	  the	  one	  hand	  it	   is	  controlled	  by	  its	  phosphorylation	  state	  
and	  on	  the	  other	  hand	  RcsB	  can	  regulate	  target	  genes	  as	  a	  homodimer	  or	  heterodimers	  with	  
RcsA,	  BglJ,	  GadE	  (Majdalani	  &	  Gottesman,	  2005,	  Venkatesh	  et	  al.,	  2010,	  Castanie-­‐Cornet	  et	  
al.,	  2010).	  Recently	  RcsB	  was	  found	  to	  also	  interact	  with	  MatA	  and	  DctR.	  This	  study	  provides	  
molecular	   insights	   into	   homo-­‐	   and	   heterodimer	   formation	   of	   RcsB.	   I	   established	   suitable	  
reporter	  systems	  for	  analyzing	  transcriptional	  activation	  by	  RcsB	  homodimers,	  and	  by	  RcsB	  
heterodimers	  with	  RcsA,	  and	  MatA.	  The	  results	  demonstrate	  that	  RcsB	  together	  with	  MatA	  
fully	  activates	  the	  matA	  promoter	  of	  UPEC	  strain	  CFT073	  and	  moreover,	  that	  MatA-­‐RcsB	   is	  
able	   to	   repress	   the	   motility	   of	   E.	   coli	   K-­‐12,	   suggesting	   that	   a	   MatA-­‐RcsB	   heterodimer	  
regulates	   expression.	   Furthermore,	   the	   results	   demonstrate	   that	   transcriptional	   activation	  
by	   MatA-­‐RcsB	   heterodimers	   is	   independent	   of	   RcsB	   phosphorylation.	   An	   RcsB	  
phosphorylation-­‐independent	  mechanism	  was	   also	   shown	   for	   BglJ-­‐RcsB	   (Stratmann	   et	   al.,	  
2012).	   The	   data	   confirmed	   that	   RcsA-­‐RcsB	   and	   RcsB-­‐RcsB	   act	   in	   a	   phosphorylation	  
dependent	  manner.	  In	  a	  systematic	  approach	  I	  found	  amino	  acid	  residues	  within	  the	  receiver	  
domain	   of	   RcsB	   that	   are	   required	   for	   transcriptional	   activation	   by	   RcsB	   homodimers	   and	  
heterodimers	  with	  RcsA,	  those	  transcription	  factors	  depending	  on	  RcsB	  phosphorylation.	  All	  
mutations	   that	   reduce	  or	   impair	   the	  activity	  are	   located	   in	  close	  vicinity	   to	   the	  active	  site.	  
These	   residues	   are	   presumably	   important	   for	   the	   structural	   change	   that	   is	   elicited	   by	  
phosphorylation.	   Additionally,	   the	   triple	   reporter	   results	   demonstrated	   that	   RcsB	  
homodimers	   as	   well	   as	   RcsA-­‐RcsB	   and	   BglJ-­‐RcsB	   heterodimers	   are	   simultaneously	   active,	  
suggesting	  that	  RcsB	  forms	  homodimers	  and	  heterodimers	  at	  the	  same	  time,	  if	  the	  auxiliary	  
regulators	   are	   present.	   Finally,	   I	   found	   indications	   that	   at	   some	   promoters	   BglJ-­‐RcsB	  
heterodimers	  activate	  transcription	  presumably	  by	  an	  interaction	  with	  the	  RNA	  polymerase	  




The	   results	   of	   this	   work	   together	   with	   previous	   publications	   suggest	   the	   following	  model	  
(Figure	   23A):	   The	   Rcs	   phosphorelay	   monitors	   the	   lipoprotein	   transport	   through	   the	  
periplasm	   and	   the	   β-­‐barrel	   assembly	   in	   E.	   coli.	   Rcs	   signaling	   is	   activated	   by	   cell	   envelope	  
stress	  conditions.	  Upon	  activation	  of	  the	  Rcs	  system	  by	  perturbations	  of	  the	  cell	  envelope,	  
RcsB	   is	   phosphorylated	   at	   the	   conserved	   phosphorylation	   site	   D56	   resulting	   in	   structural	  
changes	   of	   the	   RcsB	   protein.	   Phosphorylated	   RcsB	   can	   regulate	   the	   expression	   of	   target	  
genes	   by	   binding	   the	   promoter	   region	   as	   a	   homodimer	   or	   as	   a	   heterodimer	   with	   RcsA.	  
However,	   RcsB	   phosphorylation	   is	   not	   sufficient	   for	   activation	   of	   RcsA-­‐RcsB	   targets.	   For	  
regulation	   of	   RcsA-­‐RcsB	   targets,	   rcsA	   expression	   needs	   to	   be	   induced	   presumably	   by	  
additional	  factors.	  BglJ-­‐RcsB	  and	  MatA-­‐RcsB	  regulate	  their	  target	  genes	  independent	  of	  RcsB	  
phosphorylation	  and	  hence	  independent	  of	  the	  Rcs	  signaling	  cascade.	  Activation	  of	  BglJ-­‐RcsB	  
and	  MatA-­‐RcsB	  targets	  might	  rather	  be	  controlled	  by	  activation	  of	  bglJ	  and	  matA	  expression.	  
For	  DctR	  no	  certain	  target	  genes	  are	  known.	  For	  RcsB	  homodimers	  and	  heterodimers	  with	  
RcsA,	  especially	  amino	  acid	   residues	  within	  and	   in	  close	  proximity	   to	   the	  active	  site	  play	  a	  
role	  (Figure	  23B,C).	  These	  residues	  are	  presumably	  important	  for	  the	  structural	  change	  that	  





Figure	  23.	  Model	  of	  RcsB	  involved	  in	  different	  regulatory	  networks.	  
(A)	  The	  Rcs	   phosphorelay	  monitors	   lipoprotein	   transport	   through	   the	   periplasm	  by	   the	   Lol	   system	  
and	  β-­‐barrel	  assembly	  by	  the	  Bam	  machinery.	  It	  is	  activated	  by	  cell	  envelope	  stress	  conditions.	  Upon	  
induction	  of	  the	  Rcs	  system	  by	  cell	  envelope	  stress	  (jagged	  arrow),	  RcsB	  becomes	  phosphorylated	  via	  
RcsC	  and	  RcsD.	  As	  a	  homodimer	  or	  heterodimer	  with	  RcsA,	  phosphorylated	  RcsB	  regulates	  its	  specific	  
set	   of	   target	   genes.	   MatA-­‐RcsB	   and	   BglJ-­‐RcsB	   as	   well	   as	   GadE-­‐RcsB	   regulate	   their	   target	   genes	  
independent	   of	   RcsB	   phosphorylation	   and	   act	   uncoupled	   from	   the	   Rcs	   signaling.	   Genes	   rcsA,	  bglJ,	  
matA,	  gadE,	  and	  dctR	  are	  HNS	  repressed.	  Genes	  rcsA	  and	  matA	  are	  autoactivated.	  (B)	  The	  predicted	  
structure	  of	  the	  receiver	  domain	  with	  active	  site	  residues	  and	  (C)	  α4β5α5	  surface	  exposed	  residues.	  
All	   mutations	   that	   reduce	   or	   impair	   their	   activity	   of	   the	   phosphorylation-­‐dependent	   partners	   are	  
located	  in	  close	  vicinity	  to	  the	  active	  site.	  These	  residues	  are	  presumably	  important	  for	  the	  structural	  
change	  that	  is	  elicited	  by	  phosphorylation.	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3.2.  Homo-­‐	  and	  heterodimerization	  of	  RcsB	  regulates	  a	  variety	  of	  cellular	  functions	  
Heterodimerization	  of	  bacterial	  response	  regulators	  is	  rare,	  so	  that	  to	  date,	  the	  only	  known	  
example	  beside	  RcsB	  in	  Enterobacteriaceae	  is	  BldM	  and	  WhiI	  in	  Streptomyces	  (Al-­‐Bassam	  et	  
al.,	  2014).	  Notably,	  BldM	  and	  WhiI	  likewise	  belong	  to	  the	  FixJ/NarL	  family	  of	  transcriptional	  
regulators.	   The	   BldM	   homodimer	   and	   BldM/WhiI	   heterodimers	   play	   key	   roles	   in	   the	  
morphological	   differentiation.	   Both,	   BldM	   and	   WhiI	   are	   atypical	   and	   orphan	   response	  
regulators	   which	   are	   presumably	   not	   phosphorylated	   by	   cognate	   sensor	   kinases.	   BldM	  
homodimers	   activate	   transcription	   of	   group	   I	   genes	   required	   for	   early	   stages	   of	  
development,	  while	  BldM/WhiI	  heterodimers	  regulate	  expression	  of	  group	  II	  genes	  involved	  
in	   the	   late	   stages	   of	   development.	   Since	   no	   targets	   of	   a	   potential	   WhiI	   homodimer	   are	  
known,	  WhiI	  is	  thought	  to	  modulate	  BldM	  binding	  specificity	  through	  heterodimerization	  (Al-­‐
Bassam	  et	  al.,	  2014).	  	  
Similarly,	   RcsB	   is	   able	   to	   form	   homo-­‐	   and	   heterodimers	   with	   a	   set	   of	   transcriptional	  
regulators	  of	  the	  FixJ/NarL	  family	  of	  DNA-­‐binding	  proteins.	  RcsA,	  BglJ,	  MatA,	  DctR,	  and	  GadE	  
were	  shown	  to	  form	  heterodimers	  with	  RcsB.	  These	  auxiliary	  proteins	  of	  RcsB	  likewise	  adjust	  
RcsB	  binding	  specificity.	  According	  to	  this,	  the	  DNA-­‐binding	  motifs	  for	  RcsB	  homodimers,	  and	  
heterodimers	  with	  RcsA,	  BglJ	  and	  MatA	  are	  similar	  in	  only	  one	  half,	  which	  may	  be	  bound	  by	  
RcsB,	  with	  the	  interaction	  partner	  of	  RcsB	  presumably	  binding	  to	  the	  other	  half	  (Wehland	  &	  
Bernhard,	  2000,	  Sturny	  et	  al.,	  2003,	  Venkatesh	  et	  al.,	  2010,	  Lehti	  et	  al.,	  2013,	  Salscheider	  et	  
al.,	  2013).	  This	  ability	  of	  response	  regulators	  to	  form	  functional	  heterodimers	  with	  auxiliary	  
proteins	   allows	   the	   combination	   of	   different	   signals	   to	   a	   highly	   specific	   output	   and	   thus	  
provides	  an	  additional	  level	  of	  control.	  These	  various	  features	  of	  RcsB	  might	  be	  responsible	  
for	   the	   importance	   of	   the	   Rcs	   system	   in	   lifestyle	   decisions	   and	   colonization.	   The	   primary	  
niche	   of	   E.	   coli	   is	   the	   gastrointestinal	   tract	   of	   warm	   blooded	   animals.	   For	   effective	  
colonization	  of	   the	   intestine,	  E.	   coli	   cells	   have	   to	   successfully	   cross	   the	   gastric	   barrier	   and	  
survive	   acidic	   challenges.	   For	   that	   reason,	   the	   inverse	   regulation	   of	   motility	   and	   stress	  
responses	  as	  well	  as	  biofilm	  formation	  seems	  to	  be	  important	  for	  colonization.	  Accordingly,	  
RcsB	   is	   essential	   for	   successful	   colonization	   of	   the	   intestinal	   tract	   of	   mice	   (Lasaro	   et	   al.,	  
2014).	  Together	  with	  GadE,	  RcsB	   is	   involved	   in	  activation	  of	  acid	  stress	  genes	  (Hommais	  et	  
al.,	   2004,	   Castanie-­‐Cornet	   et	   al.,	   2010).	   Additionally,	   RcsA-­‐RcsB	   heterodimers	   repress	   the	  
flhDC	   operon	   encoding	   the	   flagella	  master	   regulator	   (Soutourina	  &	   Bertin,	   2003,	   Francez-­‐
Charlot	  et	  al.,	  2003).	  In	  addition,	  MatA	  was	  shown	  to	  repress	  flhDC	  (Lehti	  et	  al.,	  2012a)	  and	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this	  work	  demonstrates	  that	  inhibition	  of	  motility	  by	  MatA	  requires	  RcsB	  (see	  chapter	  2.1.4.,	  
Figure	  10).	  In	  the	  context	  of	  acid	  stress,	  repressing	  flagellum	  synthesis	  is	  necessary	  to	  close	  
the	   proton	   entrance	   during	   flagellum	   motor	   functioning	   (Soutourina	   et	   al.,	   2002).	  
Furthermore,	   flagellin	   can	   trigger	   the	   host	   immune	   response	   (Haiko	   &	   Westerlund-­‐
Wikstrom,	   2013)	   and	   therefore	   a	   repression	   of	   flagellum	   synthesis	   could	   be	   beneficial	   for	  
colonization.	  
3.3.  RcsB	  regulates	  targets	  dependent	  and	  independent	  of	  phosphorylation	  
Transcriptional	   regulation	   triggered	  by	  RcsB	  homodimers	  and	  RcsA-­‐RcsB	  heterodimers	  was	  
reported	  to	  be	  phosphorylation	  dependent	  (Majdalani	  &	  Gottesman,	  2005)	  and	  my	  data	  also	  
provided	   evidence	   for	   a	   phosphorylation-­‐dependent	   mechanism	   (see	   chapter	   2.1.1.	   and	  
2.1.2.).	   	   The	   activity	   of	   BglJ-­‐RcsB	   and	   MatA-­‐RcsB	   heterodimers	   is	   independent	   of	   RcsB	  
phosphorylation	   (see	   chapter	   2.1.4.	   and	   (Venkatesh	   et	   al.,	   2010)).	   The	   RcsB-­‐RcsB	   target	  
genes	   such	   as	   rprA,	   bdm,	   or	   ftsAZ	   play	   a	   role	   in	   the	   general	   stress	   response,	   biofilm	  
formation,	   or	   cell	   division,	   respectively,	   and	   are	   accordingly	   involved	   in	   energy-­‐consuming	  
processes	   (Francez-­‐Charlot	   et	   al.,	   2005,	  Majdalani	  &	  Gottesman,	   2005).	   Since	   gene	   rcsB	   is	  
expressed	  under	  standard	  growth	  conditions,	  it	  is	  coherent	  that	  this	  set	  of	  RcsB	  homodimer	  
targets	   is	   regulated	   in	   response	   to	   RcsB	   phosphorylation	   by	   the	   Rcs	   system	   (see	   chapter	  
2.2.1,	   Figure	   5)	   that	   is	   induced	   by	   cell	   envelope	   stress.	   BglJ-­‐RcsB	   and	   MatA-­‐RcsB	  
heterodimers	  activate	  transcription	  independent	  of	  RcsB	  phosphorylation	  (see	  chapter	  2.2.2,	  
Figure	   6	   and	   2.2.4,	   Figure	   9).	   The	   genes	   rcsA,	   bglJ,	   and	   matA	   are	   HNS	   repressed	   under	  
standard	  conditions.	  The	  specific	  function	  of	  BglJ	  and	  MatA	  in	  gene	  regulation	  is	  uncoupled	  
from	  Rcs	  signaling.	  Thus,	  activation	  of	  their	  own	  expression	  might	  in	  turn	  play	  a	  key	  role	  in	  
activating	  their	  set	  of	  target	  genes.	  Regulation	  of	  bglJ	  is	  likely	  a	  subject	  of	  a	  feedback	  control	  
mechanism	   in	  which	  the	  LysR-­‐type	  transcription	  factor	  LeuO	  activates	  yjjQ-­‐bglJ	  expression.	  
On	  the	  other	  hand,	  BglJ-­‐RcsB	  activates	  leuO	  expression	  (Stratmann	  et	  al.,	  2008)	  and	  BglJ	  and	  
LeuO	  form	  a	  small	  regulatory	  network	   in	  E.	  coli	  (Stratmann	  et	  al.,	  2012).	  Gene	  matA	   is	  the	  
first	  gene	  of	  the	  mat	  operon.	  In	  the	  lineages	  A	  and	  B1,	  such	  as	  laboratory	  strain	  MG1655	  the	  
mat	  operon	  is	  cryptic	  (Lehti	  et	  al.,	  2013).	  In	  NMEC	  and	  other	  E.	  coli	  strains	  belonging	  to	  the	  
lineages	  B2,	  D,	  and	  E,	  MatA	  forms	  a	  positive	  autoregulatory	  circuit	  (Lehti	  et	  al.,	  2013)	  most	  
likely	  activating	  expression	  as	  a	  MatA-­‐RcsB	  heterodimer	   (see	  chapter	  2.1.4.).	  Furthermore,	  
the	   integration	   host	   factor	   (IHF)	   has	   been	   shown	   to	   be	   essential	   for	   counteracting	   HNS	  
repression	   at	   the	  mat	   promoter	   (Martinez-­‐Santos	   et	   al.,	   2012),	   and	   binding	   sites	   for	   CRP	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(cAMP-­‐receptor	   protein)	   and	   Lrp	   (leucine-­‐responsive	   protein)	   in	   the	  mat	   promoter	   region	  
have	  been	  identified	  (Grainger	  et	  al.,	  2005,	  Cho	  et	  al.,	  2008,	  Lehti	  et	  al.,	  2013).	  This	  indicates	  
that	   additional	   factors	   are	   involved	   in	  mat	   regulation	   beside	   MatA-­‐RcsB.	   Environmental	  
signals	  inducing	  mat	  expression	  are	  low	  pH	  and	  elevated	  acetate	  concentrations	  mimicking	  
the	  host	   environment,	   but	   also	   low	   temperature	   (Lehti	   et	   al.,	   2013).	   Expression	  of	   rcsA	   is	  
repressed	   by	   HNS	   and	   autoactivated	   by	   RcsA-­‐RcsB.	   In	   addition,	   the	   RcsA	   concentration	   is	  
limited	   by	   its	   degradation	   by	   the	   ATP-­‐dependent	   Lon	   protease	   (Majdalani	   &	   Gottesman,	  
2005).	   In	   contrast	   to	  MatA-­‐RcsB,	  autoactivation	  of	   rcsA	  depends	  on	  RcsB	  phosphorylation.	  
Rcs	   signaling	   alone	   is	   presumably	   not	   sufficient	   to	   activate	   rcsA	   expression.	   I	   tested	   if	  
deletion	  of	  galU,	  which	  was	   reported	   to	   induce	  Rcs	   signaling,	  has	  a	  positive	  effect	  on	  wza	  
expression.	  In	  the	  ΔgalU	  mutant	  strain	  wza	  expression	  was	  not	  strongly	  induced,	  supposedly	  
due	   to	   low	   RcsA	   concentrations	   (see	   chapter	   2.1.2.,	   Figure	   6).	   This	   is	   why	   also	   additional	  
activators	   of	   rcsA	   expression,	   such	   as	   the	   small	   RNA	   DsrA	   were	   discussed	   (Sledjeski	   &	  
Gottesman,	   1995).	   Taken	   together,	   rcsA	   expression	   is	   repressed	   by	   HNS	   and	   activated	   by	  
RcsA-­‐RcsB	  and	  possibly	  by	  additional	   factors	   such	  as	  DsrA.	  This	   complex	  activation	  of	   rcsA	  
expression	  ensures	  tight	  regulation	  being	  necessary	  since	  rcsA	  overexpression	  driven	  by	  the	  
PL	   promoter	   (see	   2.1.2.,	   Figure	   6)	   or	   stabilizing	   RcsA	   in	   lon	   mutant	   cells	   (Ebel	   &	   Trempy,	  
1999)	   is	   sufficient	   to	   induce	   the	  mucoid	   phenotype	   by	   expressing	   capsule	   genes,	   a	   highly	  
energy-­‐consuming	  process.	  
3.4.  Residues	   within	   and	   close	   to	   active	   site	   of	   RcsB	   play	   a	   role	   for	   phosphorylation	   dependent	  
activation	  
This	   work	   identified	   particular	   residues	   of	   the	   RcsB	   receiver	   domain	   being	   relevant	   for	  
transcriptional	  activation	  in	  the	  context	  of	  interaction	  partner.	  I	  used	  the	  crystal	  structure	  of	  
the	   receiver	   domain	   of	  NarL	   to	   predict	   the	   structure	   of	   the	   receiver	   domain	   of	   RcsB	   (see	  
chapter	  2.2,	  Figure	  13).	  NarL	  exhibits	  a	  canonical	  (βα)5	  topology	  which	  is	  conserved	  among	  
bacterial	   response	  regulators.	  According	   to	   the	  prediction,	   the	  active	  quintet	   residues	   that	  
play	  a	  role	  in	  phosphoryl	  group	  chemistry	  are	  located	  central	  on	  the	  top	  of	  the	  α	  helices	  and	  
β	   sheets.	   The	   active	   site	   residues	   are	   particularly	   important	   for	   the	   activity	   of	   the	  
phosphorylation	   dependent	   RcsB-­‐RcsB	   and	   RcsA-­‐RcsB	   dimers,	   supporting	   the	   structure	  
prediction.	   Receiver	   domains	   typically	   undergo	   phosphorylation-­‐mediated	   conformational	  
changes,	  at	  which	  the	  α4-­‐β5-­‐α5	  face	   is	  the	  locus	  of	  the	  greatest	  difference	  between	  active	  
and	   inactive	   conformation	   (Gao	  &	   Stock,	   2010).	   Accordingly,	   the	   activity	   of	   BglJ-­‐RcsB	   and	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MatA-­‐RcsB,	  those	  being	  independent	  of	  RcsB	  phosphorylation,	  are	  not	  significantly	  affected	  
by	   exchange	   of	   amino	   acids	   comprising	   the	   α4-­‐β5-­‐α5	   surface.	   Therefore	   the	   α4-­‐β5-­‐α5	  
surface	   is	   likely	  not	   the	  dimerization	   interface	  of	  RcsB	  although	  there	  remains	  a	  possibility	  
that	   the	   dimerization	   surface	   varies	  with	   the	   interaction	   partner.	   However,	   the	  α4-­‐β5-­‐α5	  
residues	  being	  relevant	  for	  the	  activity	  of	  RcsB	  homodimers	  and	  RcsA-­‐RcsB	  heterodimers	  are	  
located	  in	  close	  proximity	  to	  the	  active	  site.	  Summarized,	  the	  amino	  acids	  relevant	  for	  RcsB	  
homodimers	   and	   RcsA-­‐RcsB	   heterodimers,	   those	   depending	   on	   RcsB	   phosphorylation	   are	  
presumably	   important	   for	   the	   structural	   change	   that	   is	   triggered	   by	   phosphorylation.	   A	  
similar	   approach,	   in	   which	   mutations	   of	   particular	   amino	   acids	   of	   a	   potential	   interaction	  
surface	  were	  evaluated	  for	  transcriptional	  activation,	  was	  previously	  conducted	  for	  the	  DesR	  
response	   regulator	   of	   Bacillus	   subtilis	   (Trajtenberg	   et	   al.,	   2014).	   In	   contrast,	   potential	  
interaction	   interfaces	   were	   identified	   before	   on	   the	   basis	   of	   crystallographic	   data.	   The	  
receiver	   domain	   of	   DesR	   varies	   from	   the	   canonical	   (βα)5	   topology	   of	   response	   regulators	  
with	  six	  central β sheets	  surrounded	  by	  six α helices.	  Helices	  α1	  and	  α5	  including	  the	  β5α5	  
loop	  were	   identified	   as	   a	   dimerization	   interface	   bringing	   the	   phosphorylation	   sites	   of	   the	  
monomers	   into	  close	  proximity.	   Interestingly,	  RcsB	  residue	   I14	  being	   located	   in	  helix	  α1	   in	  
proximity	  to	  the	  active	  site,	  is	  inactive	  in	  all	  tested	  systems	  if	  mutated	  to	  alanine.	  Moreover	  
the	   RcsB-­‐I14A	  mutant	   appeared	   to	   be	   stable	   in	   the	   stability	   experiment	   (see	   chapter	   2.3,	  
Figure	   13	   and	   chapter	   2.5,	   Figure	   16).	   However,	   in	   the	   protein-­‐protein	   interaction	  
experiment	  SPINE	   RcsB	  mutant	   I14A	  was	  also	   found	   to	   interact	  with	  RcsB,	  BglJ,	   and	  RcsA,	  
although	  the	  quantification	  of	  interaction	  proved	  to	  be	  difficult	  (see	  chapter	  2.6,	  Figure	  17).	  
The	  surface	  equivalent	  to	  the	  α4β5α5	  which	  is	  α4β6α6	  in	  DesR	  was	  found	  to	  be	  involved	  in	  
tetramerization.	   Analyses	  with	  mutated	   residues	   comprising	   both	   interfaces	  were	   used	   to	  
study	   the	   capacity	   to	   regulate	   transcription	   showing	   that	   both	   surfaces	   are	   essential	   for	  
transcriptional	   activation	   (Trajtenberg	   et	   al.,	   2014).	   However,	   the	   findings	   that	  
oligomerization	  of	  DesR	  brings	  the	  phosphorylation	  sites	  into	  close	  proximity	  correspond	  to	  
our	   findings	   that	   the	   amino	   acids	   within	   RcsB	   that	   are	   important	   for	   activity	   are	   located	  
within	  or	  in	  close	  vicinity	  to	  the	  active	  site.	  
3.5.  The	  mechanism	  of	  transcriptional	  activation	  by	  BglJ-­‐RcsB	  depends	  on	  the	  promoter	  
For	   repression	   of	   flhDC,	   the	   RcsA-­‐RcsB	   heterodimer	   binds	   just	   downstream	   of	   the	  
transcription	   start	   site	   (Francez-­‐Charlot	   et	   al.,	   2003).	   For	  gadA	   repression,	   RcsB	   binds	   the	  
promoter	   region	   upstream	  of	   the	   -­‐10	   promoter	   element	   (Castanie-­‐Cornet	   et	   al.,	   2010).	   In	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both	  cases	  it	  can	  be	  assumed	  that	  the	  bound	  transcription	  factors	  sterically	  prevent	  the	  RNA	  
polymerase	   from	   binding	   the	   promoter.	   For	   transcriptional	   activation,	   the	   underlying	  
mechanism	  most	   likely	   depends	   on	   the	   promoter.	   Recently,	   the	   BglJ-­‐RcsB	   binding	   sites	   at	  
different	   target	   promoters	   have	   been	  mapped	   (Salscheider	   et	   al.,	   2013).	   Further	   analyses	  
demonstrated	  a	  phasing	  dependent	  activation	  of	  the	  molR	  promoter	  and	  showed	  a	  BglJ-­‐RcsB	  
binding	   site	   in	   phase	   of	   the	  ynbA	  promoter,	   both	   located	   upstream	  of	   the	   core	   promoter	  
with	   the	  RcsB	   subunit	  binding	  more	  proximal	   to	   the	   transcription	   start	   site	   (Salscheider	   et	  
al.,	   2013).	   This	   could	   indicate	   a	   mechanism	   in	   which	   BglJ-­‐RcsB	   interacts	   with	   the	   RNA	  
polymerase	  to	  activate	  the	  promoter.	  For	  the	  experiments	  the	  αCTD,	  αNTD,	  or	  full-­‐length	  α	  
subunit	  were	  plasmidically	  expressed	   in	  different	  reporter	  strains	  to	  study	  a	  potential	  BglJ-­‐
RcsB-­‐αCTD	   interaction	   (see	   chapter	   2.6.2.,	   Figure	   20).	   Initially	   it	   was	   hypothesized	   that	   in	  
case	  of	  a	  mechanism	  in	  which	  BglJ-­‐RcsB	  interacts	  with	  αCTD,	  the	  reporter	  expression	  should	  
decrease	  upon	  αNTD	  expression	  (Figure	  19B).	  However,	  PmolR	  activation	  was	  still	  high	  upon	  
αNTD	  overexpression,	  potentially	  due	   to	   the	  presence	  of	   the	  chromosomal	   rpoA	  gene	  and	  
fully	  assembled	  wild-­‐type	  RNA	  polymerase	  (Figure	  21A).	  The	  results	  for	  PmolR,	  in	  which	  the	  
activation	  decreased	  upon	  αCTD	  expression	  and	  also	  upon	  full-­‐length	  α	  domain	  expression,	  
putatively	   indicate	   a	   pre-­‐recruitment	   mechanism	   in	   which	   BglJ-­‐RcsB	   binds	   the	   RNA	  
polymerase	  before	  binding	  the	  promoter,	  supporting	  the	  hypothesis	  of	  a	  potential	  BglJ-­‐RcsB-­‐
RNA	  polymerase	  interaction	  for	  activating	  the	  molR	  promoter	  (Figure	  21B).	  Further	  analyses	  
in	  which	  αCTD	  mutants	  were	  expressed	  that	  should	  impair	  a	  potential	  interaction	  with	  BglJ-­‐
RcsB,	   underscored	   this	   hypothesis	   (Figure	   21C).	   Besides	   this	   proposed	   mechanism	   of	  
activation	  by	   interaction	  with	   the	  RNA	  polymerase,	  BglJ-­‐RcsB	  might	  activate	  expression	  by	  
counteracting	  HNS,	  as	   it	  was	   suggested	   for	  activation	  of	  yidL,	  where	   the	  BglJ-­‐RcsB	  binding	  
site	   is	   in	   reverse	   orientation	   (Salscheider	   et	   al.,	   2013)	   This	   counteraction	   could	   occur	   for	  
example	   by	   simply	   competing	   with	   HNS	   for	   binding	   the	   DNA.	   Furthermore,	   a	   synergistic	  
mechanism	   of	   BglJ-­‐RcsB	   together	   with	   CRP	   has	   been	   demonstrated	   for	   bgl	   activation	  
(Salscheider	   et	   al.,	   2013).	   For	   osmC,	   RcsB	   was	   shown	   to	   recruit	   RNA	   polymerase	   to	   the	  
promoter	   and	   therefore	   stimulate	   expression,	   potentially	   by	   a	   synergistic	   RcsB-­‐RNA	  
polymerase	   binding	   to	   the	   DNA	   (Davalos-­‐Garcia	   et	   al.,	   2001).	   However,	   the	   underlying	  
molecular	  mechanism	   is	   unknown.	   Collectively,	   the	  mechanism	   of	   activation	   by	   BglJ-­‐RcsB	  
depends	   on	   the	   promoter	   and	   occurs	   by	   counteracting	   HNS	   repression	   (e.g.	   at	   PyidL),	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presumably	  interaction	  with	  RNA	  polymerase	  (e.g.	  at	  PmolR),	  or	  synergistically	  with	  CRP	  (e.g.	  
at	  Pbgl).	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4.   Materials	  and	  Methods	  
4.1.  Material	  
4.1.1.   Bacterial	  strains,	  plasmids	  and	  oligonucleotides	  
Escherichia	  coli	  strains	  are	  listed	  in	  Table	  4,	  plasmids	  in	  Table	  5	  and	  oligonucleotides	  in	  
Table	  6.	  
Table	  4.	  Strains	  
Strain	   Summary	   Source	  
CFT073	   UPEC	  strain	  CFT073	  (stored	  as	  KEC375)	   (Welch	  et	  al.,	  2002)	  
DH5α	   supE44	  ΔlacU159	  (Φ80	  lacZΔM15)	  hsdR17	  recA1	  endA1	  gyrA96	  thi-­‐1	  
relA1,	  stored	  as	  S103	  
(Xia	  et	  al.,	  2011)	  
BW30270	   =	  MG1655	  rph+	  (stored	  as	  S3839)	   Laboratory	  collection	  
S3974	   =	  MG1655	  rph+	  ilvG+	  (not	  motile)	   (Venkatesh	  et	  al.,	  
2010)	  
S4197	   =	  S3974	  ΔlacZ	   (Venkatesh	  et	  al.,	  
2010)	  
T21/T22	   =	  S4197	  ΔrcsBFRT	   (Stratmann	  et	  al.,	  
2012)	  
T46	   =	  S3839	  lacO1-­‐GCW	   (Perfeito	  et	  al.,	  2011)	  
T73	   =	  S3974	  ΔrcsBFRT	   (Stratmann	  et	  al.,	  
2012)	  
T175	   =	  S3974	  ΔrcsBFRT	  ΔyjjPQ-­‐bglJFRT	   (Stratmann	  et	  al.,	  
2012)	  
T768	   =	  S4197	  Δ(rcsDB-­‐rcsC)cmR	   S4197/pKD46	  x	  PCR	  
T433/T329	  (pKD3)	  
T903/T904	   =	  S4197	  ΔrcsBFRT	  kanRPL-­‐rcsA	   x	  PCR	  T466/T467	  
(pKES263)	  
T905/T906	   =	  S4197	  ΔrcsBFRT	  kanRP16-­‐rcsA	   x	  PCR	  T466/T468	  
(pKES262)	  
T1175/T1176	   =	  S3974	  ΔrcsBFRT	  ΔhnskanR	   T73	  x	  T4GT7	  (T208)	  
T1328/T1329	   =	  BW30270	  ΔmatAcmR	   x	  PCR	  T748/T749	  
(pKD3)	  
T1330/T1331	   =	  BW30270	  ΔdctRcmR	   x	  PCR	  T750/T751	  
(pKD3)	  
T1338/T1339	   =	  S3974	  ΔrcsBFRT	  ΔrcsAcmR	   T73	  x	  T4GT7	  (T449)	  
T1341/T1342	   =	  S3974	  ΔrcsBFRT	  ΔrcsAFRT	   T1338	  x	  pCP20	  
T1343/T1344	   =	  BW30270	  ΔmatAFRT	   T1328	  x	  pCP20	  
T1345/T1346	   =	  BW30270	  ΔdctRFRT	   T1330	  x	  pCP20	  
T1561/T1562	   =	  S3839	  rcsB-­‐3xFLAGkanR	   x	  PCR	  S819/T817	  
(pSUB11)	  
T1564/T1565	   =	  S3839	  rcsB-­‐3xFLAGFRT	   T1561/T1562	  x	  pCP20	  
T1574	   =	  S3839	  rcsB-­‐3xFLAGFRT	  Δ(yjjP-­‐yjjQ-­‐bglJ)cmR	   T1564	  x	  T4GT7	  (T69)	  
T1599	   =	  S3839	  rcsB-­‐3xFLAGFRT	  ΔrcsAcmR	   T1564	  x	  T4GT7	  (T449)	  
T1648	   =	  S3839	  rcsB-­‐3xFLAGFRT	  ΔmatAcmR	   T1564	  x	  T4GT7	  
(T1328)	  
T1649	   =	  S3839	  rcsB-­‐3xFLAGFRT	  ΔdctRcmR	   T1564	  x	  T4GT7	  
(T1330)	  
T1800/T1801	   =	  S4197	  ΔdctRcmR	   S4197	  x	  T4GT7	  
(T1330)	  
T1802/T1803	   =	  S4197	  ΔrcsBFRT	  ΔdctRcmR	   T21	  x	  T4GT7	  (T1330)	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T1819	   =	  S3839	  rcsB-­‐3xFLAGFRT	  Δ(yjjP-­‐yjjQ-­‐bglJ)FRT	   T1574	  x	  pCP20	  
T1832/T1833	   =	  S4197	  ΔrcsBFRT	  kanRPL-­‐dctR	   T21	  X	  PCR	  T964/T965	  
(pKES263)	  
T1839	   =	  S4197	  kanRPL-­‐dctR	   PCR	  T964/T965	  
(pKES263)	  
T1840	   =	  S4197	  ΔrcsBFRT	  FRTPL-­‐dctR	   T1832	  x	  pCP20	  
T1841	   =	  S4197	  FRTPL-­‐dctR	   T1839	  x	  pCP20	  
T1819	   =	  S3839	  rcsB-­‐3xFLAGFRT	  Δ(yjjP-­‐yjjQ-­‐bglJ)FRT	  
	  
T1574	  x	  pCP20	  
T1832/T1833	   =	  S4197	  ΔrcsBFRT	  kanRPL-­‐dctR	   T21/pKD46	  x	  PCR	  
T964/T965	  (pKES263)	  
T1839	   =	  S4197	  kanRPL-­‐dctR	   S4197/pKD46	  x	  PCR	  
T964/T965	  (pKES263)	  
T1840	   =	  S4197	  ΔrcsBFRT	  FRTPL-­‐dctR	   T1832	  x	  pCP20	  
T1841	   =	  S4197	  FRTPL-­‐dctR	   T1839	  x	  pCP20	  
T1978	   =	  S4197	  kanRPL-­‐matA	   S4197/pKD46	  x	  PCR	  
OA83/OA84	  
(pKES263)	  
T1985	   =	  S4197	  FRTPL-­‐matA	   T1978	  x	  pCP20	  
JW1224-­‐1	   Sex:	  F-­‐	  Chromosomal	  Markers:	  Δ(araD-­‐araB)567,	  ΔlacZ4787(::rrnB-­‐
3),	  λ-­‐,	  ΔgalU745::kan,	  rph-­‐1,	  Δ(rhaD-­‐rhaB)568,	  hsdR514,	  stored	  as	  
T2033	  
CGSC#	  9110	  
T2035	   =	  ER2507	  (T679)	  ΔrcsBcmR	   T679	  x	  T4GT7	  (T1)	  
T2036	   =	  ER2508	  (T680)	  ΔrcsBcmR	   T680	  x	  T4GT7	  (T1)	  
T2041	   =	  S4197	  ΔgalU745kanR	   S4197	  x	  P1(T2033)	  
T1241	   =	  BW30270	  ilvG+	  (motile)	  	   BW30270	  x	  T4GT7	  
(S3974)	  
U89	   =	  T1241	  ΔrcsBcmR	   T1241	  x	  T4GT7	  (T13)	  
U90	   =	  T1241	  ΔrcsBcmR	  kanRPL-­‐matA	   U89	  x	  T4GT7	  (T1978)	  
U91	   =	  T1241	  kanRPL-­‐matA	   T1241	  x	  T4GT7	  
(T1978)	  
S1906	   =	  S541	  attB::(SpecR	  PUV5	  lacO	  lacZ)	   S541/pLDR8	  x	  pKES99	  
S3432	   CSH50	  ΔlacZ	  Δbgl	  sulA3	  lexA71::Tn5	  ΔrcsBFRT	  	  attB::(SpecR	  lacIq	  PsulA	  
+/+	  lacZ	  )	  
(Venkatesh	  et	  al.,	  
2010)	  
S3434	   CSH50	  ΔlacZ	  Δbgl	  sulA3	  lexA71::Tn5	  ΔrcsBFRT	  Δ(yjjP-­‐yjjQ-­‐bglJ)FRT	  
attB::(SpecR	  lacIq	  PsulA	  +/+	  lacZ)	  
(Venkatesh	  et	  al.,	  
2010)	  
S3440	   CSH50	  ΔlacZ	  Δbgl	  sulA3	  lexA71::Tn5	  ΔrcsBFRT	  attB::(SpecR	  lacIq	  PsulA	  
408/+	  lacZ)	  
(Venkatesh	  et	  al.,	  
2010)	  
S3442	   CSH50	  ΔlacZ	  Δbgl	  sulA3	  lexA71::Tn5	  ΔrcsBFRT	  Δ(yjjP-­‐yjjQ-­‐bglJ)FRT	  
attB::(SpecR	  lacIq	  PsulA	  408/+	  lacZ)	  
(Venkatesh	  et	  al.,	  
2010)	  
T570	   =	  S4197	  attB::(SpecR	  PleuO	  lacZ)	  bglJC	   (Stratmann	  et	  al.,	  
2012)	  
T572	   =	  S4197	  attB::(SpecR	  PleuO	  lacZ)	  ΔrcsBFRT	  bglJC	   (Stratmann	  et	  al.,	  
2012)	  
T818/	  T819	   =	  S4197	  ΔrcsBFRT	  attB::(SpecR	  PftsA	  lacZ)	   T21/pLDR8	  x	  pKES243	  
T864/T865	   =	  S4197	  ΔrcsBFRT	  attB::(SpecR	  Pwza	  lacZ)	   S4197	  x	  pKES260	  
T866/T867	   =	  S4197	  ΔrcsBFRT	  attB::(SpecR	  PftsA	  lacZ)	  ΔrfaD::mTn10cmR	   T818	  x	  T4GT7	  (T370)	  
T868/T869	   =	  S4197	  ΔrcsBFRT	  attB::(SpecR	  PftsA	  lacZ)	  Δ(rcsDB-­‐rcsC)cmR	   T819	  x	  T4GT7	  (T768)	  
T919/T920	   =	  S4197	  ΔrcsBFRT	  attB::(SpecR	  Pwza	  lacZ)	  	  ΔrfaD::mTn10cmR	   T864	  x	  T4GT7	  (T370)	  
T921/T922	   =	  S4197	  ΔrcsBFRT	  attB::(SpecR	  Pwza	  lacZ)	  Δ(rcsDB-­‐rcsC)cmR	   T864	  x	  T4GT7	  (T768)	  
T923/T924	   =	  S4197	  ΔrcsBFRT	  attB::(SpecR	  Pwza	  lacZ)	  kanRPL-­‐rcsA	   T864	  x	  T4GT7	  (T903)	  
T925/T926	   =	  S4197	  ΔrcsBFRT	  attB::(SpecR	  Pwza	  lacZ)	  kanRP16-­‐rcsA	   T864	  x	  T4GT7	  (T905)	  
T929/T930	   =	  S4197	  ΔrcsBFRT	  attB::(SpecR	  Pwza	  lacZ)	  FRTP16-­‐rcsA	   T925	  x	  pCP20	  
T961/T962	   =	  S4197	  ΔrcsBFRT	  attB::(SpecR	  Pwza	  lacZ)	  Δ(rcsDB-­‐rcsC)cmR	  kanRPL-­‐rcsA	   T921	  x	  T4GT7	  (T903)	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T963/T964	   =	  S4197	  ΔrcsBFRT	  attB::(SpecR	  Pwza	  lacZ)	  Δ(rcsDB-­‐rcsC)FRT	  FRTPL-­‐rcsA	   T961	  x	  pCP20	  
T979/T980	   =	  S4197	  ΔrcsBFRT	  attB::(SpecR	  Pwza	  lacZ)	  FRTP16-­‐rcsA	  Δ(rcsDB-­‐rcsC)cmR	   T929	  x	  T4GT7	  (T768)	  
T1052/T1053	   =	  S4197	  ΔrcsBFRT	  attB::(SpecR	  PrprA	  lacZ)	   T21/pLDR8	  x	  pKES299	  
T1326	   =	  S4197	  Δ(yjjPQ-­‐bglJ	  )FRT	  ΔleuOFRT	  bglJC	  attB::(SpecR	  PynbAB	  lacZ)	  	   (Salscheider	  et	  al.,	  
2013)	  
T1441	   =	  S4197	  ΔleuOFRT	  bglJC	  (mTn10cm)	  	  attB::(SpecR	  PmolR	  lacZ)	   (Salscheider	  et	  al.,	  
2013)	  
T1736	   =	  S4197	  ΔrcsBFRT	  kanRPL-­‐rcsA	  attB::(SpecR	  PrprA	  lacZ)	   T1052	  x	  T4GT7	  (T903)	  
T1743	   =	  S4197	  ΔrcsBFRT	  FRTPL-­‐rcsA	  attB::(SpecR	  PrprA	  lacZ)	   T1736	  x	  pCP20	  
T1747/T1748	   =	  S4197	  ΔrcsBFRT	  attB::(SpecR	  PmatA	  lacZ)	   T21/pLDR8	  x	  
pKEDP49	  
T1749/T1750	   =	  S4197	  attB::(SpecR	  PmatA	  lacZ)	   S4197/pLDR8	  x	  
pKEDP49	  
T1751/T1752	   =	  S4197	  ΔrcsBFRT	  bglJC	  FRTPL-­‐rcsA	  attB::(SpecR	  PrprA	  lacZ)	   T1743	  x	  T4GT7	  
(S1734)	  
T1804/T1805	   =	  S4197	  ΔrcsBFRT	  ΔmatAcmR	  attB::(SpecR	  PmatA	  lacZ)	  	   T1564	  x	  T4GT7	  
(T1328)	  
T1979	   =	  S4197	  kanRPL-­‐matA	  attB::(SpecR	  PmatA	  lacZ)	   T1749/pKD46	  x	  PCR	  
OA83/OA84	  
(pKES263)	  
T1984	   =	  S4197	  ΔrcsBFRT	  kanRPL-­‐matA	  attB::(SpecR	  PmatA	  lacZ)	   T1747	  x	  T4GT7	  
(T1978)	  
T1986	   =	  S4197	  FRTPL-­‐matA	  attB::(SpecR	  PmatA	  lacZ)	   T1979	  x	  pCP20	  
T1987	   =	  S4197	  ΔrcsBFRT	  FRTPL-­‐matA	  attB::(SpecR	  PmatA	  lacZ)	   T1984	  x	  pCP20	  
T2015	   =	  S4197	  ΔrcsBFRT	  FRTPL-­‐dctR	  attB::(SpecR	  PygeF	  lacZ)	   T1840/pLDR8	  x	  
pKEDP61	  
T2016	   =	  S4197	  FRTPL-­‐dctR	  attB::(SpecR	  PygeF	  lacZ)	   T1841/pLDR8	  x	  
pKEDP61	  
T2017	   =	  S4197	  attB::(SpecR	  PygeF	  lacZ)	   S4197/pLDR8	  x	  
pKEDP61	  
T2023	   =	  S4197	  attB::(SpecR	  PrprA	  lacZ)	   S4197/pLDR8	  x	  
pKES299	  
T2037	   =	  S4197	  attB::(SpecR	  Pwza	  lacZ)	   S4197/pLDR8	  x	  
pKES260	  
T2039	   =	  S4197	  kanRPL-­‐rcsA	  attB::(SpecR	  Pwza	  lacZ)	   T2037	  x	  T4GT7	  (T903)	  
T2042	   =	  S4197	  ΔgalU745kanR	  attB::(SpecR	  Pwza	  lacZ)	   T2037	  x	  P1(T2033)	  
T2043	   =	  S4197	  ΔgalUFRT	  	  attB::(SpecR	  PrprA	  lacZ)	   T2041	  x	  pCP20	  
T2044	   =	  S4197	  ΔgalUFRT	  attB::(SpecR	  Pwza	  lacZ)	   T2042	  x	  pCP20	  
T2045	   =	  S4197	  kanRPL-­‐rcsA	  ΔgalUFRT	  attB::(SpecR	  Pwza	  lacZ)	   T2044	  x	  T4GT7	  (T903)	  
T861	   pKES260	  in	  DH5alpha	  (S103)	   This	  work	  
T872	   pKES262	  in	  T585	   This	  work	  
T873	   pKES263	  in	  T585	   This	  work	  
T1051	   pKES299	  in	  DH5alpha	  (S103)	   This	  work	  
T1081	   pKEDP01	  in	  DH5alpha	  (S103)	   This	  work	  
T1082	   pKEDP02	  in	  DH5alpha	  (S103)	   This	  work	  
T1083	   pKEDP03	  in	  DH5alpha	  (S103)	   This	  work	  
T1084	   pKEDP04	  in	  DH5alpha	  (S103)	   This	  work	  
T1085	   pKEDP05	  in	  DH5alpha	  (S103)	   This	  work	  
T1086	   pKEDP06	  in	  DH5alpha	  (S103)	   This	  work	  
T1087	   pKEDP07	  in	  DH5alpha	  (S103)	   This	  work	  
T1088	   pKEDP08	  in	  DH5alpha	  (S103)	   This	  work	  
T1089	   pKEDP09	  in	  DH5alpha	  (S103)	   This	  work	  
T1132	   pKEDP10	  in	  DH5alpha	  (S103)	   This	  work	  
T1133	   pKEDP11	  in	  DH5alpha	  (S103)	   This	  work	  
T1134	   pKEDP12	  in	  DH5alpha	  (S103)	   This	  work	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T1135	   pKEDP13	  in	  DH5alpha	  (S103)	   This	  work	  
T1136	   pKEDP14	  in	  DH5alpha	  (S103)	   This	  work	  
T1137	   pKEDP15	  in	  DH5alpha	  (S103)	   This	  work	  
T1138	   pKEDP16	  in	  DH5alpha	  (S103)	   This	  work	  
T1139	   pKEDP17	  in	  DH5alpha	  (S103)	   This	  work	  
T1140	   pKEDP18	  in	  DH5alpha	  (S103)	   This	  work	  
T1141	   pKEDP19	  in	  DH5alpha	  (S103)	   This	  work	  
T1142	   pKEDP20	  in	  DH5alpha	  (S103)	   This	  work	  
T1143	   pKEDP21	  in	  DH5alpha	  (S103)	   This	  work	  
T1173	   pKEDP22	  in	  DH5alpha	  (S103)	   This	  work	  
T1174	   pKEDP23	  in	  DH5alpha	  (S103)	   This	  work	  
T1214	   pKEDP24	  in	  DH5alpha	  (S103)	   This	  work	  
T1215	   pKEDP25	  in	  DH5alpha	  (S103)	   This	  work	  
T1216	   pKEDP26	  in	  DH5alpha	  (S103)	   This	  work	  
T1217	   pKEDP27	  in	  DH5alpha	  (S103)	   This	  work	  
T1218	   pKEDP28	  in	  DH5alpha	  (S103)	   This	  work	  
T1219	   pKEDP29	  in	  DH5alpha	  (S103)	   This	  work	  
T1244	   pKEDP30	  in	  DH5alpha	  (S103)	   This	  work	  
T1245	   pKEDP31	  in	  DH5alpha	  (S103)	   This	  work	  
T1246	   pKEDP33	  in	  DH5alpha	  (S103)	   This	  work	  
T1247	   pKEDP34	  in	  DH5alpha	  (S103)	   This	  work	  
T1248	   pKEDP35	  in	  DH5alpha	  (S103)	   This	  work	  
T1259	   pKEDP32	  in	  DH5alpha	  (S103)	   This	  work	  
T1308	   pKEDP36	  in	  DH5alpha	  (S103)	   This	  work	  
T1356	   pKEDP37	  in	  XL1-­‐Blue	  (S3984)	   This	  work	  
T1406	   pKEDP38	  in	  DH5alpha	  (S103)	   This	  work	  
T1407	   pKEDP39	  in	  DH5alpha	  (S103)	   This	  work	  
T1656	   pKEDP40	  in	  T572	   This	  work	  
T1657	   pKEDP41	  in	  T572	   This	  work	  
T1658	   pKEDP42	  in	  T572	   This	  work	  
T1659	   pKEDP43	  in	  T572	   This	  work	  
T1660	   pKEDP44	  in	  T572	   This	  work	  
T1671	   pKEDP45	  in	  T572	   This	  work	  
T1672	   pKEDP46	  in	  T572	   This	  work	  
T1673	   pKEDP47	  in	  T572	   This	  work	  
T1680	   pKEDP48	  in	  DH5alpha	  	  (S103)	   This	  work	  
T1715	   pKEDP49	  in	  DH5alpha	  (S103)	   This	  work	  
T1735	   pKEDP50	  in	  XL1-­‐Blue	  (S3984)	   This	  work	  
T1799	   pBAD24	  in	  DH5alpha	  (S103)	   This	  work	  
T1813	   pKEDP51	  in	  DH5alpha	  (S103)	   This	  work	  
T1824	   pKEDP52	  in	  DH5alpha	  (S103)	   This	  work	  
T1825	   pKEDP53	  in	  DH5alpha	  (S103)	   This	  work	  
T1826	   pKEDP54	  in	  DH5alpha	  (S103)	   This	  work	  
T1827	   pKEDP55	  in	  DH5alpha	  (S103)	   This	  work	  
T1837	   pKEDP56	  in	  DH5alpha	  (S103)	   This	  work	  
T1848	   pKEDP57	  in	  DH5alpha	  (S103)	   This	  work	  
T1939	   pKEDP58	  in	  DH5alpha	  (S103)	   This	  work	  
T1940	   pKEDP59	  in	  DH5alpha	  (S103)	   This	  work	  
T1941	   pKEDP56	  in	  DH5alpha	  (S103)	   This	  work	  
T1983	   pKEDP61	  in	  DH5alpha	  (S103)	   This	  work	  
	  




Table	  5.	  Plasmids	  
Plasmid	   Relevant	  structure	   Source	  
pCP20	   cI857	  λ-­‐PR	  flp	  in	  pSC101	  repts	  bla	   (Datsenko	  &	  Wanner,	  2000)	  
pKD46	   araC	  Para	  γ-­‐β-­‐exo	  in	  pSC101-­‐ori	  repts	  bla	   (Datsenko	  &	  Wanner,	  2000)	  
pLDR8	   cI857	  PR	  λ-­‐int	  in	  pSC101-­‐ori	  repts	  neo	   (Diederich	  et	  al.,	  1992)	  
pKD13	   KanR	  flanked	  by	  FRT	  sites,	  AmpR,	  R6K	  gamma	  repl.	  
origin	  
(Datsenko	  &	  Wanner,	  2000)	  
pKES262	   P16	  promoter	  in	  pKD13,	  R6K	  gamma	  repl.	  origin,	  KanR	  
AmpR	  
annealed	  oligos	  T462/T463	  
cloned	  in	  pKD13	  
pKES263	   P-­‐L	  promoter	  in	  pKD13,	  R6K	  gamma	  repl.	  origin,	  KanR	  
AmpR	  
cloned	  PCR	  fragment	  
T464/T465	  in	  pKD13	  
pKES243	   PftsA	  lacZ	  p15A	  KanR	  SpecR	  attP	   Laboratory	  collection	  
pKEDP49	   PmatA(-­‐608	  to	  +12)	  lacZ	  p15A	  KanR	  SpecR	  attP	   cloned	  PCR	  fragment	  
T908/T909	  of	  CFT073	  in	  
pKES268	  
pKES260	   Pwza	  lacZ	  p15A	  p15A	  KanR	  SpecR	  attP	   cloned	  PCR	  fragment	  
T460/T461	  in	  pKES243	  
pKEDP61	   PygeF	  (-­‐193	  to	  +12	  rel.	  to	  start	  codon)	  lacZ	  p15A	  KanR	  
SpecR	  attP	  
cloned	  PCR	  fragment	  
OA89/90	  of	  S3839	  in	  
pKES268	  
pKEDP52	   ParrS	  (-­‐311	  to	  +10)	  lacZ	  p15A	  KanR	  SpecR	  attP	   cloned	  PCR	  fragment	  
T954/955	  in	  pKES268	  
pKEDP53	   PdpiBA(-­‐378	  to	  +25)	  lacZ	  p15A	  KanR	  SpecR	  attP	   cloned	  PCR	  fragment	  
T958/959	  in	  pKES268	  
pKEDP54	   PacrEF	  (-­‐410	  to	  +5)	  lacZ	  p15A	  KanR	  SpecR	  attP	   cloned	  PCR	  fragment	  
T956/957	  in	  pKES268	  
pKEDP55	   PcaiT	  (-­‐471	  to	  +11)	  lacZ	  p15A	  KanR	  SpecR	  attP	   cloned	  PCR	  fragment	  
T960/961	  in	  pKES268	  
pKEDP56	   PdcuC	  (-­‐588	  to	  +9)	  lacZ	  p15A	  KanR	  SpecR	  attP	   cloned	  PCR	  fragment	  
T962/963	  in	  pKES268	  
pKEDP22	   lacIq	  Ptac	  3xFLAG	  neo	  ori-­‐p15A	   annealed	  oligos	  T687/T688	  
cloned	  in	  pKESK22	  
pKEDP23	   lacIq	  Ptac	  3xHA	  neo	  ori-­‐p15A	   annealed	  oligos	  T689/T690	  
cloned	  in	  pKESK22	  
pDP804	   PlacUV5	  lexA-­‐4081-­‐87-­‐jun	  p15A	  bla	   (Dmitrova	  et	  al.,	  1998)	  
pMS604	   PlacUV5	  lexAWT-­‐fos	  pMB1	  tet	   (Dmitrova	  et	  al.,	  1998)	  
pKES189	   PlacUV5	  lexA-­‐4081-­‐87-­‐jun	  in	  P15A	  bla	   Laboratory	  collection	  
pKEDP58	   PlacUV5	  lexA-­‐4081-­‐87-­‐dctR	  in	  P15A	  bla	   cloned	  PCR	  fragment	  
OA29/30	  of	  pKEDP31	  in	  
pKES189	  
pKEDP59	   PlacUV5	  lexA-­‐4081-­‐87-­‐matA	  in	  P15A	  bla	   cloned	  PCR	  fragment	  
OA27/28	  of	  pKEDP30	  in	  
pKES189	  
pKEDP60	   PlacUV5	  lexA-­‐4081-­‐87-­‐rcsA	  in	  P15A	  bla	   cloned	  PCR	  fragment	  
OA25/26	  of	  pKES192	  in	  
pKES189	  
pKESK22	   lacIq	  Ptac	  MCS	  in	  p15A-­‐ori	  neo	   (Venkatesh	  et	  al.,	  2010)	  
pKETS6	   lacIq	  Ptac	  rcsB	  in	  ori-­‐p15A	  neo	   (Venkatesh	  et	  al.,	  2010)	  
pKETS7	   lacIq	  Ptac	  rcsB-­‐D56E	  in	  ori-­‐p15A	  neo	  (GAT→GAG)	   (Venkatesh	  et	  al.,	  2010)	  
pKETS8	   lacIq	  Ptac	  rcsB-­‐D56N	  in	  ori-­‐p15A	  neo	  (GAT→AAT)	   (Venkatesh	  et	  al.,	  2010)	  
pKES229	   lacIq	  Ptac	  rcsB-­‐D66A	  in	  ori-­‐p15A	  neo	  (GAT→GCG)	   Laboratory	  collection	  
pKES230	   lacIq	  Ptac	  rcsB-­‐H77A	  in	  ori-­‐p15A	  neo	  (CAT→GCG)	   Laboratory	  collection	  
pKES231	   lacIq	  Ptac	  rcsB-­‐I14A	  in	  ori-­‐p15A	  neo	  (ATA→GCA)	   Laboratory	  collection	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pKES232	   lacIq	  Ptac	  rcsB-­‐M88A	  in	  ori-­‐p15A	  neo	  (ATG→GCG)	   Laboratory	  collection	  
pKES233	   lacIq	  Ptac	  rcsB-­‐R76A	  in	  ori-­‐p15A	  neo	  (CGC→GCC)	   Laboratory	  collection	  
pKES234	   lacIq	  Ptac	  rcsB-­‐Y64A	  in	  ori-­‐p15A	  neo	  (TAC→GCC)	   Laboratory	  collection	  
pKES235	   lacIq	  Ptac	  rcsB-­‐D56A	  in	  ori-­‐p15A	  neo	  (GAT→GCG)	   (Venkatesh	  et	  al.,	  2010)	  
pKES271	   lacIq	  Ptac	  rcsB-­‐D11A	  in	  ori-­‐p15A	  neo	  (GAC→GCC)	   Laboratory	  collection	  
pKES272	   lacIq	  Ptac	  rcsB-­‐	  P60A	  in	  ori-­‐p15A	  neo	  (CCT→GCT)	   Laboratory	  collection	  
pKES273	   lacIq	  Ptac	  rcsB-­‐	  G67A	  in	  ori-­‐p15A	  neo	  (GGC→GCC)	   Laboratory	  collection	  
pKES274	   lacIq	  Ptac	  rcsB-­‐	  T87A	  in	  ori-­‐p15A	  neo	  (ACT→GCT)	   Laboratory	  collection	  
pKES275	   lacIq	  Ptac	  rcsB-­‐	  K109A	  in	  ori-­‐p15A	  neo	  (AAA→GCA)	   Laboratory	  collection	  
pKES276	   lacIq	  Ptac	  rcsB-­‐	  K180A	  in	  ori-­‐p15A	  neo	  (AAA→GCA)	   Laboratory	  collection	  
pKES277	   lacIq	  Ptac	  rcsB-­‐	  S184A	  in	  ori-­‐p15A	  neo	  	  (AGC→GCC)	   Laboratory	  collection	  
pKES278	   lacIq	  Ptac	  rcsB-­‐I199A	  in	  ori-­‐p15A	  neo	  (ATC→GCC)	   Laboratory	  collection	  
pKES279	   lacIq	  Ptac	  rcsB-­‐	  N203A	  in	  ori-­‐p15A	  neo	  (AAT→GCT)	   Laboratory	  collection	  
pKESL111	   lacIq	  Ptac	  rcsB-­‐L95A	  in	  ori-­‐p15A	  neo	  (CTT→GCT)	   Laboratory	  collection	  
pKESL112	   lacIq	  Ptac	  rcsB-­‐L99A	  in	  ori-­‐p15A	  neo	  (TTG→GCG)	   Laboratory	  collection	  
pKESL113	   lacIq	  Ptac	  rcsB-­‐D100A	  in	  ori-­‐p15A	  neo	  (GAT→GCT)	   Laboratory	  collection	  
pKESL114	   lacIq	  Ptac	  rcsB-­‐E104A	  in	  ori-­‐p15A	  neo	  (GAA→GCA)	   Laboratory	  collection	  
pKESL115	   lacIq	  Ptac	  rcsB-­‐I106A	  in	  ori-­‐p15A	  neo	  (ATC→GCC)	   Laboratory	  collection	  
pKESL116	   lacIq	  Ptac	  rcsB-­‐L108A	  in	  ori-­‐p15A	  neo	  (CTG→GCG)	   Laboratory	  collection	  
pKESL117	   lacIq	  Ptac	  rcsB-­‐T114A	  in	  ori-­‐p15A	  neo	  (ACC→GCC)	   Laboratory	  collection	  
pKESL118	   lacIq	  Ptac	  rcsB-­‐K118A	  in	  ori-­‐p15A	  neo	  (AAA→GCA)	   Laboratory	  collection	  
pKESL119	   lacIq	  Ptac	  rcsB-­‐S96A	  in	  ori-­‐p15A	  neo	  (AGT→GCT)	   Laboratory	  collection	  
pKESL120	   lacIq	  Ptac	  rcsB-­‐D115A	  in	  ori-­‐p15A	  neo	  (GAT→GCT)	   Laboratory	  collection	  
pKEDP40	   lacIq	  Ptac	  rcsB-­‐F162C	  ori-­‐p15A	  neo	  (TTT→TGT)	   cloned	  error-­‐prone	  	  PCR	  
fragment	  T358/T106	  in	  
pKESK22	  
pKEDP41	   lacIq	  Ptac	  rcsB-­‐S58P	  ori-­‐p15A	  neo	  (TCC→CCC)	   cloned	  error-­‐prone	  	  PCR	  
fragment	  T358/T106	  in	  
pKESK22	  
pKEDP42	   lacIq	  Ptac	  rcsB-­‐F162S	  ori-­‐p15A	  neo	  (TTT→TCT)	   cloned	  error-­‐prone	  	  PCR	  
fragment	  T358/T106	  in	  
pKESK22	  
pKEDP43	   lacIq	  Ptac	  rcsB-­‐V98A	  ori-­‐p15A	  neo	  (GTA→GCA)	   cloned	  error-­‐prone	  	  PCR	  
fragment	  T358/T106	  in	  
pKESK22	  
pKEDP44	   lacIq	  Ptac	  rcsB-­‐L41P	  ori-­‐p15A	  neo	  (CTG→CCG)	   cloned	  error-­‐prone	  	  PCR	  
fragment	  T358/T106	  in	  
pKESK22	  
pKEDP45	   lacIq	  Ptac	  rcsB-­‐D11G	  ori-­‐p15A	  neo	  (GAC→GGC)	   cloned	  error-­‐prone	  	  PCR	  
fragment	  T358/T106	  in	  
pKESK22	  
pKEDP46	   lacIq	  Ptac	  rcsB-­‐D66N	  ori-­‐p15A	  neo	  (GAT→AAT)	   cloned	  error-­‐prone	  	  PCR	  
fragment	  T358/T106	  in	  
pKESK22	  
pKEDP47	   lacIq	  Ptac	  rcsB-­‐D62G	  ori-­‐p15A	  neo	  (GAT→GGT)	   cloned	  error-­‐prone	  	  PCR	  
fragment	  T358/T106	  in	  
pKESK22	  
pKEAP22	   pFDY127	  derivate	  with	  MCS	   Laboratory	  collection	  
pKEAP38	   lacIq	  Ptac	  rcsB-­‐HA	  bla	  pBR-­‐ori	   Laboratory	  collection	  
pKEDP01	   lacIq	  Ptac	  rcsB-­‐D56A-­‐HA	  bla	  pBR-­‐ori	   BglII,	  XhoI	  fragment	  of	  
pKES244	  cloned	  in	  pKEAP22	  
pKEDP02	   lacIq	  Ptac	  rcsB-­‐H77A-­‐HA	  bla	  pBR-­‐ori	   BglII,	  XhoI	  fragment	  of	  
pKES245	  cloned	  in	  pKEAP22	  
pKEDP03	   lacIq	  Ptac	  rcsB-­‐	  I14A-­‐HA	  bla	  pBR-­‐ori	   BglII,	  XhoI	  fragment	  of	  
pKES246	  cloned	  in	  pKEAP22	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pKEDP04	   lacIq	  Ptac	  rcsB-­‐	  R76A-­‐HA	  bla	  pBR-­‐ori	   BglII,	  XhoI	  fragment	  of	  
pKES248	  cloned	  in	  pKEAP22	  
pKEDP05	   lacIq	  Ptac	  rcsB-­‐Y64A-­‐HA	  bla	  pBR-­‐ori	   BglII,	  XhoI	  fragment	  of	  
pKES249	  cloned	  in	  pKEAP22	  
pKEDP06	   lacIq	  Ptac	  rcsB-­‐G67A-­‐HA	  bla	  pBR-­‐ori	   BglII,	  XhoI	  fragment	  of	  
pKES273	  cloned	  in	  pKEAP22	  
pKEDP07	   lacIq	  Ptac	  rcsB-­‐K109A-­‐HA	  bla	  pBR-­‐ori	   BglII,	  XhoI	  fragment	  of	  
pKES275	  cloned	  in	  pKEAP22	  
pKEDP08	   lacIq	  Ptac	  rcsB-­‐K180A-­‐HA	  bla	  pBR-­‐ori	   BglII,	  XhoI	  fragment	  of	  
pKES276	  cloned	  in	  pKEAP22	  
pKEDP09	   lacIq	  Ptac	  rcsB-­‐I199A-­‐HA	  bla	  pBR-­‐ori	   BglII,	  XhoI	  fragment	  of	  
pKES278	  cloned	  in	  pKEAP22	  
pKEDP10	   lacIq	  Ptac	  rcsB-­‐Strep	  in	  ori-­‐p15A	  neo	   cloned	  PCR	  fragment	  
T358/T639	  of	  pKETS06	  in	  
pKESK22	  
pKEDP11	   lacIq	  Ptac	  rcsB-­‐I14A-­‐Strep	  in	  ori-­‐p15A	  neo	   cloned	  PCR	  fragment	  
T358/T639	  of	  pKES231	  in	  
pKESK22	  
pKEDP12	   lacIq	  Ptac	  rcsB-­‐D56A-­‐Strep	  in	  ori-­‐p15A	  neo	   cloned	  PCR	  fragment	  
T358/T639	  of	  pKES235	  in	  
pKESK22	  
pKEDP13	   lacIq	  Ptac	  rcsB-­‐D56E-­‐Strep	  in	  ori-­‐p15A	  neo	   cloned	  PCR	  fragment	  
T358/T639	  of	  pKETS7	  in	  
pKESK22	  
pKEDP14	   lacIq	  Ptac	  rcsB-­‐D56N-­‐Strep	  in	  ori-­‐p15A	  neo	   cloned	  PCR	  fragment	  
T358/T639	  of	  pKETS8	  in	  
pKESK22	  
pKEDP15	   lacIq	  Ptac	  rcsB-­‐Y64A-­‐Strep	  in	  ori-­‐p15A	  neo	   cloned	  PCR	  fragment	  
T358/T639	  of	  pKES234	  in	  
pKESK22	  
pKEDP16	   lacIq	  Ptac	  rcsB-­‐G67A-­‐Strep	  in	  ori-­‐p15A	  neo	   cloned	  PCR	  fragment	  
T358/T639	  of	  pKES273	  in	  
pKESK22	  
pKEDP17	   lacIq	  Ptac	  rcsB-­‐R76A-­‐Strep	  in	  ori-­‐p15A	  neo	   cloned	  PCR	  fragment	  
T358/T639	  of	  pKES233	  in	  
pKESK22	  
pKEDP18	   lacIq	  Ptac	  rcsB-­‐H77A-­‐Strep	  in	  ori-­‐p15A	  neo	   cloned	  PCR	  fragment	  
T358/T639	  of	  pKES230	  in	  
pKESK22	  
pKEDP19	   lacIq	  Ptac	  rcsB-­‐K109A-­‐Strep	  in	  ori-­‐p15A	  neo	   cloned	  PCR	  fragment	  
T358/T639	  of	  pKES275	  in	  
pKESK22	  
pKEDP20	   lacIq	  Ptac	  rcsB-­‐K180A-­‐Strep	  in	  ori-­‐p15A	  neo	   cloned	  PCR	  fragment	  
T358/T639	  of	  pKES276	  in	  
pKESK22	  
pKEDP21	   lacIq	  Ptac	  rcsB-­‐I199A-­‐Strep	  in	  ori-­‐p15A	  neo	   cloned	  PCR	  fragment	  
T358/T639	  of	  pKES278	  in	  
pKESK22	  
pKEDP24	   lacIq	  Ptac	  rcsB-­‐	  D11A-­‐HA	  bla	  pBR-­‐ori	   cloned	  PCR	  fragment	  
S682/S683	  of	  pKES271	  in	  
pKEAP22	  
pKEDP25	   lacIq	  Ptac	  rcsB-­‐P60A-­‐HA	  bla	  pBR-­‐ori	   cloned	  PCR	  fragment	  
S682/S683	  of	  pKES272	  in	  
pKEAP22	  
pKEDP26	   lacIq	  Ptac	  rcsB-­‐P66A-­‐HA	  bla	  pBR-­‐ori	   cloned	  PCR	  fragment	  
S682/S683	  of	  pKES229	  in	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pKEAP22	  
pKEDP27	   lacIq	  Ptac	  rcsB-­‐D11A-­‐Strep	  neo	  ori-­‐p15A	   cloned	  PCR	  fragment	  
T358/T639	  of	  pKES271	  in	  
pKESK22	  
pKEDP28	   lacIq	  Ptac	  rcsB-­‐P60A-­‐Strep	  neo	  ori-­‐p15A	   cloned	  PCR	  fragment	  
T358/T639	  of	  pKES272	  in	  
pKESK22	  
pKEDP29	   lacIq	  Ptac	  rcsB-­‐D66A-­‐Strep	  neo	  ori-­‐p15A	   cloned	  PCR	  fragment	  
T358/T639	  of	  pKES229	  in	  
pKESK22	  
pKEDP36	   lacIq	  Ptac	  rcsA-­‐HA	  bla	  pBR-­‐ori	   cloned	  PCR	  fragment	  
T721/T722	  in	  pKEAP22	  
pKEDP37	   lacIq	  Ptac	  bglJ-­‐Strep	  bla	  pBR-­‐ori	   cloned	  PCR	  fragment	  
T757/T759	  of	  pKETS1	  in	  
pKEAP22	  
pKERV12	   lacIq	  Ptac	  εSDbglJ-­‐HA	  in	  pKK	  bla	   Laboratory	  collection	  
pKEHB17	   araC	  PBAD	  bglJ-­‐3xHA	  amp	  P15A	  ori	   Laboratory	  collection	  
pKEHB21	   lacIq	  Ptac	  bglJ-­‐3xHA	  cm	  pSC	  ori	   Laboratory	  collection	  
pKEDP30	   lacIq	  Ptac	  matA	  neo	  ori-­‐p15A	   cloned	  PCR	  fragment	  
T691/T692	  in	  pKESK22	  
pKEDP51	   araC	  PBAD	  matA	  ampR	  M13	  ori	  pBR322	  ori	   cloned	  PCR	  fragment	  
T691/T692	  in	  pBAD24	  
pKEDP32	   lacIq	  Ptac	  matA-­‐3xFLAG	  neo	  ori-­‐p15A	   cloned	  PCR	  fragment	  
T691/T693	  in	  pKEDP22	  
pKEDP33	   lacIq	  Ptac	  matA-­‐3xHA	  neo	  ori-­‐p15A	   cloned	  PCR	  fragment	  
T691/T693	  in	  pKEDP23	  
pKEDP57	   araC	  PBAD	  dctR	  M13	  pBR	   cloned	  PCR	  fragment	  
T694/695	  of	  pKEDP31	  in	  
pBAD24	  
pKEDP31	   lacIq	  Ptac	  dctR	  neo	  ori-­‐p15A	   cloned	  PCR	  fragment	  
T694/T695	  in	  pKESK22	  
pKEDP34	   lacIq	  Ptac	  dctR-­‐3xFLAG	  neo	  ori-­‐p15A	   cloned	  PCR	  fragment	  
T694/T696	  in	  pKEDP22	  
pKEDP35	   lacIq	  Ptac	  dctR-­‐3xHA	  neo	  ori-­‐p15A	   cloned	  PCR	  fragment	  
T694/T696	  in	  pKEDP23	  
pAC	  λcI-­‐β	  831-­‐
1057	  
PlacUV5,	  p15A-­‐ori,	  cat,	  cloning	  vector	  for	  cI-­‐α	  two-­‐hybrid	   (Dove	  &	  Hochschild,	  2004)	  
pBR	  α-­‐σ70	  D581G	   PlacUV5,	  pBR-­‐ori,	  bla,	  positive	  control	  for	  cI-­‐α	  two-­‐hybrid	   (Dove	  &	  Hochschild,	  2004)	  
pAC	  λcI	   PlacUV5,	  p15A-­‐ori,	  cat,	  negative	  control	  for	  cI-­‐α	  two-­‐hybrid	   (Dove	  &	  Hochschild,	  2004)	  
pBR	  α	  (NTD)	   PlacUV5,	  pBR-­‐ori,	  bla,	  negative	  control	  for	  cI-­‐α	  two-­‐hybrid	   (Dove	  &	  Hochschild,	  2004)	  
pKEDP38	   PlacUV	  cI-­‐beta-­‐rcsB(131-­‐216)-­‐fusion	  for	  two	  hybrid	  
system,	  CmR	  ori	  P15A	  
cloned	  PCR	  fragment	  
T762/T106	  in	  pKEAP22	  in	  
pAC	  cI-­‐beta831-­‐1057	  
pKEDP39	   PlacUV	  cI-­‐beta-­‐rcsB(142-­‐216)-­‐fusion	  for	  two	  hybrid	  
system,	  CmR	  ori	  P15A	  
cloned	  PCR	  fragment	  
T763/T106	  in	  pKEAP22	  in	  
pAC	  cI-­‐beta831-­‐1057	  
pKEDP50	   PlacUV	  cI-­‐beta-­‐rpoA	  (705-­‐990)-­‐fusion	  for	  two	  hybrid	  
system,	  CmR	  ori	  P15A	  
cloned	  PCR	  fragment	  
T923/T924	  of	  pLEX185	  in	  
pAC	  cI-­‐beta831-­‐1057	  
pKEKD23	   PlacUV	  cI-­‐beta-­‐rcsB-­‐fusion	  for	  two	  hybrid	  system,	  cat	  ori	  
P15A	  
Laboratory	  collection	  
pKEKD24	   PlacUV	  αNTD-­‐rcsB-­‐fusion	  for	  two	  hybrid	  system,	  bla	  ori	  
pBR	  
Laboratory	  collection	  
pLAX185	   Plpp-­‐lac	  rpoA	  lacI	  pBR	  ori	  bla	   (Hayward	  et	  al.,	  1991)	  
pLAD235	   Plpp-­‐lac	  rpoA(1-­‐705	  bp)	  lacI	  pBR	  ori	  bla	   (Hayward	  et	  al.,	  1991)	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Plasmid	   Relevant	  structure	   Source	  
pREIIα	   AmpR;	  ori-­‐pBR322;	  IppP-­‐'lacPUV5-­‐rpoA	   (Blatter	  et	  al.,	  1994)	  
pHTf1α	   AmpR;	  ori-­‐pBR322;	  ori-­‐fl;	  IppP-­‐'lacPUV5-­‐rpoA	   (Tang	  et	  al.,	  1994)	  
pKEDP48	   Plpp-­‐lac	  rpoA	  (705-­‐990)	  lacI	  ori-­‐pBR	  bla	   cloned	  PCR	  fragment	  
T894/T895	  of	  pLAX185	  in	  
pLAX185	  
pKEDP62	   Plpp-­‐lac	  rpoA(705-­‐990)-­‐T285A	  lacI	  ori-­‐pBR	  bla	   PCR	  1&2:	  T894/OA125	  of	  
pKEDP48	  and	  OA124/OA140	  
in	  pLAX185	  
pKEDP63	   Plpp-­‐lac	  rpoA(705-­‐990)-­‐E286A	  lacI	  ori-­‐pBR	  bla	   PCR	  1&2:	  T894/OA127	  of	  
pKEDP48	  and	  OA126/OA140	  
in	  pLAX185	  
pKEDP64	   Plpp-­‐lac	  rpoA(705-­‐990)-­‐V287A	  lacI	  ori-­‐pBR	  bla	   PCR	  1&2:	  T894/OA129	  of	  
pKEDP48	  and	  OA128/OA140	  
in	  pLAX185	  
pKEDP65	   Plpp-­‐lac	  rpoA(705-­‐990)-­‐E288A	  lacI	  ori-­‐pBR	  bla	   PCR	  1&2:	  T894/OA131	  of	  
pKEDP48	  and	  OA130/OA140	  
in	  pLAX185	  
pKEDP66	   Plpp-­‐lac	  rpoA(705-­‐990)-­‐L290A	  lacI	  ori-­‐pBR	  bla	   PCR	  1&2:	  T894/OA133	  
pKEDP48	  and	  OA132/OA140	  
in	  pLAX185	  
pKEDP67	   Plpp-­‐lac	  rpoA(705-­‐990)-­‐G315A	  lacI	  ori-­‐pBR	  bla	   PCR	  1&2:	  T894/OA135	  of	  
pKEDP48	  and	  OA134/OA140	  
in	  pLAX185	  
pKEDP68	   Plpp-­‐lac	  rpoA(705-­‐990)-­‐R317A	  lacI	  ori-­‐pBR	  bla	   PCR	  1&2:	  T894/OA137	  of	  
pKEDP48	  and	  OA136/OA140	  
in	  pLAX185	  
pKEDP69	   Plpp-­‐lac	  rpoA(705-­‐990)-­‐L318A	  lacI	  ori-­‐pBR	  bla	   PCR	  1&2:	  T894/OA139	  of	  
pKEDP48	  and	  OA138/OA140	  
in	  pLAX185	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Table	  6.	  Oligonucleotides	  
Oligo	   Sequencea	  (5’	  à	  3’)	   Target/purpose	  
S93	   CCGGGCCGACAACAAAGTCA λ-­‐attB	  region	  
S95	   CATATGGGGATTGGTGGCGA λ-­‐attP	  plasmids	  
S96	   CACTCTGCCAGATGGCGCAA λ-­‐attB	  region	  
S116	   TGGCACGACAGGTTTCCCGA pUC12	  
S118	   TGCGGGCCTCTTCGCTATTA lacZ	  
S123	   TGTGGAATTGTGAGCGGATA tac	  promoter	  
S150	   CGACGGGATCAGTACCGACGG pACYC	  plasmid	  
S164	   GAGCAGGGGAATTGATCCGGTGGA λ-­‐attB	  region	  
S656	   ATGTCAAGAGCTTGCTGTAGCAAGG rcsB	  
S657	   GACACTAACGCGTCTTATCTGGCC rcsB	  












cI-­‐rcsB-­‐HTH	  fusion	  BamHI,	  XbaI	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
cloning	  pKEDP38	  
T311	   AAGGGATTCGGATGTGATGGTATG rfaD	  
T312	   ATGAGGAATACCCGCGAAGAAAG rfaD	  
T327	   ACTCTGACTGTCGGCATCTCTTTAATG rcsA	  
T328	   CGCTCGGCATCTGGTTCTTTAATG rcsA	  
T331	   GTGATGATTTCTCGGCGGTGTATC rcsBCD	  
T334	   ACGACGTTGTAAAACGACGGCAACACGAATGCGGAACGGTT λ-­‐attP	  plasmids,	  P-­‐wza	  region	  in	  
pKES260	  
T358	   GACCGAATTCTTGCTGTAGCAAGGTAGCCTATTACATG Cloning	  of	  rcsB-­‐Strep	  in	  pACYC	  EcoRI	  
T369	   CTTTGTAACGGAGTAGAGACGAAAGTG PL	  and	  P16	  in	  pKES262	  and	  pKES263	  
T430	   TGTCCTACTCAGGAGAGCGTTCAC rcsB-­‐HA	  pMALc5	  
T434	   ATGCAGGATGATAAATATCACGGGAG rcsBCD	  
T460	   AGCAGTCGACCTCACATTATCCCTGAATTAAAAGTGG Pwza	  lacZ,	  SalI	  
Cloning	  pKES260	  




P16	  SalI	  	  (overhang)	  Cloning	  pKES262	  	  
T463	   P-GATCCTTTCCCTTCAGGCGGGATTATCCGTCATCCATATCA
CCACGTCAAAGGGTGAG  
P16	  BamHI	  	  (overhang)	  Cloning	  pKES262	  
T464	   AGCAGTCGACCTCTCACCTACCAAACAATGCCC PL	  SalI	  Cloning	  pKES263	  
T465	   AGCAGGATCCTCATGGTGGTCAGTGCGTCC  PL	  BamHI	  Cloning	  pKES263	  
T466	   AATACCTACGAACATCTTCCAGGATACTCCTGCAGCGAAATAT
TGTGTAGGCTGGAGCTGCTTCG 
Replacement	  of	  PrcsA	  by	  PL	  and	  P16	  	  
T467	   CATACCCTCACTCAATGCGTAACGATAATTCCCCTTACCTGAA
TCATGGTGGTCAGTGCGTCC 
Replacement	  of	  PrcsA	  by	  PL	  
T468	   CATACCCTCACTCAATGCGTAACGATAATTCCCCTTACCTGAA
TTTCCCTTCAGGCGGGATTAT 
Replacement	  of	  PrcsA	  by	  P16	  
T471	   CTTGCGGCAGCGTGAGC pKD13	  
T563	   AGCAGTCGACAATTGATATTTGCTTGCTCTTCCCC PrprA	  lacZ	  SalI	  Cloning	  pKES299	  
T564	   AGCGTCTAGACCGTGAGCTAATAGTAGGCATACGG PrprA	  lacZ	  XbaI	  Cloning	  pKES299	  
T639	  	   AGCATCTAGATTATTTTTCGAACTGCGGGTGGCTCCAGTCTTT
ATCTGCCGGACTTAAGGTCA 
Cloning	  of	  rcsB-­‐Strep	  tag	  in	  pACYC	  XbaI	  
T687	   P-CTAGAGACTACAAAGACCATGACGGTGATTATAAAGATCA 
TGATATCGACTACAAAGATGACGACGATAAATAAG 
3xFLAG	  XbaI	  (overhang)	  Cloning	  
pKEDP22	  
T688	   P-GATCCTTATTTATCGTCGTCATCTTTGTAGTCGATATCAT 
GATCTTTATAATCACCGTCATGGTCTTTGTAGTCT 













3xHA	  BamHI	  (overhang)	  Cloning	  
pKEDP23	  
T691	   AGCAGAATTCAATTACAGGTTTGGAAAGTAGTGACATG matA	  EcoRI	  Cloning	  pKEDP30	  
T692	   AGCGTCTAGATTACTGAACCAACTTATATATTTTTGAGTACAG
C 
matA	  XbaI	  Cloning	  pKEDP30	  
T693	   AGCGTCTAGACTGAACCAACTTATATATTTTTGAGTACAGCTT matA	  XbaI	  (without	  Stop)	  Cloning	  
pKEDP32	  
T694	   AGCAGAATTCGTCCGCACCAGGAGTCGG dctR	  EcoRI	  Cloning	  pKEDP31	  
T695	   AGCGTCTAGATCACACCAGATAATCAATATGCTGATG dctR	  XbaI	  Cloning	  pKEDP31	  
T696	   AGCGTCTAGACACCAGATAATCAATATGCTGATGGC dctR	  XbaI	  (without	  Stop)	  Cloning	  
pKEDP34	  








Construction	  of	  ΔmatA	  
T749	   CCAGTGAGTCATTTTTTAAAACTAACTTGCCTGGAGTTTACAT
ATGAATATCCTCCTTAGTTCCTATTCC 
Construction	  of	  ΔmatA	  
T750	   TTGGCAAACTGATTATAAAGTTAATGTCCGCACCAGGAGTCGG
TTGTGTAGGCTGGAGCTGCTTCG 
Construction	  of	  ΔdctR	  
T751	   TGTGGCAGCGTAGCCAGACTCACCGTAAGCCTGAAATTCACAT
ATGAATATCCTCCTTAGTTCCTATTCC 
Construction	  of	  ΔdctR	  
T753	   CACCGTTACCAGAGCTATTGCC matA	  
T754	   CCTTTTCCGTTCACATATTGACACTC matA	  
T755	   CTGAGCTGGTCAAATAACACCACC dctR	  
T756	   GGCAGGGGTGAAAGGCG dctR	  
T762	   AGCAGCGGCCGCAGAAAGCGTTTCTCGCCTGTTG cI-­‐rcsB-­‐HTH	  NotI	  Cloning	  pKEDP38	  
T763	   AGCAGCGGCCGCAGCTGGTGGTTACGGTGACAAG cI-­‐rcsB-­‐HTH	  NotI	  Cloning	  pKEDP38	  
T817	   GCTGAATTATCTCTCTTCAGTGACCTTAAGTCCGGCAGATAAA
GACGACTACAAAGACCATGACGGTGATTATA 
Construction	  of	  rcsB-­‐3xFLAG	  
T894	   AGCGTCTAGAGAGCTTACTACCCAAAGAGAGGACACAATGGAT
GTACGTCAGCCTGAAGTGAAAG 
αCTD	  (amino	  acids	  236-­‐329)	  XbaI	  
Cloning	  pKEDP48	  
T895	   AGCAGGATCCTTACTCGTCAGCGATGCTTGC αCTD	  (amino	  acids	  236-­‐329)	  BamHI	  
Cloning	  pKEDP48	  
T908	   AGCAGTCGACGCCATCGTTCCTGTGACAACTG PmatA	  (from	  UPEC	  strain	  CFT073)	  lacZ	  
SalI	  Cloning	  pKEDP49	  
T909	   AGCGTCTAGATTGCCATGTCACTACTTTCCAAACC PmatA	  (from	  UPEC	  strain	  CFT073)	  lacZ	  
XbaI	  Cloning	  pKEDP49	  
T923	   AGCAGCGGCCGCAGATGTACGTCAGCCTGAAGTGAAAG cI-­‐αCTD	  NotI	  Cloning	  pKEDP50	  
T924	   AGCGGGATCCTTACTCGTCAGCGATGCTTGC cI-­‐αCTD	  BamHI	  Cloning	  pKEDP50	  
T954	   AGCAGTCGACAACTTGCTCCTTAGCCGTTATCG ParrS	  lacZ	  SalI	  Cloning	  pKEDP52	  
T955	   AGCGTCTAGAATCGGATTACATTTTAACTTTAGTAATATTCTT
C 
ParrS	  lacZ	  XbaI	  Cloning	  pKEDP52	  
T956	   AGCAGTCGACTCTTTTTGCCATGATTAATTATTCAGG 
 
PacrEF	  lacZ	  SalI	  Cloning	  pKEDP54	  
T957	   AGCGTCTAGAGTCATTACTATTCCTCAAAAAACCAAAAG PacrEF	  lacZ	  XbaI	  Cloning	  pKEDP54	  
T958	   AGCAGTCGACAATAAATAGTATCCTGAAGGTGCATGTTG PdpiBA	  lacZ	  SalI	  Cloning	  pKEDP53	  
T959	   AGCGTCTAGAGTTTATTCTCGTTAAGCTGCAACATTG 
 





PcaiT	  lacZ	  SalI	  Cloning	  pKEDP55	  
T961	   AGCGTCTAGATCATTCTTCATGAGTTAATTCCACTGTG 
 
PcaiT	  lacZ	  XbaI	  Cloning	  pKEDP55	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PdcuC	  lacZ	  SalI	  Cloning	  pKEDP56	  
T963	   AGCGTCTAGATGTCAGCATAATTTTTCCTGTCTCC 
 
PdcuC	  lacZ	  XbaI	  Cloning	  pKEDP56	  
T964	   CACCTGAGCTGGTCAAATAACACCACCGAAAGATGCAGATGCG
TGTAGGCTGGAGCTGCTTCG 
Replacement	  of	  PdctR	  by	  PL	  
T965	   ATCCCTGGTAATTATAAGAAACATAACCGACTCCTGGTGCGGT
CATGGTGGTCAGTGCGTCC 
Replacement	  of	  PdctR	  by	  PL	  
OA10	   ATCTGGTGAATGAAGGAACGCTC yjbM	  qPCR	  
OA11	   ATTGTGGTGCAGCATCTCGC yjbM	  qPCR	  
OA12	   CTACCACTGCAACCATTAGTTCCTG ygeF	  qPCR	  
OA13	   ATGTGTTAGATATTTTCCTCCAAGAGATTC ygeF	  qPCR	  
OA14	   GAATGGGCAAATCAACTAAAACACG ygeG	  qPCR	  
OA15	   TACCCTTTTCATGGTAGTCGAATGC ygeG	  qPCR	  
OA16	   TTGTCATTATGGGAGCTGGAGAAC ypjC	  qPCR	  
OA17	   CAGGCTCACCAGAACTAACTAACTCG ypjC	  qPCR	  
OA18	   TCAAAGCGAGTGGTGAATGTGTC yjbI	  qPCR	  
OA19	   GGTGAAGTGCGAAGCGTAAAGA yjbI	  qPCR	  
OA20	   GCTGTTCCTGATTTCGTTACTTGG ycdU	  qPCR	  
OA21	   TGCTTGACATAACTGGTGCGG ycdU	  qPCR	  
OA25	   AGCACTCGAGTCAACGATTATTATGGATTTATGTAGTTACAC LexA408-­‐rcsA	  XhoI	  Cloning	  pKEDP60	  
OA26	   AGCGAGATCTTTAGCGCATGTTGACAAAAATACC LexA408-­‐rcsA	  BglII	  Cloning	  pKEDP60	  
OA27	   AGCACTCGAGACATGGCAAAGTGATTACAGTAGGGAC LexA408-­‐matA	  XhoI	  Cloning	  pKEDP59	  
OA28	   AGCGAGATCTTTACTGAACCAACTTATATATTTTTGAGTACAG
CTT 
LexA408-­‐	  matA	  BglII	  Cloning	  pKEDP59	  
OA29	   AGCACTCGAGTTTCTTATAATTACCAGGGATACGATGTTC LexA408-­‐dctR	  XhoI	  Cloning	  pKEDP58	  
OA30	   AGCGAGATCTTCACACCAGATAATCAATATGCTGATG LexA408-­‐	  dctR	  BglII	  Cloning	  pKEDP58	  
OA81	   CGACTCTAGATTTTAACTGGATTAACGGATTTCTCTTC ygeF	  XbaI	  5’	  RACE	  
OA82	   CGACTCTAGATCCAATAAAAGCCTATCAGAATAAGTCC ycdU	  XbaI	  5’	  RACE	  
OA83	   TCTTCAATGACAGCTCATCATAGTTTTATATTCTATCCCTTAG
TGTAGGCTGGAGCTGCTTCG 
Replacement	  of	  PmatA	  by	  PL	  	  
OA84	   ACTGTAATCACTTTGCCATGTCACTACTTTCCAAACCTGTAAT
CATGGTGGTCAGTGCGTCC 
Replacement	  of	  PmatA	  by	  PL	  
OA85	   CGACTCTAGAAATATAATTTAAACCAGACCCCATTGTGA ygeF	  XbaI	  5’	  RACE	  
OA88	   ATTTTGTGCGGCATGTTAATCC matA	  
OA89	   AGCAGTCGACTGTATACCTCACATTTTTACCGTGACTC PygeF	  lacZ	  SalI	  Cloning	  pKEDP61	  
OA90	   AGCGTCTAGATCGTGGCTTCATTTTACATTTCTC PygeF	  lacZ	  XbaI	  Cloning	  pKEDP61	  
OA100	   GGTGCTGATATACTGGGATGCG galU	  
OA101	   ACGGCGTCGATTGCTCAAC galU	  
OA124	   GGTACAGCGTgccGAGGTTGAGCTCCTTAAAACGC αCTD	  mutagenesis	  T285A	  
OA125	   CTCAACCTCggcACGCTGTACCAGATCACCGATATA αCTD	  mutagenesis	  T285A	  
OA126	   AGCGTACCgcgGTTGAGCTCCTTAAAACGCCTAA αCTD	  mutagenesis	  Q286A	  
OA127	   GAGCTCAACcgcGGTACGCTGTACCAGATCACCG αCTD	  mutagenesis	  Q286A	  
OA128	   CGTACCGAGgctGAGCTCCTTAAAACGCCTAACCT αCTD	  mutagenesis	  V287A	  
OA129	   TAAGGAGCTCagcCTCGGTACGCTGTACCAGATCA αCTD	  mutagenesis	  V287A	  
OA130	   TACCGAGGTTgcgCTCCTTAAAACGCCTAACCTTGG αCTD	  mutagenesis	  Q288A	  
OA131	   GTTTTAAGGAGcgcAACCTCGGTACGCTGTACCAG αCTD	  mutagenesis	  Q288A	  
OA132	   GGTTGAGCTCgctAAAACGCCTAACCTTGGTAAAAA αCTD	  mutagenesis	  L290A	  
OA133	   AGGCGTTTTagcGAGCTCAACCTCGGTACGCT αCTD	  mutagenesis	  L290A	  
OA134	   TGTCTCTGgccATGCGCCTGGAAAACTGGC αCTD	  mutagenesis	  G315A	  
OA135	   AGGCGCATggcCAGAGACAGTCCACGGGAAGC αCTD	  mutagenesis	  G315A	  
OA136	   GGGCATGgccCTGGAAAACTGGCCACCGG αCTD	  mutagenesis	  R317A	  
OA137	   GTTTTCCAGggcCATGCCCAGAGACAGTCCACG αCTD	  mutagenesis	  R317A	  
OA138	   CATGCGCgcgGAAAACTGGCCACCGGCA αCTD	  mutagenesis	  L318A	  
OA139	   CAGTTTTCcgcGCGCATGCCCAGAGACAGT αCTD	  mutagenesis	  L318A	  
OA140	   GCGTTGTATCGTCGGGCAG pKEDP48	  reverse	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Oligo	   Sequencea	  (5’	  à	  3’)	   Target/purpose	  
T385	   TGACCATCCGgcaGTCTTGTTCGGTATTCGCAAATCA rcsB	  mutagenesis	  I14A	  
T386	   CGAACAAGACTgccGGATGGTCATCGGCAATAAT rcsB	  mutagenesis	  I14A	  
T387	   GCGATAAGgccGGCGATGGCATTACCTTAATCAA rcsB	  mutagenesis	  Y64A	  
T388	   GCCATCGCCggcCTTATCGCCAGGCATGGAGAG rcsB	  mutagenesis	  Y64A	  
T389	   AAGTACGGCgcgGGCATTACCTTAATCAAGTACATCAAGC rcsB	  mutagenesis	  D66A	  
T390	   AGGTAATGCCcgcGCCGTACTTATCGCCAGGCA rcsB	  mutagenesis	  D66A	  
T391	   CATCAAGgccCATTTCCCAAGCCTGTCGATCA rcsB	  mutagenesis	  R76A	  
T392	   TGGGAAATGggcCTTGATGTACTTGATTAAGGTAA rcsB	  mutagenesis	  R76A	  
T393	   CATCAAGCGCgcgTTCCCAAGCCTGTCGATCA rcsB	  mutagenesis	  H77A	  
T394	   TGGGAAcgcGCGCTTGATGTACTTGATTAAGGTAA rcsB	  mutagenesis	  H77A	  
T395	   TGTTCTGACTgcgAACAACAACCCGGCGATTCTT rcsB	  mutagenesis	  M88A	  
T396	   GGTTGTTGTTcgcAGTCAGAACAATGATCGACAGGCTT rcsB	  mutagenesis	  M88A	  
T397	   TGTTGATTACCgcgCTCTCCATGCCTGGCGATAAG rcsB	  mutagenesis	  D56A	  
T398	   GCATGGAGAGcgcGGTAATCAACACATGCGCATCC rcsB	  mutagenesis	  D56A	  
T489	   P-AACAATATGAACGTAATTATTGCCgctGACCATCCGATAGT
CTTGTTC 
rcsB	  mutagenesis	  D10A	  
T490	   P-ATATGAACGTAATTATTGCCGATgccCATCCGATAGTCTTG
TTCGGT 
rcsB	  mutagenesis	  D11A	  
T491	   P-TTGATTACCGATCTCTCCATGgctGGCGATAAGTACGGCGA rcsB	  mutagenesis	  P60A	  
T492	   P-TTGATTACCGATCTCTCCATgccTGGCGATAAGTACGGCGA rcsB	  mutagenesis	  G67A	  
T493	   P-GCCTGTCGATCATTGTTCTGgctATGAACAACAACCCGGC rcsB	  mutagenesis	  T87A	  
T494	   P-TATCGAAGGGATCGTGCTGgcaCAAGGTGCACCGACCG rcsB	  mutagenesis	  K105A	  
T495	   P-TAAAAAGCTGAACCGCAGTATTgcaACCATCAGTAGCCAGA
AGAAAT 
rcsB	  mutagenesis	  K180A	  
T496	   P-CCGCAGTATTAAAACCATCAGTgccCAGAAGAAATCTGCGA
TGATG 
rcsB	  mutagenesis	  S198A	  
T497	   P-GCTGGGTGTCGAGAACGATgccGCCCTGCTGAATTATCTCT
CT 
rcsB	  mutagenesis	  I199A	  
T498	   P-AACGATATCGCCCTGCTGgctTATCTCTCTTCAGTGACCTT
AAGTCC 
rcsB	  mutagenesis	  N203A	  
OA33	   CGGCGATTgctAGTGCGGTATTGGATCTGGATATC rcsB	  mutagenesis	  L95A	  
OA34	   CGCACTagcAATCGCCGGGTTGTTGTTC rcsB	  mutagenesis	  L95A	  
OA35	   CGATTCTTgctGCGGTATTGGATCTGGATATCG rcsB	  mutagenesis	  S96A	  
OA36	   CCAATACCGCagcAAGAATCGCCGGGTTGTTGT rcsB	  mutagenesis	  S96A	  
OA37	   GTGCGGTAgcgGATCTGGATATCGAAGGGATCGT rcsB	  mutagenesis	  L99A	  
OA38	   TCCAGATCcgcTACCGCACTAAGAATCGCCG rcsB	  mutagenesis	  L99A	  
OA39	   AGTGCGGTATTGgctCTGGATATCGAAGGGATCGTG rcsB	  mutagenesis	  D100A	  
OA40	   ATATCCAGagcCAATACCGCACTAAGAATCGCC rcsB	  mutagenesis	  D100A	  
OA41	   TCTGGATATCgcaGGGATCGTGCTGAAACAAGGT rcsB	  mutagenesis	  E104A	  
OA42	   ACGATCCCtgcGATATCCAGATCCAATACCGCACTA rcsB	  mutagenesis	  E104A	  
OA43	   CGAAGGGgccGTGCTGAAACAAGGTGCACCG rcsB	  mutagenesis	  I106A	  
OA44	   CAGCACggcCCCTTCGATATCCAGATCCAATAC rcsB	  mutagenesis	  I106A	  
OA45	   GGATCGTGgcgAAACAAGGTGCACCGACCG rcsB	  mutagenesis	  L108A	  
OA46	   CCTTGTTTcgcCACGATCCCTTCGATATCCAGA rcsB	  mutagenesis	  L108A	  
OA47	   TGCACCGgccGATCTGCCGAAAGCTCTCGC rcsB	  mutagenesis	  T114A	  
OA48	   CAGATCggcCGGTGCACCTTGTTTCAGC rcsB	  mutagenesis	  T114A	  
OA49	   ACCGACCgctCTGCCGAAAGCTCTCGCC rcsB	  mutagenesis	  D115A	  
OA50	   CGGCAGagcGGTCGGTGCACCTTGTTTCA rcsB	  mutagenesis	  D115A	  	  
OA51	   TCTGCCGgcaGCTCTCGCCGCGCTG rcsB	  mutagenesis	  K118A	  
OA52	   CGAGAGCtgcCGGCAGATCGGTCGGTG rcsB	  mutagenesis	  K118A	  
a)	  Sites	  for	  restriction	  endonucleases	  are	  underlined.	  Mutated	  base	  triplets	  are	  indicated	  in	  lowercase.	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4.1.2.   Media,	  buffers	  and	  antibiotics	  
LB	  medium	  
For	  1000	  ml:	  10	  g	  BactoTryptone,	  5	  g	  BactoYeast	  extract,	  5	  g	  NaCl	  
	  
LB	  agar	  plates	  
LB	  medium	  with	  1.5	  %	  (w/v)	  BactoAgar	  
	  
LB	  X-­‐gal	  agar	  plates	  
LB	  medium	  with	  1.5	  %	  (w/v)	  BactoAgar,	  40	  μg/ml	  X-­‐gal	  
	  
X-­‐gal	  (5-­‐Brom-­‐4-­‐chlor-­‐3-­‐indoxyl-­‐β-­‐D-­‐galactopyranoside)	  
Stock:	  20	  mg/ml	  in	  Dimethylformamide	  
Use:	  40	  μg/ml	  for	  plates	  	  
	  
IPTG	  (Isopropyl-­‐β-­‐D-­‐thiogalactopyranoside)	  
Stock:	  100	  mM	  in	  H2O	  (filter	  sterilized)	  
Use:	  0.2	  mM	  for	  plates;	  1	  mM	  for	  cultures	  
	  
LB	  soft	  agar	  plates	  
LB	  medium	  with	  0.2	  %	  (w/v)	  BactoAgar	  
	  
SOB	  medium	  
For	  1000	  ml:	  20	  g	  BactoTryptone,	  5	  g	  BactoYeast	  extract,	  0.5	  g	  NaCl,	  1.25	  ml	  2M	  KCl,	  adjust	  pH	  to	  7.0	  
with	  NaOH,	  after	  autoclaving	  add	  10	  ml	  1	  M	  MgCl2	  
	  
SOC	  medium	  
Add	  19.8	  ml	  20%	  Glucose	  to	  1000	  ml	  SOB	  
	  
TE	  buffer	  
For	  1000	  ml:	  10	  ml	  1	  M	  Tris-­‐HCl	  (pH	  8.0),	  2	  ml	  0.5	  M	  EDTA	  (ethylenediaminetetraacetic	  acid)	  
	  
TEN	  buffer	  
20	  mM	  Tris-­‐HCl	  (pH	  7.5),	  1	  mM	  EDTA,	  50	  mM	  NaCl	  
	  
50x	  TAE	  buffer	  
For	  1000	  ml:	  242	  g	  Tris,	  100	  ml	  0.5	  M	  Na2EDTA	  (pH	  8.0),	  57.1	  ml	  glacial	  acetic	  acid	  
	  
Z	  buffer,	  pH	  7.0	  
60	  mM	  Na2HPO4,	  40	  mM	  NaH2PO4,	  10	  mM	  KCl,	  1	  mM	  MgSO4,	  100	  μg/ml	  chloramphenicol	  
	  
ONPG	  (2-­‐Nitrophenyl	  β-­‐D-­‐galactopyranoside)	  
4	  mg/ml	  in	  0.1	  M	  phosphate	  buffer	  (pH	  7.0)	  (60	  mM	  Na2HPO4	  +	  40	  mM	  NaH2PO4)	  
	  
10x	  PBS	  buffer	  (phosphate-­‐buffered	  saline)	  pH	  7.4	  
For	  1000	  ml:	  2	  g	  KCl,	  80	  g	  NaCl,	  17.8	  g	  Na2HPO4	  x2H2O,	  2.4	  g	  KH2PO4	  
	  
10x	  TBS	  buffer	  (Tris	  buffered	  saline)	  pH	  7.5	  
For	  1000	  ml:	  60.5	  g	  Tris	  (50	  mM)	  and	  87.6	  g	  NaCl	  (150	  mM)	  
	  
10x	  TBE	  buffer	  pH	  8.0	  




BTB	  agar	  	  
For	  1000	  ml:	  15	  g	  BactoAgar,	  1	  g	  YeastExtract,	  1	  g	  BactoTryptone,	  5	  g	  NaCl,	  1	  ml	  1	  M	  MgSO4,	  1	  ml	  
0.1	  M	  CaCl2,	  1	  ml	  of	  1	  mg/ml	  Vitamin	  B1,	  20	  ml	  of	  10	  %	  (w/v)	  casamino	  acids,	  50	  ml	  of	  10	  %	  (w/v)	  
salicin,	  10	  ml	  bromthymol	  blue	  stock	  solution	  (2	  %	  bromthymol	  blue	  in	  50	  %	  EtOH,	  0.1	  N	  NaOH)	  
	  
T4	  top	  agar	  
For	  1000	  ml:	  6	  g	  of	  BactoAgar,	  10	  g	  of	  BactoTryptone,	  8	  g	  of	  NaCl,	  2	  g	  of	  trisodiumcitrate	  dihydrate,	  
3	  g	  of	  glucose.	  
	  
SPINE	  ZAP	  buffer	  pH	  7.5	  
50	  mM	  TRIS-­‐HCl,	  200	  mM	  NaCl	  
	  
SPINE	  washing	  buffer	  pH	  8.0	  
100	  mM	  TRIS-­‐HCl,	  150	  mM	  NaCl,	  1	  mM	  EDTA	  
	  
SPINE	  elution	  buffer	  
0,536	  g	  D-­‐Desthiobiotin	  in	  100	  ml	  washing	  buffer	  
	  
Antibiotics	  
Antibiotics	  were	  used	  as	  following	  concentrations:	  ampicillin	  50	  μg/ml,	  chloramphenicol	  15	  μg/ml,	  
kanamycin	  25	  μg/ml,	  spectinomycin	  50	  μg/ml,	  tetracyclin	  12	  μg/ml	  
	  
	  
4.1.3.   Enzymes,	  kits	  and	  chemicals	  
Company	   Article	  
	   	  
5PRIME,	  Hamburg,	  Germany	   Agarose	  GelExtract	  
PCRExtract	  
	  
Affymetrix,	  Ohio,	  USA	   GeneChip®	  E.	  coli	  Genome	  2.0	  
	  
Ambion,	  Carlsbad,	  CA,	  USA	   SUPERAse	  In	  RNase	  Inhibitor	  
	  
Becton,	  Dickinson,	  and	  Company,	  Sparks,	  USA	   BactoAgar	  
BactoTryptone	  
YeastExtract	  
Difco	  MacConkey	  Agar	  Base	  
	  
Epicentre,	  Madison,	  WI,	  USA	   Tobacco	  Acid	  Pyrophosphatase	  (TAP)	  
Ampligase	  
	  
IBA	  Lifesciences,	  Göttingen,	  Germany	   D-­‐Desthiobiotin	  
Streptactin	  Sepharose	  columns	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Company	   Article	  
Life	  Technologies,	  Carlsbad,	  CA,	  USA	   FastDigest	  restriction	  enzymes	  
T4	  DNA	  ligase	  
HighFidelity	  Enzyme	  Mix	  
dNTPs	  
DNA	  and	  RNA	  ladders	  
RNaseH	  
SuperScript	  III	  reverse	  transcriptase	  
Platinum	  Taq	  DNA	  polymerase	  
RNase	  OUT	  
Pierce	  ECL	  Western	  Blotting	  Substrate	  
	  
Macherey-­‐Nagel,	  Düren,	  Germany	   NucleoBond	  Gel	  and	  PCR	  clean-­‐up	  
NucleoSpin	  Plasmid	  EasyPure	  
New	  England	  Biolabs,	  Frankfurt	  am	  Main,	  Germany	   T4	  RNA	  ligase	  
	  
	  
Promega,	  Madison,	  WI,	  USA	   Wizard	  Plus	  MaxiPrep	  
GoTaq	  DNA	  polymerase	  
qPCR	  master	  mix	  
	  
Qiagen,	  Hilden,	  Germany	   QIAquick	  Gel	  Extract	  
QIAquick	  PCR	  extract	  
RNeasy	  MiniKit	  
RNAprotect	  Bacteria	  Reagent	  
	  





4.2.1.   Standard	  molecular	  techniques	  
Standard	  molecular	   techniques	   that	   are	  not	  described	  below	   (agarose	   gel	   electrophoresis,	  
PCR,	  cloning)	  were	  done	  according	  to	  published	  protocols	  (Ausubel,	  2005).	  Sequencing	  was	  
performed	  by	  GATC	  Biotech	  AG,	   Konstanz.	   The	   sequences	  were	   analyzed	  by	   the	   Software	  
Vector	  NTI	  Advance	  11	  (Invitrogen).	  
4.2.2.   CaCl2	  competent	  cells	  and	  transformation	  
To	   prepare	   competent	   cells,	   25	   ml	   LB	   medium	   was	   inoculated	   with	   200	   μl	   of	   a	   fresh	  
overnight	  culture	  and	  incubated	  in	  a	  shaker	  at	  37°C.	  The	  cultures	  were	  harvested	  on	  ice	  at	  
OD600	  =	  0.3,	  transferred	  into	  pre-­‐cooled	  centrifuge	  tubes	  and	  centrifuged	  for	  10	  minutes	  at	  
3000	  rpm	  and	  4°C.	  The	  pellet	  was	  resuspended	  in	  12.5	  ml	  ice-­‐cold	  CaCl2	  solution	  and	  further	  
incubated	   on	   ice	   for	   20	  minutes.	   After	   a	   second	   centrifuge	   step	   (10’,	   3000	   rpm,	   4°C),	   the	  
pellet	  was	   resuspended	   in	   1	  ml	   CaCl2	   solution.	   These	   cells	  were	   ready	   for	   transformation.	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Alternatively	  100-­‐200	  μl	  aliquots	  of	  the	  cell	  solution	  were	  stored	  at	  -­‐80°C	  supplemented	  with	  
glycerol	   (15	   %	   final	   concentration).	   For	   the	   transformation	   1-­‐12	   ng	   of	   vector	   DNA	   was	  
prepared	  on	  ice	  and	  filled	  up	  with	  TEN	  buffer	  to	  a	  volume	  of	  50	  μl.	  After	  adding	  100	  μl	  of	  the	  
competent	   cells	   and	   incubation	   for	   20	   minutes	   on	   ice,	   the	   cells	   were	   heat-­‐shocked	   for	  
2	  minutes	  at	  42°C.	  After	  10	  minutes	  further	  incubation	  on	  ice,	  1	  ml	  LB	  medium	  was	  added,	  
the	   cultures	   were	   incubated	   for	   one	   hour	   at	   37°C	   (plasmids	   with	   temperature	   sensitive	  
replication	  origin	  at	  28°C).	  Afterwards	  100	  µl	  or	  varying	  volumes	  of	  the	  cultures	  were	  plated	  
on	  LB	  plates	  containing	  antibiotics	  for	  selection.	  
4.2.3.   Electro-­‐competent	  cells	  and	  electroporation	  
For	  preparation	  of	  electro-­‐competent	  cells,	  50	  ml	  SOB	  medium	  was	  inoculated	  with	  200	  μl	  of	  
an	  overnight	  culture.	  This	  culture	  was	   incubated	   in	  a	  shaker	  at	  37	  °C,	  harvested	  at	  OD600	  =	  
0.6	  –	  0.7	  and	  kept	  on	  ice	  for	  1	  hour.	  The	  first	  centrifuging	  step	  was	  done	  in	  a	  4°C	  pre-­‐cooled	  
centrifuge	   at	   3000	   rpm	   for	   15	  minutes.	   The	   cell	   pellet	  was	   resuspended	   in	   50	  ml	   ice	   cold	  
sterile	  H2O.	  After	   the	  second	  centrifuging	  step	   (15	  minutes,	  3000	   rpm,	  4°C)	   the	  pellet	  was	  
resuspended	   in	   25	  ml	   water.	   After	   a	   third	   centrifugation	   under	   the	   same	   conditions,	   the	  
pellet	  was	   resuspended	   in	  2	  ml	  10	  %	  glycerol,	   again	  centrifuged	  at	  6000	  rpm	   (15	  minutes,	  
4°C)	  and	  finally	  resuspended	  in	  200	  μl	  glycerol	  and	  used	  for	  transformation.	  Alternatively	  the	  
cells	   were	   stored	   at	   -­‐80°C.	   For	   electroporation	   0.5	   to	   1	   μl	   of	   plasmid	   DNA	   of	   different	  
concentrations	  was	  prepared,	  40	  μl	  competent	  cells	  added	  and	  incubated	  for	  10	  minutes	  on	  
ice.	  This	  preparation	  was	  transferred	  to	  a	  pre-­‐chilled	  electro	  cuvette	  and	  electro	  shocked	  for	  
3	  seconds	  at	  1.8	  kV.	  Immediately	  afterwards	  1	  ml	  SOC	  medium	  was	  pipetted	  in	  the	  cuvette	  
and	   this	   solution	   incubated	   for	   1	   hour	   in	   a	   37°C	   in	   a	   culture	   tube.	   Afterwards	   various	  
dilutions	  were	  plated	  on	  selection	  plates.	  
4.2.4.   Mutagenesis	  PCR	  
Site-­‐directed	  mutagenesis	   to	   replace	   amino	   acid	   residues	   of	   RcsB	   or	   the	   CTD	   of	   the	   RNA	  
polymerase	   alpha	   subunit	  was	   carried	  out	  by	  overlap	  extension	  PCR	   (Ho	   et	   al.,	   1989).	   For	  
each	  mutagenesis,	  three	  standard	  polymerase	  chain	  reactions	  A,	  B,	  and	  C	  were	  conducted.	  
PCR	   A	   contained	   a	   forward	   primer	   flanking	   the	   gene	   upstream	   and	   a	   reverse	   primer	  
including	   the	   mutation	   matching	   the	   region	   of	   mutagenesis.	   PCR	   B	   contained	   a	   reverse	  
primer	   flanking	   the	   gene	   downstream	   and	   a	   forward	   primer	   including	   the	   mutation,	  
matching	   the	   region	   of	   mutagenesis.	   The	   fragments	   obtained	   by	   PCR	   A	   and	   B	   were	   gel	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purified	  and	  used	  as	  templates	  in	  equal	  measures	  for	  PCR	  C	  with	  the	  forward	  primer	  of	  PCR	  
A	  and	  reverse	  primer	  of	  PCR	  B.	  Both	  oligonucleotides	  contain	  specific	   restriction	  sites.	  The	  
PCR	   fragment	  was	   gel	   purified,	   digested	  with	   appropriate	   restriction	   enzymes	   and	   cloned	  
into	  a	  specific	  vector.	  
4.2.5.   Random	  mutagenesis	  screen	  
A	   non-­‐saturated	   random	   mutagenesis	   screen	   was	   performed	   to	   find	   RcsB	   mutants	   that	  
affect	   the	  activities	  of	  BglJ-­‐RcsB,	  RcsA-­‐RcsB	  and	  RcsB-­‐RcsB.	  Random	  mutations	  within	  RcsB	  
were	  introduced	  by	  an	  error-­‐prone	  PCR	  utilizing	  the	  GoTaq	  DNA	  polymerase	  (Promega)	  that	  
lacks	  a	  3’-­‐5’	  proofreading	  activity	  and	  has	  an	  error	  rate	  of	  about	  10-­‐5	  errors	  per	  synthesized	  
nucleotide	  (Zhou	  et	  al.,	  1991).	   In	  brief,	  rcsB	  was	  amplified	  with	  oligos	  T358	  and	  T106	  using	  
vector	  pKETS6	  as	  template,	  the	  fragments	  purified,	  digested	  with	  restriction	  endonucleases	  
EcoRI	   and	   XbaI	   and	   ligated	   into	   the	   vector	   pKESK22.	   For	   finding	   potential	   RcsB	   mutants,	  
reporter	  strains	  T572	  (PleuO	   lacZ	  ΔrcsB	  ΔlacZ	  bglJC),	  T963	  (Pwza	   lacZ	  ΔrcsBCD	  ΔlacZ	  rcsAPL)	  
and	  T1052	  (PrprA	  lacZ	  ΔrcsB	  ΔlacZ)	  were	  transformed	  with	  each	  ligation,	  plated	  on	  LB	  X-­‐gal	  
plates	  (IPTG,	  kanamycin)	  and	  a	  blue/white	  screen	  was	  performed.	  In	  order	  to	  find	  particular	  
amino	   acids	   that	   are	   important	   for	   the	   activity	   of	   RcsB	   related	   to	   a	   specific	   interaction	  
partner,	   the	   screen	   focused	  on	   finding	  RcsB	  mutants	  with	  different	   Lac-­‐phenotypes	   in	   the	  
three	   reporter	   backgrounds.	   Thus,	   colonies	   exhibiting	   Lac-­‐negative	   phenotype	   in	   one	   and	  
Lac-­‐positive	   phenotype	   in	   the	   other	   reporter	   system(s)	   were	   picked	   and	   the	   rcsB	   allele	  
analyzed	  by	  sequencing.	  
4.2.6.   Promoter	  replacement	  and	  gene	  deletion	  	  
The	   replacement	   of	   promoters	   or	   deletion	   of	   chromosomal	   genes	  was	   done	   according	   to	  
(Datsenko	  &	  Wanner,	  2000).	  By	  this	  method,	  a	  specific	  chromosomal	  locus	  was	  replaced	  by	  a	  
linear	  DNA	  fragment	  mediated	  by	  the	  λ-­‐Red	  recombination	  system.	  The	  linear	  DNA	  fragment	  
was	   prepared	   by	   PCR	   by	   amplifying	   a	   sequence	   with	   a	   resistance	   cassette	   for	   selection,	  
flanked	  by	  FRT	  (Flp	  Recombinase	  Target)	  sites.	  The	  oligonucleotides	  were	  designed	  to	  have	  
around	  40	  nt	  long	  homologue	  sequences	  to	  the	  chromosomal	  locus	  that	  should	  be	  replaced.	  
The	  cells	  were	  transformed	  with	  the	  temperature	  sensitive	  plasmid	  (pKD46)	  encoding	  for	  the	  
λ-­‐Red	   system	   under	   the	   control	   of	   the	   arabinose-­‐inducible	   promoter.	   In	   parallel	   the	   PCR	  
product	   was	   prepared	   using	   pKD3,	   pKD4	   or	   derivatives	   carrying	   the	   resistance	   cassette	  
flanked	  by	  FRT	  sites	  as	  template.	  The	  cells	  harboring	  the	  pKD46	  helper	  plasmid	  were	  electro-­‐
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transformed	  with	  the	  gel	  purified	  PCR	  product	  (>	  100	  ng/μl	  in	  H2O).	  Due	  to	  the	  temperature	  
sensitivity	  of	  replication	  of	  the	  pKD46	  plasmid,	  the	  electro-­‐competent	  cells	  were	  prepared	  at	  
28°C	   in	   SOB	   medium	   containing	   10	   mM	   L-­‐arabinose	   for	   induction	   of	   λ-­‐recombinase	  
expression.	   The	   recombinants	   were	   selected	   on	   LB	   plates	   containing	   the	   appropriate	  
antibiotic	  at	  37°C.	  The	  deletion	  of	  the	  target	  gene	  was	  analyzed	  by	  PCR	  and	  the	  loss	  of	  the	  
helper	  plasmid	  confirmed	  by	  ampicillin	  sensitivity.	  The	  resistance	  cassettes	  were	  flipped	  out	  
expressing	   the	   Flp	   recombinase	   from	   the	   plasmid	   pCP20.	   This	   plasmid	   has	   a	   temperature	  
sensitive	   replication	   origin;	   transformants	   were	   selected	   at	   28°C	   on	   LB	   ampicillin	   plates.	  
Colonies	   were	   restreaked	   on	   LB	   and	   incubation	   at	   42°C	   induced	   expression	   of	   the	  
recombinase	   and	   repressed	   replication	   of	   the	   plasmid.	   The	   excision	   of	   the	   resistance	  
cassette	  was	   confirmed	  by	   PCR	  with	   locus	   specific	   oligonucleotides	   and	   the	   loss	   of	   pCP20	  
was	  confirmed	  by	  ampicillin	  sensitivity.	  
4.2.7.   Preparation	  of	  lysate	  and	  transduction	  
Generalized	  transduction	  was	  applied	  to	  transfer	  DNA	  between	  bacteria	  with	  the	  help	  of	  the	  
bacteriophage	  T4GT7	  (Wilson	  et	  al.,	  1979).	  For	  the	  preparation	  of	  a	  phage	  lysate	  100	  μl	  of	  an	  
overnight	  culture	  of	  the	  donor	  strain	  whose	  genes	  should	  be	  transduced,	  were	  incubated	  for	  
20	  minutes	  at	  room	  temperature	  with	  different	  dilutions	  (e.g.	  10-­‐2,	  10-­‐3	  and	  10-­‐4	  in	  LB)	  of	  a	  
phage	  lysate.	  Afterwards	  1	  ml	  LB	  medium	  as	  well	  as	  3	  ml	  of	  liquid	  42°C	  warm	  top	  agar	  was	  
added,	  carefully	  mixed	  and	  plated	  on	  fresh	  LB	  plates.	  After	  8	  –	  14	  hours	  of	  incubation	  at	  37°C	  
those	  plates	  showing	  almost	  confluent	  lysis	  were	  chosen	  and	  the	  top	  agar	  transferred	  into	  a	  
glass	  tube.	  After	  adding	  the	  same	  volume	  of	  chloroform,	  the	  mixture	  was	  homogenized	  with	  
a	  glass	  pestle.	  The	  homogenate	  was	  centrifuged	  at	  12.000	  rpm	  for	  3	  minutes.	  The	  top	  phase	  
was	   pipetted	   into	   a	   new	   tube,	   the	   same	   volume	   of	   chloroform	   is	   added,	   mixed	   and	  
centrifuged	  again.	  The	  top	  phase	  was	  stored	  at	  4°C.	  For	  the	  transduction	  100	  –	  200	  μl	  of	  an	  
overnight	   culture	   of	   the	   acceptor	   strain	   was	   mixed	   with	   different	   volumes	   of	   the	   phage	  
lysate	  (e.g.	  0.2	  μl,	  1	  μl,	  3	  μl,	  10	  μl),	  incubated	  for	  less	  than	  20	  minutes	  at	  room	  temperature	  
and	  plated	  on	  selection	  plates.	  Colonies	  of	  transduced	  cells	  were	  restreaked	  three	  times	  as	  
soon	  as	  possible	  and	  the	  transduced	  locus	  analyzed	  by	  PCR.	  
4.2.8.   Chromosomal	  integration	  
The	   integration	   of	   reporter	   constructs	   into	   the	   chromosome	   at	   the	  attB	   site	  was	   done	   as	  
described	   (Diederich	   et	   al.,	   1992).	   For	   integration,	   cells	   of	   the	   desired	   strain	   were	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transformed	  with	  the	  helper	  plasmid	  pLDR8	  that	  encodes	  for	  the	  integrase.	  On	  the	  plasmid	  
pLDR8	   the	   integrase	   encoding	   gene	   is	   under	   the	   control	   of	   the	   λ	   promoter	   PR	   and	   the	  
temperature	   sensitive	   repressor	   cI857.	   The	   origin	   of	   replication	   of	   pLDR8	   is	   temperature	  
sensitive.	  The	   transformants	  were	  selected	  on	  LB	  plates	  with	  kanamycin	  at	  28°C.	  The	  next	  
day	   LB	  medium	   containing	   kanamycin	  was	   inoculated	  with	   a	   single	   colony	   and	   incubated	  
overnight	  in	  a	  shaker	  at	  28°C.	  The	  next	  morning	  this	  culture	  was	  diluted	  1:20	  with	  fresh	  LB	  
medium	   containing	   kanamycin.	   This	   culture	   was	   incubated	   in	   a	   shaker	   at	   37°C	   for	   90	  
minutes,	  harvested	  and	  chemo-­‐competent	  cells	  prepared.	  In	  parallel	  the	  plasmid	  containing	  
the	  promoter	  lacZ	  fusion	  was	  digested	  with	  BamHI,	  the	  fragment	  gel-­‐purified	  and	  re-­‐ligated.	  
The	   competent	   cells	  were	   transformed	  with	   the	   re-­‐ligation	  and	   incubated	   for	  one	  hour	  at	  
37°C.	   Afterwards	   200	   μl	   of	   the	   cultures	   were	   plated	   on	   LB	   spectinomycin	   plates	   and	  
incubated	   at	   42°C.	   This	   temperature	   fully	   induced	   the	   integrase	   expression	   and	   the	  
replication	  of	  the	  plasmid	  was	   inhibited.	  For	  the	  analysis	  of	   integration,	  four	  colonies	  were	  
analyzed	  by	  PCR	  with	  S93/S164	   (analysis	  of	   attB/P’	   site),	   S95/S96	  or	   S95/T912	   (analysis	  of	  
attP/B’	   site),	   S95/S164	   (exclusion	   of	   dimers)	   and	   T334/S118	   (analysis	   of	   the	   reporter	  
construct).	   The	   colonies	   were	   analyzed	   for	   kanamycin	   sensitivity	   (loss	   of	   pLDR8)	   and	   two	  
independent	  clones	  were	  stored.	  
4.2.9.   RcsB	  structure	  prediction	  
The	   RcsB	   protein	   consists	   of	   216	   amino	   acids	   with	   the	   N-­‐terminal	   receiver	   domain	  
comprising	  residues	  1	  to	  124,	  and	  the	  C-­‐terminal	  DNA-­‐binding	  domain	  comprising	  residues	  
144	  to	  209	   (Majdalani	  &	  Gottesman,	  2005).	  The	  structure	  of	   the	  DNA-­‐binding	  domain	  was	  
solved	  for	  RcsB	  derived	  from	  Erwinia	  amylovora	  (Pristovsek	  et	  al.,	  2003)	  but	  the	  structure	  of	  
the	   receiver	   domain	   has	   not	   been	   solved.	   The	   model	   of	   the	   RcsB	   receiver	   domain	   was	  
predicted	  using	  the	  Phyre2	  server	  (Kelley	  et	  al.,	  2015).	  For	  this,	  amino	  acids	  1	  to	  124	  of	  RcsB	  
derived	  from	  E.	  coli	  K-­‐12	  served	  as	  query	  sequence.	  The	  3D	  model	  prediction	  is	  based	  on	  a	  
comparison	   of	   the	   query	   sequence	   with	   templates	   having	   a	   solved	   structure	   through	   (1)	  
gathering	  homologous	  sequences,	  (2)	  a	  fold	  library	  scan,	  (3)	  loop	  modeling	  and	  (4)	  side	  chain	  
replacement	  (Kelley	  et	  al.,	  2015).	  Through	  this,	  20	  models	  based	  on	  different	  templates	  have	  
been	   predicted	   that	   are	   ranked	   according	   to	   raw	   alignment	   scores.	   The	   highest	   scoring	  
model	  was	  based	  on	  the	  crystal	  structure	  of	  NarL	  (PDB#	  3EUL)	  (Schnell	  et	  al.,	  2008)	  with	  a	  
sequence	   identity	  of	  26	  %,	  a	   coverage	  of	  97	  %	  and	  a	   confidence	  of	  99.9	  %.	  Coverage	  and	  
confidence	  indicate	  that	  residues	  4	  to	  124	  of	  the	  query	  sequence	  (97	  %)	  were	  aligned	  to	  the	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template	  and	  have	  been	  modeled	  with	  a	  99.9	  %	  probability	  that	  query	  sequence	  and	  NarL	  
template	  are	  homologous	  (Kelley	  et	  al.,	  2015).	  
4.2.10.  β-­‐galactosidase	  assay	  
Expression	  analyses	  of	  promoter	  lacZ	  fusions	  were	  carried	  out	  according	  to	  (Miller,	  1992).	  To	  
this	  end,	  exponential	  cultures	  were	  inoculated	  from	  a	  fresh	  overnight	  culture	  to	  an	  OD600	  =	  
0.05	   in	   LB	  medium	   containing	   appropriate	   antibiotics	   for	   transformants.	   If	   required,	   IPTG	  
was	  added	   to	  overnight	   and	  exponential	   culture	   for	   induction	   (1	  mM	   final	   concentration).	  
Bacteria	  were	  harvested	  on	   ice	  at	  an	  OD600	  =	  0.5.	  The	  assays	  were	  repeated	  at	   least	   three	  
times	   from	   independent	  cultures.	  The	  standard	  deviations	  are	   indicated	  as	  error	  bars.	  The	  
statistical	  significance	  was	  calculated	  by	  t-­‐test	  with	  *p	  <	  0.05;	  **p	  <	  0.01;	  ***p	  <	  0.001.	  
4.2.11.  Motility	  assays	  
3	  µl	  of	  a	  fresh	  overnight	  culture	  grown	  in	  LB	  medium	  (with	  25	  μg/ml	  kanamycin	  and	  1	  mM	  
IPTG	  for	  transformants)	  was	  pipetted	  in	  the	  center	  of	  freshly	  poured	  LB	  soft	  agar	  plates	  (0.2	  
%	   agar,	   with	   25	  μg/ml	   kanamycin	   and	   0.2	   mM	   IPTG	   for	   transformants).	   The	   plates	   were	  
incubated	  for	  5	  hours	  at	  37°C	  and	  scanned	  using	  Epson	  Perfection	  V700	  Photo	  transparency	  
scanner.	  The	  motility	  radii	  were	  measured	  in	  mm.	  
4.2.12.  RNA	  isolation	  
Exponential	  cultures	  were	  inoculated	  from	  a	  fresh	  overnight	  culture	  to	  an	  OD600	  =	  0.05	  in	  LB	  
medium	  containing	  appropriate	  antibiotics	  for	  transformants.	  If	   induction	  required,	  IPTG	  (1	  
mM	  final	  concentration)	  or	  arabinose	  (0.2	  %	  final	  concentration)	  was	  added	  at	  an	  OD600	  =	  0.3	  
and	   harvested	   after	   30	   minutes	   further	   growth.	   Bacteria	   were	   harvested	   using	   the	  
RNAprotect	  Bacteria	  Reagent	  (Qiagen).	  The	  total	  RNA	  was	  isolated	  using	  the	  RNeasy	  MiniKit	  
system	   (Qiagen)	   according	   to	   manufacturer’s	   instructions	   including	   an	   on-­‐column	   DNaseI	  
treatment.	  The	  RNA	  was	  analyzed	  by	  denaturing	  urea	  PAGE	  and	  by	  measuring	  the	  UV	  light	  
absorption	  ratio	  260/280	  nm.	  The	  RNA	  concentration	  was	  measured	  at	  260	  nm	  and	  isolated	  
RNA	  stored	  at	  -­‐80°C	  in	  H2O.	  
4.2.13.  Urea	  PAGE	  
Isolated	  RNA	  was	  analyzed	  using	  urea-­‐polyacrylamide	  gel	  electrophoresis	  under	  denaturing	  
conditions.	  For	  this,	  0.5	  µg	  RNA	  was	  mixed	  with	  2	  x	  RNA	  loading	  dye	  (Life	  Technologies)	  to	  a	  
total	  volume	  of	  10	  µl	  with	  H2O.	  The	  RNA	  sample	  and	  Riboruler	  High	  Range	  RNA	  ladder	  (Life	  
Technologies)	  were	  heated	  at	  70°C	  for	  10	  minutes	  and	  separated	  on	  5	  %	  polyacrylamide	  gel	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(19:1	  acrylamide:bisacrylamide	  40	  %	  stock)	  containing	  7	  M	  UREA	  in	  0.5	  x	  TBE	  for	  1.5	  hours	  at	  
200	  V.	  Subsequently,	  the	  gel	  was	  stained	  for	  30	  minutes	  	   in	  0.5	  x	  TBE	  containing	  0.5	  µg/ml	  
ethidium	   bromide.	   The	   23S	   rRNA	   (2904	   nt)	   and	   16S	   rRNA	   (1542	   nt)	   bands	   served	   as	  
reference	  for	  intact	  RNA	  without	  degradation	  products.	  
4.2.14.  cDNA	  synthesis	  
For	  first	  strand	  cDNA	  synthesis,	  1	  μg	  of	  RNA	  was	  reverse	  transcribed	  with	  the	  SuperScript	  III	  
First	   Strand	   Synthesis	   Kit	   (Life	   Technologies)	   according	   to	   the	  manufacturer’s	   instructions.	  
For	  this,	  RNA	  was	  mixed	  with	  random	  hexameric	  oligonucleotides	  as	  primers	  and	  dNTPs.	  The	  
samples	  were	  heat-­‐denatured	  at	  65°C	  and	  cooled	  on	  ice.	  For	  reverse	  transcription,	  200	  U	  of	  
SuperScript	  III	  reverse	  transcriptase	  and	  40	  U	  of	  RNaseOUT	  were	  used	  (final	  reaction	  volume	  
was	  20	  μl).	  Samples	  were	  incubated	  at	  25°C	  for	  10	  min,	  at	  50°C	  for	  60	  min,	  at	  85°C	  for	  5	  min	  
and	  cooled	  on	  ice.	  1	  μl	  of	  RNase	  H	  (Fermentas)	  was	  added	  and	  samples	  were	  incubated	  for	  
20	  min	  at	  37°C.	  The	  cDNA	  was	  stored	  at	  -­‐20°C.	  
4.2.15.  Microarray	  analysis	  
For	  finding	  putative	  target	  genes	  regulated	  by	  MatA	  or	  DctR,	  E.	  coli	  strain	  BW30270	  (S3839)	  
was	  transformed	  with	  either	  pKEDP30	  (MatA)	  or	  pKEDP31	  (DctR)	  respectively.	  From	  a	  fresh	  
overnight	  culture,	  15	  ml	  LB	  medium	  with	  Kanamycin	  was	  inoculated	  to	  an	  OD600	  =	  0.05	  and	  
incubated	  in	  a	  shaker	  at	  37°C	  until	  the	  culture	  has	  reached	  an	  OD600	  =	  0.3.	  At	  this	  point,	  IPTG	  
was	   added	   to	   a	   final	   concentration	   of	   1	   mM	   and	   the	   cultures	   were	   harvested	   after	   30	  
minutes	  further	   incubation	  using	  the	  RNAprotect	  Bacteria	  Reagent	  (Qiagen).	  The	  total	  RNA	  
was	  isolated	  as	  described	  above.	  As	  a	  control,	  the	  same	  procedure	  was	  done	  in	  parallel	  with	  
S3839	  harboring	   the	  empty	  control	  plasmid	  pKESK22	   instead	  of	  pKEDP30	  or	  pKEDP31.	  The	  
Microarray	  analysis	  was	  performed	  by	  the	  Cologne	  Center	  for	  Genomics	  with	  the	  Affymetrix	  
system	  (E.	  coli	  Genome	  2).	  Differential	  expression	  levels	  between	  sample	  and	  control	  were	  
calculated	  as	  fold	  change.	  
4.2.16.  qPCR	  analysis	  
RNA	  was	  isolated	  from	  cultures	  grown	  in	  LB	  medium	  containing	  antibiotics.	  At	  an	  OD600	  =	  0.3	  
IPTG	   (1	  mM	   final	   concentration)	   or	   arabinose	   (0.2	   %	   final	   concentration)	   was	   added,	   the	  
bacteria	  were	  harvested,	  and	  the	  total	  RNA	  was	  isolated	  as	  described	  above.	  The	  cDNA	  was	  
synthesized	  using	  the	  SuperScript	  III	  First	  Strand	  Synthesis	  Kit	  (Invitrogen)	  using	  1	  mg	  of	  RNA	  
and	   random	  hexameric	  oligonucleotides	  as	  primers.	  Quantitative	  PCR	  measurements	  were	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carried	   out	   using	   gene	   specific	   oligonucleotide	   primers,	   SYBR	  Green	   I	   	   and	   a	   C1000	   touch	  
thermalcycler	  with	  optical	  reaction	  module	  CFX96	  (Bio-­‐Rad).	  The	  cDNA	  derived	  from	  1	  mg	  of	  
total	   RNA	   was	   diluted	   1:10	   in	   DEPC-­‐treated	   water.	   For	   one	   assay,	   4	   ml	   of	   dNTPs	   (1	  mM	  
each),	  4	  ml	  of	  5x	  GoTaq	  buffer	  (Promega),	  6.8	  ml	  of	  DEPC	  treated	  water,	  0.8	  ml	  of	  DMSO,	  0.2	  
ml	  of	  SYBR	  green	  (1:1000	  in	  DMSO),	  0.2	  ml	  of	  GoTaq	  DNA	  Polymerase	  (Promega),	  and	  1	  ml	  
of	   each	   primer	   (10	   pmol/µl)	   were	   used.	   Two	   microliters	   of	   diluted	   cDNA	   served	   as	   the	  
template.	   Assays	   were	   pipetted	   on	   96-­‐well	   PCR	   plates	   and	   sealed	   with	   optical	   quality	  
adhesive	  film	  (Bio-­‐Rad).	  Samples	  were	  prepared	  in	  triplicate.	  For	  PCR	  efficiency	  correction,	  a	  
pool	   of	   cDNA	   samples	   served	   as	   calibration	   line.	   Gene	   rpoD	   served	   as	   reference	   for	   data	  
normalization.	   Data	   were	   analyzed	   with	   Bio-­‐Rad	   CFX	   Manager	   3.1	   Software	   applying	   a	  
normalized	  expression	  (ΔΔCt)	  algorithm.	  
4.2.17.  SDS	  PAGE	  and	  western	  blotting	  
The	  stability	  of	  RcsB	  mutant	  proteins	  was	  analyzed	  by	  western	  blot.	  For	   that	   reason	  ΔrcsB	  
strain	   T21	   was	   transformed	   with	   plasmids	   being	   able	   of	   IPTG	   inducible	   expression	   of	   C-­‐
terminally	   HA-­‐tagged	   RcsB	   mutants	   (pKEAP38,	   pKEDP1-­‐9).	   To	   estimate	   the	   RcsB	  
concentration	  in	  the	  cells,	  cultures	  were	  grown	  without	  induction	  of	  rcsB-­‐HA	  expression.	  At	  
OD600	   =	   0.3	   the	   first	   samples	   (1	   ml	   each)	   were	   harvested	   on	   ice.	   At	   the	   same	   time	   the	  
expression	   was	   induced	   by	   adding	   IPTG.	   The	   second	   sample	   was	   taken	   30	   minutes	   after	  
induction.	  Immediately,	  chloramphenicol	  (200	  μg/ml)	  was	  added	  to	  inhibit	  protein	  synthesis.	  
After	   further	   30	  minutes	   the	   third	   sample	  was	   taken.	   The	  OD600	  was	  documented	   in	   each	  
case.	  The	  1	  ml	  aliquots	  were	  centrifuged	  (1	  minute,	  13.000	  rpm),	  the	  supernatant	  discarded	  
and	  the	  pellet	  resuspended	  in	  appropriate	  volume	  of	  sample	  buffer	  (OD600	  x	  200	  =	  volume	  of	  
sample	  buffer	  in	  μl)	  or	  alternatively	  frozen	  at	  -­‐20°C.	  These	  samples	  were	  boiled	  for	  5	  minutes	  
at	  95°C,	  spun	  down	  and	  5	  or	  10	  μl	  per	  slot	  were	   loaded	  on	  15	  %	  polyacrylamide	  gels	   (5	  μl	  
LifeTechnologies	   Prestained	   Protein	   Ladder).	   The	   gels	  were	   run	   at	   100	  V,	   40	  mA	  until	   the	  
blue	  loading	  dye	  had	  reached	  the	  separation	  gel.	  At	  this	  point	  the	  voltage	  was	  increased	  to	  
150	  V	   for	  around	  1.5	  hours	  until	   the	  dye	  has	  reached	  the	  end	  of	   the	  gel.	  The	  blotting	  was	  
done	  on	  Nitrocellulose	  or	  PVDF	  membrane	  in	  a	  semi-­‐dry	  transfer	  chamber	  for	  at	  least	  1	  hour	  
at	  50	  V	  and	  0.8	  mA/cm2.	  Afterwards	  the	  membrane	  was	  rinsed	  with	  distilled	  water,	  blocked	  
for	  1	  hour	  at	  RT	  or	  overnight	  at	  4°C	   in	  TBS	  or	  PBS	  containing	  3-­‐5	  %	  skimmed	  milk	  powder.	  
The	  primary	  antibody	  staining	  occurred	  as	  listed	  below	  for	  at	  least	  1	  hour.	  After	  the	  primary	  
antibody	   staining	   the	  membrane	  was	  washed	   3	   x	   10	  minutes	   in	   TBS-­‐T	   or	   PBS-­‐T,	   the	   blot	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stained	  with	  secondary	  antibodies	  (see	  below)	  for	  1	  hour	  and	  washed	  again.	  The	  detection	  
was	   done	   according	   to	   the	   secondary	   antibodies	   with	   Odyssey	   (Li-­‐Cor)	   for	   fluorescence	  
coupled	  antibodies	  or	  with	  ImageQuant	  (GE	  Healthcare)	  for	  HRP	  coupled	  antibodies.	  Before	  
developing	   the	   blot	   by	   ImageQuant,	   the	   membranes	   were	   treated	   with	   ECL	  
chemiluminescence	  reagent	  from	  Pierce	  according	  to	  the	  manual.	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Table	  7.	  Western	  blot	  staining	  and	  developing	  conditions	  
	   HA	  tag	  staining	   Strep	  tag	  staining	   FLAG	  tag	  staining	  
Membrane	   Nitrocellulose	   Nitrocellulose	  or	  PVDF	  (activate	  
in	  MeOH)	  
Nitrocellulose	  
Blocking	   TBS,	  3%	  skimmed	  milk	  
powder,	  1	  h	  gently	  shaking	  
PBS,	  3	  %	  BSA,	  0.5	  %	  TWEEN	  or	  
PBS,	  1%	  skimmed	  milk	  powder	  
1	  h	  gently	  shaking	  
PBS,	  3%	  skimmed	  milk	  
powder,	  1	  h	  gently	  shaking	  
Washing	   	   3	  x	  for	  5	  min	  with	  PBS-­‐T	  (0,05%	  
Tween)	  
3	  x	  for	  5’	  with	  PBS-­‐T	  (0,05%	  
Tween)	  
1°	  Antibody	   rat	  anti	  HA	  in	  TBS,	  3%	  
skimmed	  milk	  powder	  
(1:500	  or	  1:1000)	  1	  h	  
gently	  shaking	  
StrepMAB	  classic	  HRP	  conj.	  in	  
PBS-­‐T	  (0,2%	  BSA,	  0,1%	  Tween)	  
(1:30.000)	  
	  
When	  blocking	  with	  milk	  
powder:	  add	  4	  µl	  undiluted	  
StrepMAB	  classic	  HRP	  conj.	  In	  
blocking	  buffer	  (1:4000)	  1	  h	  
gently	  shaking	  
anti	  FLAG	  polyclonal	  from	  
rabbit	  PBS,	  3%	  skimmed	  milk	  






Washing	   3	  x	  for	  10	  min	  with	  TBS-­‐T	   2	  x	  for	  1	  min	  with	  PBS-­‐T	  and	  2	  x	  
for	  1’	  with	  PBS	  
3	  x	  for	  5	  min	  with	  PBS-­‐T	  
2°	  Antibody	   rat	  anti	  HA	  (1:500	  or	  
1:1000)	  1	  h	  gently	  shaking	  
	   anti	  rabbit	  in	  PBS-­‐T	  (1:2000)	  
1	  h	  gently	  shaking	  
Washing	   Wash	  membrane	  3	  x	  for	  
10	  min	  with	  TBS-­‐T	  
	   3	  x	  for	  5’	  with	  PBS-­‐T	  (0,05%	  
Tween)	  
Detection	   Fluorescence	  detection	  
with	  Odyssey	  
Proceed	  to	  the	  chromogenic	  
reaction	  (Pierce	  ECL)	  
Fluorescence	  detection	  with	  
Odyssey	  
	  
4.2.18.  Strep-­‐protein	  interaction	  experiment	  (SPINE)	  
For	   analyzing	   the	   interaction	   of	   proteins	   the	   SPINE	   (Strep-­‐Protein-­‐Interaction-­‐Experiment)	  
method	  according	  to	  (Herzberg	  et	  al.,	  2007)	  was	  applied.	  For	  this	  purpose	  ΔrcsB	  strain	  (T73)	  
was	   transformed	   with	   two	   different	   low-­‐copy	   expression	   vectors.	   One	   harboring	   an	   HA	  
tagged	  RcsB	  version,	  the	  other	  one	  the	  Strep	  tagged	  dimerization	  partner.	  In	  brief,	  1	  liter	  LB	  
medium	  containing	  the	  appropriate	  antibiotics	  was	  inoculated	  with	  a	  fresh	  overnight	  culture	  
of	   the	   transformants.	   This	   culture	   was	   incubated	   in	   a	   shaker	   at	   37°C	   until	   the	   OD600	   has	  
reached	  0.8.	  At	   this	   time	  point	   the	   induction	  of	   rcsB	   expression	  was	   induced	  with	   IPTG	   (1	  
mM	   final	   concentration)	   and	   further	   incubated	   for	   1	   hour.	   Then	   the	   crosslinking	   agent	  
formaldehyde	  was	   added	   (0.4	  %	   final	   concentration)	   and	   the	   incubation	   continued	   for	   20	  
minutes.	  After	  harvesting	  the	  cells	  on	  ice	  they	  were	  centrifuged	  (5000	  rpm,	  15	  minutes,	  4°C),	  
resuspended	   in	  15	  ml	  ZAP	  buffer,	  again	  centrifuged,	   resuspended	   in	  15	  ml	  ZAP	  buffer	  and	  
disrupted	  with	  an	  EmulsiFlex	  french	  press.	  The	  crude	  extracts	  were	  centrifuged	  for	  1	  hour	  at	  
19.000	   rpm	  and	   the	  obtained	  protein	   lysates	   loaded	  onto	  a	  Streptactin	  Sepharose	  column	  
(IBA	  Lifesciences)	   to	   isolate	  the	  cross-­‐linked	  protein	  complexes.	  The	  columns	  were	  washed	  
86	  
	  
four	  times	  with	  10	  ml	  washing	  buffer	  and	  eluted	  with	  three	  times	  1	  ml	  elution	  buffer.	  The	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